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ABSTRACT 
The series of experiments described in this thesis examine two relatively unexplored 
aspects of the exercise response in patients with chronic obstructive pulmonary 
disease (COPD), namely respiratory muscle performance and whole body endurance 
exercise. 
Incremental threshold loading (ITL) was used to examine respiratory muscle 
performance. The technique imposes a threshold load to inspiration which must be 
overcome prior to the onset of airflow. An electronic solenoid valve was used to 
impose standardised increments in threshold load in 12 patients with moderately 
severe COPD. The peak mouth pressure (peak Pm) and pressure-time product (iPdt) 
were assessed and found to be repeatable after one rractice test (mean differences 
(SE) between tests were 0.4 (2.3) cm H20, and 110 (201) cmH 20.s·' respectively). 
Using the solenoid valve, ITL was quick and simple to perform and acceptable to the 
majority of patients. 
The respiratory muscle performance was reduced in the patients examined, and 
though the external work achieved was repeatable (Le. peak Prn and jPdt) the internal 
work, reflected by the cardio-respiratory response to the test, was more variable. The 
VO, and V E attained at peak Pm were (mean (SD)) 367 (65) ml.min·' and 24.2 (6.2) 
l.min·' respectively. The ITL provoked a small increase in blood lactate concentration 
(mean increase 0.32 (0.21) and 0.15 (0.24) mmol.r', at 2 and 4 min post test). 
The ITL was compared to treadmill exercise in the same group of patients. The 
oxygen cost of the ITL test was high and equated to 30% of the VO,,"k' whilst the 
ITL blood lactate response equated to 40% of the whole body response. There was 
a significant relationship between peak Pm and treadmill exercise ventilation (r=0.702, 
p<0.025). This relationship improved following a bronchodilator, as did the exercise 
ventilation and VO, (during both ITL and whole body exercise). However, there were 
no significant improvements in the external work achieved (treadmill time, peak 
threshold load or shuttle distance walked). This suggested factors additional to the 
ventilatory limit were important in the exercise limitation in COPD e.g. deconditioning. 
This finding, in addition to the improved relationship between the components of the 
exercise response (respiratory muscle performance and exercise ventilation), 
suggested exercise training could be introduced to maximise the bronchodilator 
changes and address the possibility of deconditioning. 
In order to assess the effects of exercise training in COPD, a standardised field test for 
the assessment of endurance capacity was developed. The test was complementary 
to the incremental shuttle walk test (ISWT), incorporating a 10 m shuttle circuit, and an 
audio-signal to control pace. The exercise intensity was determined from the individual 
maximal performance achieved during the ISWT. The endurance field test performance 
was assessed in 10 patients with COPD at 3 levels of exercise intensity, which 
related to 75%, 85% and 95% of the V02 ... k predicted from the ISWT. The endurance 
field test performance was compared to the laboratory assessment of endurance, and 
was found to provoke similar heart rate responses and subjective ratings of 
breathlessness and exertion. 
The field test was repeatable after one practice walk (mean difference (SE) 15 (6) s, 
between tests 2 and 3). To assess the sensitivity of the test, and the effects of an 
intervention, 19 patients with COPD underwent a course of pulmonary rehabilitation. 
Endurance capacity was not significantly different at the start and end of a 5 week 
control period (mean difference(SE) 4 (10) s), however following rehabilitation there 
were substantial improvements in endurance capacity (419(71 )s, 160% improvement). 
The endurance shuttle walk test was simple to perform, and possessed good 
repeatability and sensitivity to the therapeutic intervention. The test was 
complementary to the incremental shuttle test and did not involve additional resources, 
apart from a set of pre-recorded cassette tapes. The intensity of the endurance 
exercise was easily determined from the VO,,"k predicted from the ISWT. 
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Chapter 1 
INTRODUCTION 
The series of studies reported in this thesis are concerned with two 
important, though relatively neglected, aspects of the exercise response in 
chronic obstructive pulmonary disease (COPD), namely respiratory muscle 
performance and whole body endurance exercise. Exercise performance 
and respiratory muscle function are affected adversely by COPD, thus 
objective assessment which is sensitive and reliable is important for the 
evaluation of disability and for monitoring disease progression. Both 
respiratory muscle performance and the whole body endurance response in 
COPD are still poorly understood, therefore additional physiological 
characterisation and the development of new assessment methods will 
assist in the application of appropriate and effective treatment regimens. 
Dynamic hyperinflation of the lungs during exercise is common in patients 
with moderate and severe COPD (Gibson 1996) and imposes an additional 
burden on the respiratory muscles. Changes in dynamic hyperinflation 
(assessed from changes in end-inspiratory lung volume) were found to be 
important determinants of exercise breathlessness in patients with moderate 
to severe COPD (O'Donnell 1993, Belman 1996). Thus the response of the 
respiratory muscles may constitute an important component of the whole 
body exercise response in COPD. Decramer (1994) suggests respiratory 
muscle endurance may have a significant role in the ventilatory limitation 
during exercise. Since many existing pharmacological and exercise training 
interventions have the potential to affect both respiratory muscle and whole 
body exercise performance, suitable objective measurements, which 
possess specificity and sensitivity to change, are important in the 
assessment and clinical management of patients with COPD. 
Assessment of how the respiratory muscles respond to an additional 
inspiratory load, similar to that encountered from dynamic hyperinflation 
during exercise, is desirable. A simple and reliable test to enable the 
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objective measurement of dynamic performance would help establish the 
degree of impairment, monitor disease progression and assess therapeutic 
intervention. The technique of incremental threshold loading (ITL) provides 
the opportunity to determine respiratory muscle strength and endurance, 
under dynamic conditions, in response to standardised increments in 
respiratory muscle work rate. The standardised, incremental nature of the 
applied work rate is analogous to an incremental and progressive whole 
body exercise test. As such, ITL would also allow the examination of the 
cardio-respiratoryand metabolic responses to the respiratory exercise. 
The first two experimental chapters of this thesis examine ITL in a group of 
patients with COPD. The threshold load was imposed by a recently 
developed electronic solenoid device. The fundamental questions examined 
by the study were: 1) can the solenoid valve device provide a simple, 
repeatable and well tolerated method of assessing respiratory muscle 
performance in patients with COPD? 2) How do the measurements of ITL 
relate to other, more conventional measures of exercise performance? 3) 
can the measurement of respiratory muscle performance reflect changes 
associated with a common therapeutic intervention used in this patient 
group? 
The first study describes the use of ITL in a group of patients with moderate 
to severe COPD. In addition to the descriptive purpose of the study, the aims 
were to quantify the repeatability of the test, and determine the cardio-
respiratory and metabolic response to the task. The clinical relevance of ITL 
is largely unclear. How it relates to other tests of physical performance and 
measures of functional capacity is therefore important in understanding the 
measurement and its appropriate clinical application. Additionally, the 
sensitivity of the test is important, since any measurement which proves 
insensitive to change will have limited application. In order to address these 
two issues, the group of patients from the first part of the study performed 
additional tests of whole body exercise, and repeated all tests following a 
single dose of an inhaled bronchodilator. The study was carried out in a 
2 
double-blind, randomised, cross-over manner with nebulised placebo and 
ipratropium bromide. The purpose of the second part of the study was to 
examine how ITL related to conventional measurements of whole body 
exercise performance, and to determine the test sensitivity to the intervention 
of an inhaled bronchodilator. 
The intervention of the inhaled bronchodilator revealed two important 
changes in the exercise response of this patient group, namely a closer 
coupling of events contributing to the exercise performance, i.e. respiratory 
muscle performance and exercise ventilation, and increases in the exercise 
ventilatory capacity during both the whole body and respiratory muscle 
exercise (ITL). However these improvements were not accompanied by any 
significant increases in the peak exercise work rates. The finding that 
isolated improvements in the ventilatory capacity do not lead to 
improvements in the exercise capacity of patients with COPD, suggested 
other therapeutic interventions, such as exercise training, could be 
introduced in order to maximise these improvements. In addition, the oxygen 
cost of the ITL test was found to constitute a large proportion of the maximum 
oxygen consumption in this patient group, which emphasised the need to 
introduce treatment strategies to optimise energy efficiency during physical 
exertion. The results of the second study therefore suggested additional 
investigations of the whole body exercise response and the role of exercise 
training in CO PD. Thus the remaining experimental chapters of the thesis 
examine whole body endurance capacity in COPD, with the development of 
a standardised field test of walking endurance and an examination of the 
effects of an exercise training intervention (pulmonary rehabilitation) in this 
patient group. 
Field based walking tests are popular assessment methods of exercise 
performance in COPD. The 12 and 6 minute walking tests (McGavin 1976, 
Butland 1982) are self-paced and measure the distance covered in a 
prescribed time. Recently a standardised, incremental and externally paced 
field walking test has been described (Singh 1992). Although limited in the 
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amount of physiological information which may be collected, field tests have 
a number of advantages which make them attractive as an alternative, or an 
adjunct to laboratory based clinical exercise tests. They are quick and simple 
to perform, and are less costly than laboratory tests requiring only minimal 
equipment and a single operator. They employ a universal mode of exercise 
- free walking, and the absence of complex equipment and robust exercise 
machines make them less daunting for the patient, and free from the 
apprehension which may lead to under-performance. However there are 
concerns with the performance of the self-paced field tests. A number of 
studies have demonstrated the effects of operator encouragement (Guyatt 
1984), learning effects from repeat measurement (Knox 1988) and the 
effects of attitudes a~d beliefs on performance (Morgan 1983). Additionally 
the prescribed time limit may influence performance (individual judgement of 
walking pace) and compromise the nature of the test in reflecting endurance 
capacity. 
The development of the shuttle walking test (Singh 1992) addressed a 
number of the concerns associated with the self-paced tests. It has a 
standardised walking pace and clearly defined end-points. It is less variable 
on repeat testing and requires only one practice walk. The standardised 
walking pace of the test will act to improve intra- and inter-subject 
comparison. The work rate is incremental and as such provides a measure 
of symptom limited maximal exercise capacity. However, a number of studies 
have demonstrated endurance capacity is particularly sensitive to 
interventions of both high and low intensity exercise training in COPD (Holle 
1988, Niederman 1991, Punzal 1991, Singh 1996). Thus, there existed a 
strong argument for the development of a standardised, constant-paced field 
endurance test for the assessment of exercise training interventions in 
patients with COPD. 
The aims of the third and fourth experimental studies were to: 1) develop a 
standardised, constant-paced, field walking test to assess endurance 
capacity in patients with COPD; 2) examine the cardio-respiratory and 
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metabolic responses to different intensities of endurance exercise in COPD; 
3) assess the validity of the field test against the laboratory based 
assessment of endurance capacity. The purpose of the field test 
developmental study was to design a test which complemented the shuttle 
walk test, where the maximal performance achieved during the incremental 
shuttle test would determine the exercise intensity of the endurance field test. 
Additionally, the new test would be externally paced, utilise the same 10 rn 
shuttle course and use an audio signal to control walking speed. The test 
would allow endurance capacity to be assessed to a constant walking pace 
without a prescribed time limit. 
In order to explore the cardio-respiratory and metabolic responses to 
endurance exercise, and assess the validity of the new field test against 
conventional measures of exercise performance, patients were also required 
to walk at a constant pace on a treadmill. Three different intensities of 
exercise were examined, which related to 75%, 85% and 95% of the 
individual V02peak. In comparing the patients performance during the field 
endurance test against the laboratory based assessment it was possible to 
reveal if the field test was a valid indicator of endurance capacity. 
The final study of the thesis examines an intervention of pulmonary 
rehabilitation on the endurance capacity in this patient group. Any new test 
will be of limited value if it lacks sensitivity to change. Therefore the 
sensitivity of the newly developed field test was examined in a group of 
patients following a 7 week course of pulmonary rehabilitation. In order to 
incorporate a control period, patients were recruited 6 to 8 weeks prior to 
their commencement of the Hospital rehabilitation course, which contained 
educational and exercise training components. The endurance field test was 
performed at the start of the control period (no change to usual treatment), 
and repeated at the start and end of the rehabilitation course. Additionally, 
the between day repeatability of the test was assessed. 
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1.1 Organisation of the thesis 
There are five experimental chapters in this thesis. The first two chapters 
examine incremental threshold loading as a measure of respiratory muscle 
performance in a group of patients with COPD. Chapter 4 describes the 
technique and the cardio-respiratory and blood lactate response to the test. It 
also examines the repeatability of the test. Chapter 5 examines how ITL 
relates to conventional measures of whole body exercise, and the effect of 
an inhaled bronchodilator on the outcome of the test. 
The following experimental studies examine the measurement of whole 
body endurance exercise in COPD. Chapter 6 describes the development of 
a standardised field test for the assessment of endurance capacity. In order 
to describe the cardia-respiratory and metabolic changes associated with 
endurance exercise in COPD, the same group of patients from the 
developmental study underwent laboratory assessment of endurance 
exercise. This also enabled the relationships between the field and treadmill 
responses to be examined. The results from this study are presented in 
chapter 7. 
Finally, in order to evaluate the sensitivity of the field test to a cli n ical 
intervention, and to quantify the short term variability of the test an exercise 
training study was undertaken. Patients were assessed at the start and end 
of a control period, and following a 7 week course of pulmonary 
rehabilitation. The findings of this study are described in chapter 8. 
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Chapter 2 
REVIEW OF THE LITERATURE 
2.1 INTRODUCTION 
The general aim of this thesis was the development of simple assessment 
methods to examine two relatively unexplored components of the exercise 
response in COPD, namely respiratory muscle performance and endurance 
exercise. One of the principal symptoms of COPD is breathlessness, which 
increases progressively with disease severity. With increasing dyspnoea, 
patients tend to avoid exertion and enter into what Young (1983) defines as 
a 'dyspnoea spiral' where deconditioning occurs as a result of adopting a 
more sedentary lifestyle. Exercise imposes an additional ventilatory burden 
to the already compromised respiratory muscle function (Belman 1993) 
whilst the development of dynamic hyperinflation, during exercise, has been 
identified as a key determinant of exercise dyspnoea (O'Donnell 1993). 
Whilst there is increasing interest in the role of the respiratory musculature 
during exercise, and evidence of deconditioning and peripheral muscle 
weakness, tests of respiratory muscle performance are poorly understood 
and not widely applied. Additionally, there is a lack of concensus concerning 
the most appropriate methods for the assessment of the whole body exercise 
response and therapeutic interventions, such as pulmonary rehabilitation. 
The term COPD covers a spectrum of symptoms and pathological change 
within the lungs, therefore the first part of this review describes the pathology 
of the disease. Additionally, the risk factors and aspects of clinical 
management are considered. A wide range of clinical measurements may 
be applied in the diagnosis, and assessment of the functional abnormalities 
arising from the condition. The measurements most relevant to the 
experimental work of the thesis, namely the assessment of exercise capacity 
and respiratory muscle performance, will be considered in detail. 
Throughout this review the rationale for the experimental work will be 
developed. 
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2.2 PATHOLOGY 
2.2.1 Terminology 
Diseases of the chest may be classified into two broad physiological 
categories: 1) restrictive i.e. restrict lung expansion either as a result of 
changes to the lung parenchyma or changes to the thoracic cage; 2) 
obstructive i.e. obstruct airflow as a result of changes to the airways. Within 
the obstructive classification are three main pathological types, though 
patients may demonstrate a combination of changes. The major conditions 
associated with the obstructive classification are asthma, chronic bronchitis 
and emphysema. 
A consensus to adopt a single term to embrace all three conditions does not 
exist at present. Asthma remains largely distinct whilst chronic obstructive 
airways disease (COAD), chronic obstructive pulmonary disease (COPD) 
and chronic obstructive lung disease (COLD) are used synonomously for 
chronic bronchitis with airflow obstruction and for emphysema. The 
experimental work contained within this thesis is concerned with the 
exercise performance of patients with chronic bronchitis with airflow 
obstruction, and patients with emphysema, and the term COPD is adopted 
throughout. 
2.2.2 Chronic obstructive pulmonary disease 
Chronic obstructive bronchitis is primarily a disease of the airways, with 
changes in the larger airways (> 2 mm in diameter) a predominant feature. 
Lesions in the small airways « 2 mm) are increasingly recognised in the 
early stages of the disease, and are a major feature of mild airflow 
obstruction. Alternatively, emphysema is considered a disease of the 
parenchyma (gas exchanging tissue) and is defined as permanent, 
abnormal enlargement of the airspaces distal to the terminal bronchioles 
accompanied by destruction of their walls and without obvious fibrosis 
(American Thoracic Society (ATS) 1995). In most patients with chronic 
obstructive bronchitis there may be varying degrees of emphysema since 
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tobacco smoke is the common (though not necessarily the exclusive) trigger 
to both conditions. 
Chronic obstructive bronchitis 
The Lancet (Editorial 1965) published a statement from the Medical 
Research Council outlining the definition and classification of chronic 
bronchitis based on the outcome of a key symposium in 1958 (Ciba 
Symposium 1959) and work from the previous decade. The statement 
included a definition for chronic obstructive bronchitis:- 'chronic bronchitis in 
which there is persistent, widespread narrowing of the intra-pulmonary 
airways, at least on expiration, causing increased resistance to airflow'. The 
term chronic bronchitis is used to denote chronic or recurrent bronchial 
mucus hypersecretion for 3 months or more in each of two successive years 
when other causes have been excluded (Editorial 1965). More recent 
statements from the American Thoracic Society (1995) define COPD as a 
disease state characterised by the presence of airflow obstruction due to 
chronic bronchitis or emphysema; the airflow obstruction is generally 
progressive, may be accompanied by airway hyperactivity, and may be 
partially reversible. 
The pathological changes associated with chronic obstructive bronchitis 
include hypertrophy of the mucus secreting glands mainly in the larger 
bronchi with increased numbers of mucus secreting cells (goblet cells) within 
the walls of the gland (Seaton 1989). There is strong evidence the small 
airways « 2 mm in diameter) are particularly affected in the early stages of 
the disease (Thurlbeck 1990). Inflammatory processes are present in the 
respiratory bronchioles, and there may be varying degrees of mucus 
plugging, globlet cell metaplasia, increased smooth muscle and fibrotic 
changes in bronchioles less than 2 mm in diameter. The pathological 
changes are progressive, and associated with increasing functional 
impairment. 
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The concept of small airways disease was described by Hogg (1968) who 
proposed the bronchioles (or small airways) as the main site of increased 
airflow resistance. Additionally, lesions within the small airways are believed 
to be the most important cause of mild chronic airflow obstruction (Thurlbeck , 
1990). However, Thurlbeck emphasises the lesions that are important in mild 
airflow obstruction may not be important in patients with severe COPD, and 
other (rare) forms of bronchiolitis (inflammation of the small airways) are 
associated with irritants other than tobacco smoke. 
The functional consequences of the changes associated with chronic 
obstructive bronchitis are narrowing of the lumen of the airways due to the 
excess mucus, and thickening of the airway walls due to enlarged glands, 
inflammatory oedema and increased amounts of airway smooth muscle. The 
narrowing of the airways leads to increased airflow resistance thus imposing 
a greater resistive load to breathing. In addition, the obstructed airways lead 
to gas trapping and hyperinflated lungs which imposes a greater mechanical 
load to breathing. Increased airway reactivity may be present in a significant 
number of patients, Thurlbeck (1990) suggests this may be present in 25% of 
patients, although estimates vary. 
Chronic cough and persistent sputum expectoration are the major features. 
Most patients have a history of smoking. Sputum is usually mucoid but 
becomes purulent with an exacerbation. Exacerbations of the disease occur 
more frequently as the disease progresses, and are associated with 
increased and .purulent sputum, increased cough, wheeze and dyspnoea. In 
the later stages of the disease increasing dyspnoea is a feature, initially 
associated with exertion. Hypercapnia may develop with increasingly severe 
hypoxemia when central cyanosis is apparent. Polycythaemia may be 
present when there is long standing hypoxaemia. Cor pulmonale with right 
heart failure and oedema can often develop during an exacerbation or 
infection, though it may persist and become a chronic feature. There appears 
to be a spectrum of response to the occurrence of hypoxia, with those most 
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sensitive developing pulmonary hypertension and right heart failure early on 
in the disease (Seaton 1989). 
Respiratory muscle function is often compromised from a combination of 
factors including the increased resistive and mechanical loads, changes in 
muscle configuration as a result of lung hyperinflation, muscle weakness 
from malnutrition and possibly, in some cases, muscle fatigue (Rochester 
1991). Airway resistance is elevated in both inspiration and expiration. The 
expiratory airflow limitation causes airtrapping and is responsible for most of 
the hyperinflation. Rochester (1991) notes both residual volume (RV) and 
functional residual capacity (FRG) are often markedly increased (e.g. to 70% 
and 85% of predicted total lung capacity (TLG) respectively), thus patients 
breathe at much higher lung volumes than healthy individuals, where FRG is 
more usually < 50% of TLG. The forced expiratory volume in one second 
(FEV1) is reduced as a result of the narrowed airways and increased 
resistance, the reduction increasing with the severity of the disease. Since 
smoking is a significant factor in the development of chronic obstructive 
bronchitis and emphysema, many patients with chronic obstructive bronchitis 
may have coexistent emphysematous changes. These changes can only be 
quantified at post mortem, although lung function measurements may reveal 
gas exchange and blood gas abnormalities commonly associated with the 
condition. 
Emphysema 
Emphysema is defined in structural or pathologic terms, and is characterised 
by abnormally large airspaces and destruction of the alveolar walls and 
capillary bed, which consequently leads to a reduction in the gas 
exchanging capacity and elastic recoil properties of the lung. Individuals with 
genetically inherited alpha-1-antitrypsin deficiency are particularly 
susceptible to emphysema if they smoke. Alpha-1-antitrypsin modulates the 
activity of some of the protease enzymes, which are responsible for tissue 
degradation (Thurlbeck 1990). Without protease inhibition there would be 
widespread tissue damage. In the healthy, non smoking individual there is 
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usually a balance between protease activity and inhibition from 
antiproteases. In some individuals alpha-1-antitypsin is deficient, and the 
normal protease activity overwhelms any anti protease activity. In smokers 
protease production is increased, which will greatly aggravate the problems 
in antiprotease deficient individuals. Smoking is the greatest risk factor to the 
development of acquired emphysema, and to a lesser extent occupational 
dust exposures. 
There are three commonly recognised forms of emphysema identified from 
the primary location of the pathological changes and these are described by 
Thurlbeck (1990) as follows: panacinar emphysema where the abnormally 
large airspaces are found evenly distributed across the acinar units; 
centriacinar emphysema where the abnormal airspaces are found initially in 
association with the respiratory bronchioles; and paraseptal emphysema 
where the abnormal airs paces run along the edge of the acinar unit where it 
abuts a fixed structure. Additionally emphysematous changes may be 
associated with the margins of a pre-existing scar. Larger air-filled spaces (> 
1 cm3 ) which may form from areas of overdistended emphysema are termed 
bullae. The common types of emphysema (panacinar and centriacinar) have 
differing distributions within the lung. Pan acinar is found in both the upper 
and lower lobes and tends to be maximal at the base where it is associated 
with alpha-1-antitrypsin deficiency, whilst centriacinar tends to be located in 
the upper zones of both the upper and lower lobes. 
In the emphysematous lung there is a loss of elastic recoil and therefore a 
reduction in expiratory pressure and increased resistance as a result of the 
loss of support for the surrounding lung which then encroaches on the 
airway lumen (Pare 1991). With the increased airway resistance there is 
usually an accompanying reduction in expiratory airflow. The loss of elastic 
recoil and increased airway resistance leads to gas trapping (hyperinflation) 
and an increase in the TLC, and to a greater extent the subdivisions RV and 
FRC (Gibson 1996). With increasing loss of elastic recoil, forced expiration 
may cause premature airway collapse trapping gas beyond the collapsed or 
12 
narrowed airway segment, in which case the forced vital capacity (FVC) is 
reduced (Pare 1991). The vital capacity (VC) measured under relaxed 
conditions will often yield a larger volume than the FVC. The increased 
airway resistance and hyperinflated lungs lead to an increase in the work of 
breathing, and total respiratory muscle oxygen consumption may be 10 to 20 
times the normal values (Rochester 1979). 
The loss of alveoli in emphysema leads to a decrease in transfer factor whilst 
the maldistribution of inspired gas and blood flow are important 
consequences of the disease process. Mismatching of ventilation and blood 
flow (\//0. mismatch) lead to reductions in gas exchange, which may be 
reflected in abnormal blood gases (Belman 1993). Regions of wasted 
ventilation (limited or no blood perfusion) are referred to as deadspace, and 
the deadspace to tidal volume ratio (VdNt ratio) is increased. Areas of 
perfusion in excess of ventilation lead to a reduction in the mixed venous 
Pa02 • There may be varying degrees of both wasted ventilation and wasted 
perfusion present (Bel man 1993). 
The main symptom of emphysema initially noticed by the patient is usually 
shortness of breath. Cough and sputum may be present but are usually 
associated with coexistent chronic bronchitis. Reduced body weight is often 
present. Common signs of the disease are low body weight, obvious 
dyspnoea, pursed lip expiration, use of accessory respiratory muscles, 
hyperinflated chest, and diminished breath sounds though some expiratory 
wheezes may be heard on forced expiration (Seaton 1989). 
2.2.3 Risk factors for COPD 
There are a number of risk factors associated with the development of 
COPD. Tobacco smoke is the single most important risk factor in adult life 
whilst passive smoking in utero and during childhood results in diminished 
lung function (Hanrahan 1992). The association between early childhood 
respiratory infections (especially lower respiratory tract infections) and the 
13 
development of COPD in later life is unclear. The message is confounded by 
environmental tobacco smoke exposure and lung function development in 
infancy (Tager 1993). 
Atmospheric pollution was the major factor in the increase of mortality from 
chronic respiratory illness during the notorious London smog episode of 
1952. This led to changes in legislation governing atmospheric pollution and 
a gradual decrease in both industrial and domestic smoke emissions. The 
relationship between sulphur dioxide and airborne particulates, so called 
'black smoke', and increases in morbidity amongst adult patients with 
chronic respiratory illness led the World Health Organisation in 1992 to issue 
guidelines on the concentrations which might be expected to trigger such 
increases. Additionally the so-called 'summer' pollutants are beginning to 
receive attention. These are commonly the photochemical pollutants 
occurring around urban areas during periods of bright sunshine (e.g. ozone, 
nitrogen oxides and acid aerosols). However work has tended to focus on 
the effects on patients with asthma, and there is little evidence so far 
concerning the risk for people with COPD. 
Chronic bronchitis is more prevalent in workers exposed to either inorganic 
or organic dusts or to noxious fumes (Seaton 1989). Focal dust emphysema 
is found in coal miners where coal dust deposits in the lung are incorporated 
into macrophages and aggravated in the respiratory bronchioles. Intense 
exposure may lead to accumulation of dust around the lobular pulmonary 
arterioles and veins (Morgan 1991). In non-smoking coal miners there is an 
increased prevalence of bronchitis, with an increasing gradient of 
occurrence in increasingly dusty conditions. In miners who smoke the effects 
of dust versus smoking cannot be distinguished, both dust and smoking 
increase bronchial gland dimensions, with mucus hypersecretion and 
increased cough and expectoration (Morgan 1991). 
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2.3 RESPIRATORY MUSCLE PERFORMANCE IN COPD 
2.3.1 Normal function 
To appreciate the changes in the mechanical properties of the respiratory 
system and the disturbances in respiratory muscle function as a result of 
COPD the following is a brief overview of the sequence of events which take 
place during breathing in the healthy individual. 
During rest the diaphragm is the most important inspiratory muscle. 
Anatomically, the structure of the muscle may be described in terms of a 
central tendon and muscular domes with attachments to the lower six ribs, to 
the xiphisternum and pericardium, and, via the arcuate ligaments and 
diaphragmatic crura, to the lumber vertebrae (Gibson 1989). The muscle 
separates the thoracic from the abdominal cavity. The level of the diaphragm 
varies with posture, it is at its highest in the chest when supine, and assumes 
a slightly lower position when standing. 
During inspiration the muscle fibres shorten and the diaphragm moves 
downward. The changes in muscle length are accommodated mainly by 
increasing and decreasing the area of the upper surface of the diaphragm in 
direct contact with the inner surface of the ribcage. This is known as the area 
of apposition, where the lower ribcage is expanded as a result of the 
insertion of the diaphragm into the ribcage, and the changes in abdominal 
pressure as a result of diaphragm descent (Gibson 1996). During inspiration 
abdominal pressure increases and pleural pressure decreases (becomes 
more negative). Air enters the lungs as a result of the decrease in pleural 
pressure. 
To achieve inspiration the diaphragm has to overcome a number of 
impedances to move the chest wall. These consist mainly of the elastic 
resistance of tissue and the alveolar gas/liquid interface and the frictional 
resistance to gas flow (Nunn 1987). The more minor sources of impedance 
arise from the inertia of gas and tissue and the friction of tissue deformation. 
Quiet expiration is a passive mechanism, the result of inspiratory muscle 
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relaxation and the elastic recoil of the respiratory structures and the surface 
tension forces at the gas/liquid interface within the lungs. The compliance of 
the respiratory system is described in terms of the change in lung volume per 
unit change in transmural pressure (1. kPa·1) and is the reciprocal sum of the 
compliance of the lungs and of the thoracic cage (ribcage and diaphragm). 
Factors affecting compliance are lung volume (and recent ventilatory 
history), pulmonary blood volume, age and disease. The neutral position of 
the respiratory system, where the inward acting deflationary forces (elastic 
recoil) within the lungs are counter-balanced by the outward recoil of the 
thoracic cage, occurs at end-expiration and the lung volume approximates 
the functional residual capacity (FRC). In paralysis the true relaxation volume 
(Vr) is approximately 400 ml lower than FRC, with diaphragmatic muscle 
tone accounting for the difference in volumes (Nunn 1987). 
The main determinant of the resistance to airflow is the lumen size of the 
branching airways. Airway patency is regulated via the parasympathetic 
nervous system controlling bronchomotor tone. Resistance to airflow can be 
assessed by the simultaneous measurement of gas flow and the driving 
pressure gradient (usually alveolar pressure assessed from intrathoracic 
pressure changes) though more usually resistance is inferred from timed-
volume measurements (e.g. FEV1) and expiratory gas flow (Nunn 1987). 
Although the diaphragm is responsible for the greater part of inspiration at 
rest, other muscles, termed the accessory muscles of respiration, show 
electrical activity during various stages of respiration. Rhythmic electrical 
activity has been recorded from the anterior and medial scalene muscles in 
the neck, and from the inspiratory intercostal muscles during rest (Gibson 
1989). The scalene muscles help to fix the first and second ribs and assist in 
upper rib elevation. During deep or forced inspiration the diaphragm 
contracts maximally and an increasing number of intercostal muscles are 
recruited in addition to the scalene muscles and the sternomastoids. Other 
muscles, recruited to varying degrees depending on the level of ventilation, 
include the erectores spinae, latissimus dorsi, the pectoral muscles and the 
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serratus anterior (Gibson 1989). Forced expiration is associated with 
contraction of the expiratory intercostal muscles and the muscles of the 
abdominal wall. The anteriolateral muscle group of the abdominal wall is 
able to compress the abdominal viscera and the external oblique muscles 
are able to depress and compress the lower part of the thorax so fu rther 
aiding expiration (Gibson 1989). 
Measurements of respiratory muscle strength are based on the assessment 
of inspiratory and expiratory pressure generation, and may be divided into 
those which assess global function reflecting the contraction of most or all of 
the respiratory muscles, and measurements which specifically isolate 
diaphragm function. Additionally measurements are made during periods of 
airflow (dynamic) or no airflow (static). The measurement of mouthpressure 
during maximal inspiratory (Plmax) or expiratory (PEmax) efforts against an 
occluded mouthpiece is the simplest measure of global muscle strength. 
The pressure difference across the diaphragm (transdiaphragmatic 
pressure, Pdi) is assessed from the pressure differential which exists 
between the oesophagus and the abdomen. Pleural pressure is estimated 
from an oesophageal balloon catheter, and abdominal pressure from a 
catheter positioned in the stomach. Milic-Emili (1964) recorded an inverse 
relationship between Pdi and lung volume, and Pdi should always be 
expressed at the lung volume at which it is measured. Expiratory pressures 
assessed at TLC include the forces exerted by the elastic recoil of the 
respiratory system, and conversely inspiratory pressures assessed at RV will 
include elastic inflationary forces. These effects will be minimised for 
measurements at FRC. Maximal diaphragmatic strength may be assessed 
from a variety of voluntary manoeuvres which vary in complexity e.g. the 
M [j lIer manoeuvre and short sharp nasal sniffs. Electrical, or magnetic 
stimulation of the phrenic nerve provides a measure of involuntary 
diaphragmatic contraction (twitch Pdi), and thus avoids interference from 
other muscle activity. 
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2.3.2 Respiratory muscle dysfunction in COPD 
The function of the respiratory muscles is profoundly disturbed in COPD 
(Rochester 1979). Increases in airway resistance, decreases in dynamic 
compliance and loss of elastic recoil lead to hyperinflation of the lungs and 
chest wall which greatly increases the work of breathing (Pride 1995). As a 
consequence of lung hyperinflation the inspiratory muscles, especially the 
diaphragm, are shortened and the curvature of the diaphragm is reduced 
(Le. assumes a flatter position). This results in the inspiratory muscles 
assuming a disadvantageous position on the length-tension curve, such that 
the maximum pressure developed during inspiration is substantially reduced 
(Rochester 1979). In addition the zone of apposition is decreased, thus the 
ability of the diaphragm to expand the ribcage is reduced. As a consequence 
patients with COPD show increased use of ribcage muscles and the 
inspiratory accessory muscles e.g. the sternomastoid, which becomes more 
pronounced during periods of increased ventilation (Gibson 1996). 
The effects of lung hyperinflation on respiratory muscles other than the 
diaphragm appear to be less profound. X-ray studies and skeletal muscle 
measurements have revealed a degree of shortening (5 to 8%) in the 
scalene muscles, the sternomastoids and the external intercostals compared 
to healthy control subjects, but this is markedly less than the 30 - 40 % 
shortening found in the diaphragm (Sharp 1986). In addition animal studies 
indicate the diaphragm bears a much higher fraction of the increased work 
load than do the other respiratory muscles. Using a series of inspiratory 
resistances in canines Robertson (1977) was able to demonstrate large 
increases of blood flow and oxygen consumption by the diaphragm 
compared to much smaller changes found in the intercostal and scalene 
muscles. The author concluded this represented preferential changes in 
favour of the diaphragm. 
The mechanism of lung hyperinflation is thought to arise from the loss of 
elastic recoil (static hyperinflation) which tends to increase the relaxation 
volume of the lungs (Vr) , and the development of prolonged expiratory time 
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constants, as a result of increased airway resistance which tends to increase 
FRC (dynamic hyperinflation) (Pride 1995). Dynamic hyperinflation is often 
present at rest, and increases further on exercise and during acute 
exacerbations associated with increasing airway obstruction (Gibson 1996). 
The elevation in end-expiratory lung volume above. the true relaxation 
volume of the respiratory system results in the persistence of an elastic recoil 
pressure at end-expiration i.e. it is no longer effectively zero, thus giving rise 
to the development of an intrinsic positive end-expiratory pressure, (PEEP i). 
The elevated end-expiratory pressure imposes an additional 'threshold 
load', which the inspiratory muscles must overcome prior to the lowering of 
alveolar pressure and the onset of inspiratory air flow. The development of 
PEEPi places a significant extra burden on the inspiratory muscles already 
operating under disadvantageous force-length conditions and abnormal 
geometry (Pride 1995). 
There are mixed reports concerning any adaptive mechanisms of the 
respiratory muscles as a result of the chronic resistive and mechanical 
loading. Measurements at post mortem have revealed reduced diaphragm 
weight, thickness, area and volume (Steele 1973, Thurlbeck 1978), whilst 
other studies have shown thicker diaphragms with similar or increased 
surface areas compared to normal controls (Ishikawa 1973, Scoll 1976). De 
Troyer (1991) concluded the majority of studies indicated a loss of 
diaphragm weight and thickness in COPD, and there are several 
confounding factors including loss of body weight and other, as yet 
unidentified, factors which contribute to the muscle changes. Indirect 
measurements of diaphragm muscle length reveal a 30 - 40% shortening 
(Sharp 1986), though when corrected for the absolute lung volumes at which 
the measurements were made Arora (1987) argued the differences to 
normal controls are only small. Studies in hamsters with experimentally 
induced emphysema have revealed adaptive changes in the chronically 
shortened diaphragm such that the length-tension curve of the muscle is 're-
set', i.e. undergoes a left-hand shift, producing similar tensions at shorter 
fibre lengths compared to the normal diaphragm (Supinski 1982). Gibson 
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(1996) notes the mechanism of any likely muscle adaptation to hyperinflation 
in humans is still speculative, however patients with severely hyperinflated 
lung volumes are still able to generate inspiratory pressures from voluntary 
manoeuvres and phrenic nerve stimulation. 
In addition to the increased resistive (increased airway resistance) and 
mechanical (hyperinflation) loads, there are a number of blood biochemical 
changes which may produce less than ideal conditions for the already 
compromised respiratory muscle function. The oxygen cost of breathing 
(V02resp) is elevated in COPD and at higher levels of ventilation is 
proportionately much greater than in normal subjects (Rochester 1979). 
Roussos (1982) determined the oxygen cost of breathing from the rate of 
work performed (W) and the efficiency (E), such that V02resp = (W)/E. If the 
lungs are stiff or airways obstruction is present, the work performed to inflate 
the lung will increase. In addition, when the load is increased respiratory 
muscle efficiency will be reduced therefore increasing the VO,resp for a given 
work rate. A reduced efficiency was demonstrated in patients with 
emphysema, where for the same degree of ventilation the oxygen cost was 
greater than in normal subjects, and breathing through resistances was 
more costly than isocapnic hyperventilation (McGregor 1961). Reduced 
oxygen delivery is a consequence of chronic hypoxaemia, however there is 
evidence of a compensatory adjustment in diaphragm blood flow and 
oxygen extraction to satisfy diaphragmatic metabolic requirements 
(Rochester 1979). However more recent work (in canines) suggests the 
development of an oxygen debt during periods of repeated maximal 
diaphragm contractions (Bellemere 1983). 
In the long term a combination of hypoxaemia, hypercapnia, an elevated 
energy demand due to the increased work of breathing, and decreased 
muscle efficiency are factors which will predispose the respiratory muscles 
towards fatigue (Roussos 1982). Poor nutritional status is common in severe 
COPD increasing the likelihood of glycogen depletion and shifting the 
balance towards anaerobic metabolism. Increases in blood lactate 
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concentration of approximately 1 mmol.l"' have been measured in normal 
individuals following the imposition of high, fatiguing resistances (Eldridge 
1966). However for the patient with chronic disease there are likely to be 
multiple confounding factors including electrolyte and mineral deficiencies, 
impaired muscle membrane function, reductions in energy metabolite 
concentrations, the effects of hypoxia, hypercapnia, acid-base imbalance 
and recurrent infection (Gibson 1996). 
Measurements of respiratory muscle strength are reduced in patients with 
COPD and hyperinflation (Black 1968). However when corrected for the 
abnormally high lung volumes Sharp (1986) suggested muscle strength was 
fairly well preserved. In severe COPD there is evidence of an elevated 
general metabolic rate (Donahoe 1989), and reduced body weight (with 
insufficient calorific intake to satisfy the increased energy demands) is 
common (Ferguson 1993). Additionally electrolyte imbalance and mineral 
depletion will accompany poor nutritional status. Respiratory muscle weights 
closely parallel body weight, and concurrent reductions in respiratory muscle 
strength have been measured in patients with low body weights (Rochester 
1986). Rochester (1991) suggests inspiratory muscle strength in COPD is 
determined not only by the degree of mechanical disadvantage to the 
diaphragm but also by the presence or absence of generalised muscle 
weakness. 
In summary, the pathological changes leading to increased airway 
resistance and loss of elastic recoil with the resultant gas trapping and 
hyperinflation have a profound effect on the functioning of the respiratory 
muscles. In addition the confounding factors of low body weight, poor 
nutritional status, hypoxia, hypercapnia and recurrent infection associated 
with the later stages of this chronic condition are likely to contribute to the 
sub-optimal operating conditions. 
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2.3.3 Assessment of respiratory muscle performance 
As the main function of the respiratory musculature is to generate changes in 
pressure, indirect assessment of respiratory muscle strength is achieved 
from the measurement of an individuals pressure generating capacity. As 
such, the assessment of respiratory muscle strength is fairly well established 
with the use of simple mouthpressure measurements (Plmax and PEmax). More 
complex techniques involve the use of oesophageal and abdominal 
pressure catheters, and electrical and magnetic muscle stimulation. 
However measurement of respiratory muscle performance (strength and 
endurance) during dynamic testing has not gained wide application. In an 
editorial, Decramer (1994) suggested its relevance in the clinical setting 
remains only partly understood even though respiratory muscle endurance 
may have a significant role in the ventilatory limitation during exercise. 
The demands on respiratory muscle performance in COPD, already 
compromised as a result of increased resistive and mechanical loads, will 
increase during periods of ventilatory stress e.g. exercise, exacerbation of 
symptoms etc. As endurance cannot be inferred from measurements of 
strength, the use of dynamic tests enable respiratory muscle performance to 
be examined under stress. Dynamic tests of respiratory muscle performance 
include maximum voluntary ventilation (MVV), resistive and threshold 
loading, which impose an additional inspiratory load on the respiratory 
musculature. 
The MVV test describes the upper limit of the body's ability to ventilate the 
lungs. It is conventionally measured from maximal volitional effort for short 
periods of time e.g. 12, 15 or 20 seconds and is expressed in litres per 
minute. The test reflects voluntary neural drive, airway resistance and 
respiratory muscle strength (Goldstein 1993). Studies using isocapnoeic 
hyperventilation have reported the maximum sustained ventilatory capacity 
for 15 minutes is 60% of the MVV for normal subjects (Keens 1977), whilst 
for patients with COPD it may be as high as 100% (Belman 1980). The 
difference between the MVV and the V Emax during exercise is used as a 
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measure of breathing reserve. In healthy subjects this is usually >30%, whilst 
in subjects with COPD it is often reduced, and in severe cases ventilation 
during exercise may exceed the measured MVV (Belman 1993). The 
manoeuvre is highly dependant on motivation, effort and performance 
technique, therefore its use is less attractive where more reliable measures 
of respiratory muscle performance may be required. 
Resistive loading involves the addition of alinear resistances to the 
inspiratory port of a two-way breathing valve. The resistance imposed is 
usually flow dependant. Much of the preliminary work examining diaphragm 
fatigue was performed with this type of inspiratory load. Using alinear 
resistances Roussos (1977) described a curvilinear relationship between 
Pdi (expressed as a fraction of the Pdimax at FRC) and the time required to 
produce diaphragm fatigue (Tum). The Pdi associated with an indefinite Tum 
was approximately 40% of the Pdimax. The study also found that quite high 
inspiratory loads could be tolerated indefinitely, and the authors suggested 
diaphragm fatigue should develop once the energy consumption of the 
respiratory muscles exceeded a critical value. Bellemere (1982) suggested, 
since inspiration is associated with active muscle contraction, an important 
component of respiratory muscle endurance is the ratio of inspiratory time to 
the total duration of the breathing cycle i.e. the duty cycle (TifTTot)' 
Additionally the pressure generated, as a percentage of the maximum 
available pressure Pdimax (Pdi/Pdimax), was also important. This led 
Bellemere to propose a tension-time index (TTDI) which incorporated both 
the duty cycle and the PdilPdimax. 
The use of alinear resistive loads as a means of examining respiratory 
muscle performance requires careful control and standardisation of 
breathing pattern. This is a major drawback with any popularisation of the 
technique for routine clinical assessment. Moreover rigid standardisation of 
breathing pattern and inspiratory flow prevents the examination of the 
natural breathing strategies developed by healthy individuals, and patients 
with respiratory impairment, to overcome additional inspiratory loads. 
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The use of inspiratory threshold loading as a means of examining respiratory 
muscle performance may in some cases, also be influenced by the breathing 
pattern, depending on the application of the technique. The weighted 
plunger device, described by Nickerson (1982), has been used to measure 
Tum (the length of time a particular load may be tolerated before the onset of 
fatigue) and sustainable inspiratory pressure (maximum load tolerated for 10 
minutes) (Clanton 1985, Nickerson 1982). Both inspiratory flow and the duty 
cycle were found to have significant effects on the measurement of Tlim 
(Clanton 1985). However, when the technique was applied using an 
incremental and progressive loading protocol (which provides a measure of 
peak mouth pressure - peak Pm) it was uninfluenced by breathing pattern 
(Martyn 1987, Morrison 1989). In addition, threshold loading using an 
incremental protocol, which allowed subjects to develop an individual 
response to the increasing inspiratory loads, was more reproducible 
compared to the Tlim test (McElevaney 1989). 
The ideal protocol and method with which to assess respiratory muscle 
performance is unresolved. As with the assessment of whole body exercise 
performance it is unlikely a single protocol or method will suffice for all 
situations. MVV is beset with subject motivational problems whilst resistive 
loading requires a high degree of subject co-operation and breathing 
control. It is also recognised that if the resistance is too high endurance may 
be limited by CO2 retention, and if it is too low subjects may hyperventilate 
(Nickerson 1982). Practical accessibility is important for both practitioner and 
patient. This is a constraint with resistive loading which requires patient 
feedback circuits. Alternatively incremental threshold loading, which does 
not require breathing regulation, allows the subject to develop an individual 
strategy to overcome the additional inspiratory load. 
The use of a progressive and incremental loading protocol was a departure 
from the original description of the technique which described sustainable 
inspiratory pressure as a measure of ventilatory muscle endurance 
(Nickerson 1982). However, if endurance is considered the capacity for 
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sustained performance of a 'task', then the task may involve either a constant 
workload (usually identified as a fraction of the individual maximum 
workload achieved) or a workload that varies. Incremental threshold loading 
is influenced by muscle strength and therefore assesses both strength and 
endurance since performance is measured over a period of time. The Tllm 
test assesses how long an additional threshold load, which remains 
constant, can be endured. As a practical clinical test the requirement of 
breathing regulation during the Tllm test is a disadvantage. 
The weighted plunger device consists of a plunger covering a large aperture 
within a chamber which is connected to the inspiratory port of a two-way 
mouthpiece valve (Nickerson 1982). Weights may be added to the plunger, 
which will only rise once a sufficient threshold pressure has been generated 
by the subject to lift the plunger from the aperture thus allowing air to flow 
during inspiration. The expiratory port is unimpeded. In the original 
description the device was shown to produce a constant inspiratory pressure 
independent of inspiratory flow. However, more recent studies have 
demonstrated higher loads (> 350 g) produce an inconsistent relationship 
between the weight on the plunger (threshold load) and the mouth pressure 
generated by the subject (Bardsley 1993, Eastwood 1995). Only partial 
opening of the plunger occurred at higher loads thus imposing an additional 
resistive load to inspiration. In addition, Clanton (1985) demonstrated the 
vertical displacement of the plunger was critical since the pressure load 
produced by the valve was highly dependent on its vertical orientation above 
the aperture. 
As a result of the limitations with the original design of the weighted plunger 
apparatus Bardsley (1993) described an electronic, solenoid valve device 
which only triggered when the set threshold pressure had been generated 
by the subject. Once the threshold pressure had been achieved, the 
solenoid valve opened to allow un impeded airflow. It avoided the manual 
application of weights to a plunger, therefore increases in threshold load 
(which are varied electronically by the operator) were smoother and quicker 
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to introduce. In a study on healthy individuals there was good reproducibility 
of peak Pm and the pressure-time product (fPdt, integration of pressure with 
time and an index of the oxygen cost of breathing, Collet! 1985) using a one 
minute incremental loading protocol. Additionally, the measurements were 
uninfluenced by varying breathing patterns therefore precluding the use of 
external regulation. The application of a threshold load from the solenoid 
device differs to that presented by the weighted plunger. Once the initial 
threshold load from the solenoid valve has been overcome the load 
disappears and airflow proceeds unimpeded. The load from the weighted 
plunger persists throughout inspiration. The load presented by the solenoid 
valve may be likened to increasing PEEPi, - the intrinsic pressure associated 
with dynamic hyperinflation. 
In terms of sensitivity to a therapeutic intervention both constant th reshold 
loading tests (assessment of T"rn) and incremental threshold loading tests 
(measurement of peak Pm) have demonstrated improvements following 
inspiratory muscle training programmes in patients with COPD (Larson 
1988, Goldstein 1989, Flynn 1989, Weiner 1992, Wanke 1994, Lisboa 
1994). However, there is little evidence of the utilisation of the technique 
following other types of intervention such as inhalation therapy or general 
rehabilitation programmes. 
Incremental threshold loading using the solenoid valve device has a number 
of potential qualities which are desirable for a simple test for the routine 
clinical situation. A linear and accurate response was demonstrated over a 
wide range of threshold pressures in a group of healthy individuals 
(Bardsley 1993). Performance was uninfluenced by breathing pattern and 
therefore excludes the requirement for cumbersome external regulation, and 
allows the natural strategies, developed by an individual to overcome the 
additional inspiratory loads, to be studied (Bardsley 1993). However the 
acceptability and performance of the device has not been tested in the 
clinical situation. Prior to any routine use the device and technique requires 
26 
assessment within the patient population it is likely to serve, to enable the 
variability (test - re-test) and the sensitivity to change to be quantified. 
2.3.4 Effects of therapy on respiratory muscle performance 
Although respiratory muscle function is compromised in patients with COPD 
its assessment is not always routinely applied, however simple 
measurements are becoming more common. A number of well established 
pharmacological therapies, and exercise training, have the potential to affect 
respiratory muscle function either directly or indirectly. This makes 
respiratory muscle assessment all the more important since therapeutic 
intervention is most effectively directed where there are appropriate and 
sensitive evaluation methods. 
Bronchodilators 
Inhaled bronchodilators act 10 reduce airway narrowing and therefore might 
be considered an indirect route to improving respiratory muscle function as a 
result of the reduction in the resistive and mechanical (hyperinflation) load. 
Assessment of the effectiveness of bronchodilator therapy tends to 
concentrate on the changes in lung function i.e. routine measurement of 
airflow (Calverley 1995). Several studies which have assessed changes in 
respiratory muscle function following bronchodilator therapy have produced 
conflicting results. Therapeutic doses of methylxanlhines produced 
increases in Pdi and changes in the EMG power spectrum, suggesting a 
reduction in fatigue in COPD (Murciano 1984), whilst others have found no 
change (Moxham 1985, Foxworth 1988). However, more recent work has 
shown benefits in hyperinflated lungs and in diaphragm fatigue (Gauthier 
1995). 
Two recent studies with Beta-2-agonists (B2-agonists) have demonstrated 
beneficial effects in the reduction of hyperinflation and consequent 
improvements in the muscle force reserve. These were accompanied by 
changes in breathing pattern and inspiratory muscle EMG activity (Duranti 
1995), and reductions in exercise breathlessness (Belman 1996). Other 
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studies with 132-agonists have shown improvements in static strength 
measurements (Plmax) (Gigliotti 1993) and respiratory muscle endurance 
(Tllm) (Nava 1992). Additional to the evidence for a reduction in the 
mechanical and resistive load on the respiratory musculature there is some 
evidence that methylxanthines, and to a lesser extent 132-agonists, have an 
intrinsic effect on the contractility of the diaphragm (van Der Heijden 1996). 
However this is doubted by some investigators who attribute most of the 
changes in respiratory muscle function to the deflationary effects in the lung 
(Moxham 1985, Belman 1996). 
Whatever the mechanism of improvements in respiratory muscle function 
reliance on spirometric evidence alone to evaluate the response to 
bronchodilators in COPD may undervalue their usefulness. Symptomatic 
relief is widely reported (Guyatt 1987a, Chrystyn 1988), whilst improvements 
in exercise tolerance (Chrystyn 1988, Hay 1992) and reductions in exercise 
breathlessness (Belman 1996) are also reported. In a study which examined 
the deflationary effects of 132-agonists and consequent respiratory muscle 
changes during exercise, Belman (1996) suggested breathlessness should 
always be evaluated following bronchodilator administration. Belman (1996) 
examined 13 patients with moderate to severe COPD (mean FEV, 1.20 1) 
and demonstrated reductions in exercise dynamic hyperinflation following 
bronchodilation, and concomitant improvements in inspiratory pressure 
reserve and neuroventilatory coupling (rati~ of inspiratory effort to resultant 
mechanical event) were the main determinants of reduced exercise 
breathlessness. These findings further support the association between 
dynamic hyperinflation and exercise dyspnoea proposed by O'Donnell in 
1993. Gibson (1996) summarises the likely mechanism of improvement with 
bronchodilator therapy as a reduction in the load/capacity ratio (Le. ratio of 
the pressure generated during any given change in lung volume to the 
maximum pressure available) achieved from the combined effects of a 
reduced load and improved inspiratory muscle capacity accompanying 
partial reversal of hyperinflation. 
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Exercise training 
Belman (1993) suggests improvements in exercise tolerance following a 
period of exercise training may be ascribed to one or more of the following 
factors: improved aerobic capacity and/or muscle strength, increased 
motivation, desensitisation to dyspnoea, improved ventilatory muscle 
function, and improved technique of performance. Casaburi (1991 and 
1995) has suggested reductions in the lactic acidosis, following periods of 
high intensity exercise training, lead to concomitant reductions in ventilation 
in patients with mild to moderate airways disease. Many patients with more 
severe disease often fail to show a lactate response (Belman 1993), 
nevertheless useful improvements in exercise tolerance have been 
demonstrated in such patients (Punzal 1991, Niederman 1991, Carter 1988). 
What the predominant mechanism of improvement might be in these cases 
remains speculative. A reduction in the ventilatory requirement as a result of 
adopting a more efficient respiratory pattern of slower and deeper breathing 
has been proposed by Casaburi (1995). This mechanism was suggested 
following the preliminary results of a study which examined a range of 
respiratory variables in a group of patients with severe airway obstruction 
(FEV1 <0.91) (Casaburi 1994). 
If exercise training achieves a fall in the ventilatory demand for a given work 
rate the burden on the respiratory muscles will be reduced. Additionally, 
improvements in general mechanical skill and co-ordination decreases both 
the oxygen cost and ventilatory requirements of a given work rate, i.e. an 
improved efficiency for a given task performance. The improved mechanical 
skill might also extend to improved co-ordination and efficiency of the 
respiratory muscles. However there are few studies which have incorporated 
measures of respiratory muscle performance and efficiency into the 
examination of whole body training. 
A study from Wanke (1994) examined the effects of combining inspiratory 
muscle training with general exercise training (cycle ergometer training) and 
compared this with general training alone. Forty-two patients with COPD 
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(mean FEV, 1.331) were split into the 2 groups. The inspiratory muscle 
training consisted of maximal static inspiratory efforts against an almost 
occluded mouthpiece, and endurance training with a threshold loading 
device. The author found no change in respiratory muscle strength 
(oesophageal and Pdi during a sniff manoeuvre) or endurance (Tlim) 
following cycle ergometer training alone, whilst there were significant 
improvements in these measurements for the combined training group. Both 
groups increased maximal cycle work rate and maximal oxygen 
consumption (V02max)' however the improvement was significantly greater in 
the group which had received the additional inspiratory muscle training. 
Similar results were demonstrated by Weiner (1992) who examined 
changes in a group of 36 patients with more severe airway obstruction. The 
patients were split into 3 groups, inspiratory muscle training and cycle 
training exercise, cycle training and sham inspiratory muscle training, and a 
control group received no training. Respiratory muscle strength was 
assessed from maximal inspiratory and expiratory mouth pressures (Plmax 
and PEmax) and respiratory muscle endurance from incremental threshold 
loading with the measurement of peak Pm. The cycle training alone had no 
effect on the measures of respiratory muscle function whilst the combined 
training produced substantial improvements. Additionally, the combined 
training group improved 12 minute walking distance and endurance cycling 
significantly more than the cycle training only group. 
The findings from the study of Weiner (1992) and those of Wanke (1994) 
suggest additional training specific for the respiratory muscles, is more 
advantageous to the whole body exercise response than generalised 
training alone for this patient group. However there are a number of 
additional issues which these two studies pose concerning the effect of 
generalised training on respiratory muscle performance: 1} cycle training 
alone does not improve respiratory muscle function even though both 
studies demonstrated significant improvements in whole body exercise 
performance; 2} the measurements of respiratory muscle function employed 
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were not sensitive enough to detect any subtle changes induced by the cycle 
training alone, and/or any such improvement may require a longer training 
period to become established; 3) changes in respiratory mechanical 
efficiency or work of breathing may have occurred but these were not 
examined. 
It has been suggested by a number of workers that the oxygen cost of 
increased ventilation during exercise may become uneconomical and 
eventually act as a limiting factor in COPD (Levison 1968, Rochester 1979, 
Bye 1983), however methods to establish the oxygen cost of breathing are 
complex and timely. Incremental threshold loading presents the possibility of 
assessing respiratory muscle performance in a simple and standardised 
fashion, analogous to a whole body incremental exercise test. As such it 
would allow the examination of the cardio-respiratory and metabolic 
response to the task. If a therapeutic intervention has the potential to alter the 
efficiency of the respiratory musculature, either directly or indirectly, can the 
assessment of the cardio-respiratory and metabolic response to a simple 
task for the respiratory musculature reflect that change? 
The possibility of improving respiratory muscle function by specific upper 
extremity training exercise has been examined by a number of workers. Celli 
(1994) demonstrated significant improvements in maximal inspiratory 
pressures in patients with COPD following unsupported arm training. Keens 
(1977) demonstrated a vigorous training regimen, consisting of swimming 
and canoeing, in patients with cystic fibrosis, produced similar improvements 
in the maximal ventilatory capacity as a programme of ventilatory muscle 
training. However other studies were unable to detect improvements in the 
measures of respiratory muscle performance employed (Ries 1988, Lake 
1990). 
In a training study which used low intensity peripheral muscle conditioning, 
including arm exercises and breathing techniques, Clark (1996) found 
hyperinflation of the lungs increased in the control group which had received 
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no training during the study period. The author speculated that the breathing 
techniques, taught during the various exercises, may have contributed to 
decreased airway narrowing which acted to inhibit further increases in 
hyperinflation in the actively training group. Additionally the training group 
improved work capacity for the same level of dyspnoea measured pre-
training. The perception of breathlessness has been shown to be closely 
associated with dynamic hyperinflation during exercise in COPD (O'Donnell 
1993 and 1997, Belman 1996). O'Donnell (1995) suggested a possible 
mechanism of reduced elastic and resistive loading, and/or improved 
ventilatory muscle strength for the relief of breathlessness following exercise 
training. Although assessment of whole body exercise provides insight into 
the symptoms associated with increased ventilatory stress, it involves many 
other muscle groups not related to breathing, therefore it may not be 
sufficiently sensitive to evaluate changes in ventilatory muscle function. 
There is still considerable debate concerning the usefulness of specific 
respiratory muscle training in COPD and any transfer effects leading to 
improvements in whole body exercise and functional capacity (Goldstein 
1993, Gosselink 1994). Although improvements in respiratory muscle 
strength and endurance have been demonstrated in a large number of 
studies and the improvements appear to be mode specific (Belman 1993), 
the functional advantages are still unclear. Improvements in exercise 
capacity have been demonstrated in two randomised, controlled studies 
(Larson 1988, Dekhuijzen 1991), which used a training programme of 
threshold loading, and Lisboa (1994) measured decreased breathlessness 
associated with activities of daily living following inspiratory muscle training 
in a placebo controlled study. The two studies (Weiner 1992, Wanke 1994) 
which found additional improvements from combining inspiratory muscle 
training with general exercise training have already been discussed. 
In an editorial Gosselink (1994) suggests the strongest indication for 
inspiratory muscle training lies in its combination with general exercise 
training, though careful monitoring of the training intensity and consideration 
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of the type of training employed is necessary to achieve measurable change. 
Training using inspiratory threshold loading has been associated with 
increases in exercise capacity and improvements in breathlessness (Larson 
1988, Lisboa 1994). More recently improvements in the disposable devices 
which deliver a training threshold load have occurred (Gosselink 1996a, 
Johnson 1996). 
In conclusion, popular methods of therapeutic inteNention used in this 
patient group, namely bronchodilator therapy and exercise training, have the 
potential to affect respiratory muscle performance, yet its assessment is not 
routinely applied. A simple and reliable test which does not require 
cumbersome external regulation and equipment, would make assessment 
more accessible. Additionally, greater clarity of the clinical relevance and 
application of the assessment of respiratory muscle performance, and its 
relationship to other conventional measures of exercise performance is 
required. Incremental threshold loading using the solenoid valve offers the 
potential for such a test, and with standardised increments in work rate 
would enable the energetics of the task to be examined. 
Although there is increasing evidence of the role of the respiratory 
musculature in the response to exercise in COPD, many aspects of the 
whole body exercise response remain poorly understood. Deconditioning 
and skeletal muscle weakness are gaining recognition as potential factors in 
the limitation of whole body exercise in this patient group. Since 
measurements of lung function at rest are poor predictors of functional 
capacity, the assessment of the whole body exercise response is important 
in the quantification of disability and application of therapeutic interventions. 
2.4 ASSESSMENT OF EXERCISE CAPACITY IN COPD 
The indications for performing an exercise test in COPD are varied and 
include the objective measurement of an individuals exercise capacity, the 
evaluation of disability, dyspnoea and exercise related symptoms, the 
establishment of a differential diagnosis, guidelines for exercise prescription, 
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and assessment of a therapeutic intervention. There are a wide variety of 
exercise tests, laboratory based tests may be as comprehensive as 
resources allow, whilst field-based tests are quick, simple to apply, less 
intimidating for the patient and usually do not involve major resource 
commitments. 
2.4.1 The response to exercise in COPD 
The abnormal ventilatory mechanics and increased airway resistance act to 
reduce the ventilatory capacity, which is one of the most important factors in 
the exercise limitation of patients with COPD (Belman 1993). A limited 
breathing reserve is characteristic of the condition, where the difference 
between the maximum exercise ventilation and the MW is less than 10 
l.min·' (Wasserman 1993). The recognition of a ventilatory limit to exercise in 
patients with COPD was acknowledged by Jones (1971) in a study which 
examined the exercise responses in 50 men with the condition. Maximal 
exercise work capacity was reduced in comparison to predicted normal 
values, and low ventilatory capacities were measured, whilst the 
cardiovascular response for a given work rate was essentially normal. Whilst 
it is generally accepted the maximal ventilatory capacity is reduced, Spiro 
(1975) demonstrated, for a given oxygen uptake, ventilation was significantly 
higher in patients compared to age-matched controls. Spiro also 
demonstrated a reduced maximal oxygen uptake, consistent with the 
reduced peak work rate, compared to the control group. The true V02max, 
where V02 assumes a plateau despite an increasing work rate, is not 
usually attained in patients with COPD since exercise is symptom limited. 
More appropriately the 'symptom limited' V02max or peak V02 (V02peak) is 
reduced when compared with predicted normal values, or control subjects 
(Jones 1988). 
Arterial oxygen desaturation is a fairly common finding during exercise in 
COPD, and is largely accounted for by a worsening of the V/Q mismatch 
(Belman 1993). Marked inhomogeneity in the distribution of ventilation and 
perfusion leads to areas with a high V/Q ratio, which act as deadspace, and 
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areas with low via ratios which act as venous admixture and contribute to 
arterial O2 desaturation (Jones 1991). There is little evidence for a diffusion 
limitation in COPD (Belman 1993) though this may occur during periods of 
infection and inflammation. 
In healthy individuals there is usually a reduction in the VdNt during 
exercise. In COPD the reverse is true, Ihe VdNI ratio lends 10 increase 
during exercise. This acls to increase the ventilatory equivalent for carbon 
dioxide elimination (V E IVC02) and thus contributes 10 the sensation of 
dyspnoea (Jones 1991). In some patients this may be lessened by alveolar 
hypoventilalion at the expense of a rising arterial CO2 (PaC02). The concept 
of an arterial CO2 set-point describes the widely differing alveolar ventilation 
requirements between patients who regulate a normal PaC02, and are less 
able to tolerate variation in PaC02 and pH, and patients who are able to 
tolerate a higher PaC02 • The former patient is likely to experience a greater 
degree of breathlessness at any given metabolic rate since a higher degree 
of alveolar ventilation is required to maintain the PaC02 within tight limits 
(Wasserman 1993). The alveolar mass balance equation describes the level 
of ventilation (V E) for a given PaC02, and the effect of the VdNt : 
VE :: kVQQ2: __ 
PaC02 (1 - VdNt) 
where k is a constant, VC02 is carbon dioxide output, PaC02 is arterial CO2 
partial pressure, and VdNt is the deadspace 10 tidal volume ratio and 
quantifies the efficacy with which CO2 is expelled from the lung. 
The work of breathing and the increased cost of ventilation in COPD was 
proposed by Levison (1968) as an important limiting factor of exercise. In a 
study which examined the response to exercise in both normal subjects and 
patients with COPD, Levison (1968) measured a disproportionate increase 
in the oxygen cost of breathing in the patient group. Rochester (1979) 
estimated the level of activity which might be sustained by two hypothetical 
patients with COPD and a normal subject, based on the amount of oxygen 
available to the body after the oxygen consumed by the respiratory muscles 
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had been subtracted. Based on a minute ventilation of 30 l.min·1 a patient 
who maintains a normal PaC02 manages only minimal activity equivalent to 
slow walking, whilst the patient who tolerates hypercapnia is able to perform 
a higher rate of activity equivalent to light work, for example. The former 
patient is expending more energy eliminating CO2 and therefore less is 
available for other muscular activity. However both types of patient have a 
much reduced work capacity compared to the normal subject, who at the 
same level of ventilation is capable of moderately heavy manual work. The 
oxygen cost of breathing in the normal subject is small in comparison to the 
patients with COPD and not a limiting factor at that level of ventilation. Bye 
(1983) described the concept of 'energy stealing' i.e. the respiratory muscles 
'steal' blood flow and energy potentially available for other working muscles, 
and suggests it may be a rate limiting step in healthy individuals at very high 
ventilations. 
The ventilatory and gas exchange kinetics, measured during moderate, 
constant-load exercise in patients with COPD, have been shown to be 
significantly different from the normal response (Nery 1982). The phase 1 
increases (which describes the change from rest to exercise and represents 
the period in which mixed venous tensions have not changed) in ventilation 
CV E)' carbon dioxide production (VC02), V °2, heart rate (HR) and 02Pulse 
were significantly smaller, and the phase 2 kinetics (slow exponential rise to 
steady state) were significantly slower than in a normal control group. The 
authors attributed the slowed ventilatory kinetics during phase 2 to a slowed 
cardiovascular response in the patient group. Breathing 30% O2 was found 
to accelerate the V02 kinetics, and consequently reduced the O2 deficit 
(difference between the minute V02 and the average V02 during a 10 
minute bout of constant-load exercise) in mildly hypoxaemic COPD patients 
(Palange 1995). The authors suggested the observed improvements with O2 
supplementation were consistent with an enhancement of aerobic 
metabolism in skeletal muscles during moderate exercise. 
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There is generally a high heart rate reserve (predicted maximum heart rate 
minus the peak exercise heart rate) at peak exercise levels since most 
patients terminate exercise prematurely due to symptoms. However, a 
number of workers have found higher heart rates in comparison with normal 
individuals at equivalent V02 or work rates. Matthews (1989) found 
consistently higher heart rates over a wide range of work rates compared to 
an age matched control group, and suggested it possibly represented a 
combination of both deconditioning and the increased energy demands of 
the ventilatory muscles. Spiro (1975) also measured significantly higher 
heart rates at equivalent, absolute levels of V O2, and postulated a reduced 
stroke volume as a result of raised pulmonary artery pressure, or the 
development of left ventricular dysfunction. Wasserman (1993) suggested a 
reduced stroke volume may partly explain the reduced oxygen-pulse which 
is commonly observed in COPD. 
One of the main symptoms of exercise in COPD is breathlessness, though 
recent work has suggested symptoms of leg fatigue, and a combination of 
leg fatigue and dyspnoea occur more frequently. Killian (1992) compared 
each of the respective symptoms in a large group of patients with chronic 
airflow limitation and a control group. A greater proportion of patients rated 
leg fatigue in excess of dyspnoea (43%), whilst only 26% rated dyspnoea in 
excess of leg fatigue. The remainder of the group (31%) rated both 
symptoms equally. Similar findings were reported by Rampulla (1992) with 
proportions of 46% reporting fatigue at exercise termination and 36% 
reporting dyspnoea. These findings suggest fatigue of the peripheral 
muscles and general deconditioning also contribute to the exercise limitation 
in this group. Peripheral muscle weakness, in terms of reduced quadriceps 
and handgrip force, was confirmed in a study of 41 patients with COPD 
(Gosselink 1996b). The study also found quadriceps force and Plmax 
explained 45% of the variance in the 6 minute walk distance, whilst transfer 
factor, FEV1 and quadriceps force explained 58% of the variance in V02max• 
The authors concluded lung function and peripheral muscle force were 
important determinants of exercise capacity in COPD. 
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In a large retrospective study of over 4,617 subjects referred for clinical 
exercise testing, reduced peripheral and respiratory muscle strength (Plmax 
and PE
max
) were measured in subgroups classified with respiratory disorders 
and cardiorespiratory conditions (Hamilton 1995). There were also 
significant relationships between symptom intensity and muscle strength and 
between maximal work capacity and muscle strength. The authors 
suggested the most likely cause for the systematic decline in peripheral 
muscle strength, observed in the presence of cardiorespiratory disorders, 
was a reduction in the level of habitual activity. 
Reductions in muscle size and strength following limb immobilisation are 
generally well known, whilst differences between active and sedentary 
individuals in muscle strength and oxidative enzymes have been widely 
demonstrated (Jones 1991). Additionally steroid usage and diuretic therapy 
are important factors which may account for weakness in some patients, and 
theoretically hypoxaemia and hypercapnia may also impair muscle function 
(Jones 1991). Whilst patients experience increasing dyspnoea to a range of 
daily activities, a greater motivation and tolerance will be required to achieve 
the same level of activity. Alternatively, many patients will avoid activities 
which provoke dyspnoea and adopt a more sedentary lifestyle, which leads 
to further deconditioning and the downward spiral of dyspnoea described by 
Young (1983). 
Wasserman (1993) acknowledges the contribution of cardiovascular and 
muscle deconditioning to the reduced exercise capacity in COPD, with the 
occurrence of anaerobic metabolism at low exercise levels and the 
contribution of lactic acidosis to the ventilatory burden. The increased 
concentration of hydrogen ions, as a result of lactic acid dissociation, 
stimulate the carotid bodies to increase ventilatory drive. Casaburi (1991) 
demonstrated a high intensity exercise training programme in patients with 
mild and moderate disease, and with evidence of an anaerobic threshold, 
reduced the exercise lactic acidosis and ventilation at set work rates 
compared to pre-training levels, and improved the total work capacity. 
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However Belman (1993) points out more severely affected patients often fail 
to demonstrate an anaerobic threshold or a significant exercise lactic 
acidosis, yet often show large improvements in submaximal exercise 
endurance following a course of exercise training. 
2.4.2 Laboratory-based exercise tests 
Laboratory tests include both incremental and constant workload tests. The 
. . 
incremental and symptom limited maximal test enables peak V °2, V E and 
heart rate to be measured, with additional monitoring of pulse oximetry for 
arterial oxygen saturation (%Sp02)' ECG, dyspnoea and perceived exertion. 
There exists a number of incremental treadmill and cycle ergometer 
protocols for clinical assessment (American College of Sports Medicine, 
ACSM 1995). However, to date there are no consensus guidelines 
concerning the assessment of exercise capacity in COPD, or the respiratory 
patient in general. Many protocols have evolved from the investigation of 
cardiac disorders, with the Bruce protocol (1973) being popular in the UK. Its 
application in the respiratory patient is not recommended since the work rate 
increments are large and may quickly exceed the V02 mechanisms in most 
patients (Jones 1988). Protocols with smaller increments are better suited for 
elderly subjects, and patients with respiratory disease, and the modified 
Balke or Naughton protocols are suggested by the ACSM guidelines (1995). 
Such protocols adopt a constant treadmill walking speed, individualised to 
each subject, with an increase in gradient of 2 - 3% every 2 to 3 minutes. 
Increments of 10 - 15 watts.min·1 are suggested for the cycle ergometer. 
Ideally the total test time should be 8 to 12 minutes for the symptom limited 
maximal test (Wasserman 1993) with the work rate increments adjusted 
accordingly. 
Constant work rate tests may be used to elicit steady state conditions in the 
measured physiological variables (e.g. heart rate and V 02)' measure 
endurance capacity, and discontinuous constant work rate tests, with 
intervening rest periods, used for the measurement of V02max. A constant 
work rate test at near (90%) maximal predicted values for either heart rate or 
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V02 is the recommended challenge for exercise-induced asthma (Eggleston 
1979). When measuring endurance capacity the intensity of exercise is 
usually set to a proportion of the maximal work rate or V02max determined 
from a maximal incremental test, and the endurance capacity is defined as 
the duration of exercise at the set work rate (Astrand 1986). Constant work 
rate tests are ideal for measuring cardiovascular, ventilatory, and gas 
exchange kinetics, and using breath-by-breath analysis allows the 
measurement of time constants (rate of rise - the time for 63% of the final 
response to be reached) of the physiological responses (Wasserman 1994). 
Whipp (1972) examined the V02 kinetics over a 6 minute constant work rate 
test and found that for work rates above the anaerobic threshold the V02 
failed to reach a plateau after 3 minutes. The rate of rise in the V02 during 3 
to 6 minutes of a constant-load test (8 V02 (6-3)) was found to correlate with 
the magnitude of any lactic acidosis (Roston 1987). Analysis of the breath-
by-breath measurement of CO2 production and 02 uptake during constant-
load exercise can also be used to derive a noninvasive evaluation of the 
magnitude of blood lactate increase, by estimating the degree of lactic acid 
buffering by bicarbonate ions and the subsequent dissociation to CO2 and 
Hp (Wasserman 1994). 
With the increasing sophistication of computerised exercise test systems it is 
easy to obtain a wide range of derived variables from the gas analysis, flow 
and volume measurements. However caution is suggested since the 
computer algorithms may be based on a number of assumptions which may 
not apply in all circumstances. For example, use of end-tidal CO2 
measurement as a substitute for PaC02, and used in the calculation of 
physiological deadspace (e.g. VdNt) has been shown to be erroneous in 
COPD (Clark 1992, Lewis 1993). 
There is evidence that the cardio-respiratory response to a maximal test is 
mode specific in healthy subjects, and unsupported walking on the treadmill 
may produce a V02max 5 - 10% greater than the cycle ergometer (ACSM 
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1995). In severe COPD, were it may be hypothesised the support for the 
upper body offered by the cycle ergometer may provoke a higher \/02peak 
than the treadmill, there is no significant difference between the two forms of 
exercise (Mathur 1995). However, the same study demonstrated a 
significantly higher lactate concentration following cycle exercise compared 
to the treadmill test, which was in agreement with the findings of Cockcroft 
(1985) from a study on patients with COPD, and with studies on healthy 
individuals (Koyal 1976, Hermansen 1969). Cockcroft (1985) suggested the 
smaller muscle mass used in cycling may account for the differences in 
lactate concentration, since the mean metabolic rate per unit of contracting 
muscle is greater than for the equivalent treadmill work and thus engages 
anaerobiosis at a lower level of \/°2. Additionally, Cockcroft (1984) found 
less oxygen desaturation during the cycle test compared to that during the 
treadmill exercise, and suggested the greater lactic acidosis, provoked by 
the cycling, stimulated a greater ventilatory response, therefore minimising 
the fall in Pa02 • Spence (1993) similarly found less desaturation during cycle 
exercise compared to corridor walking in patients with severe COPD. 
The differences in the metabolic (lactate concentration and Pa02) responses 
to cycle and treadmill exercise in severe COPD might influence the choice of 
exercise modality in specific circumstances. Where exercise prescription is 
based on the development of an anaerobic threshold, then a cycle exercise 
test may be more appropriate to elicit a higher lactate concentration. 
Alternatively, domiciliary oxygen prescription may rely on the demonstration 
of a certain level of oxygen desaturation during exercise, in which case 
walking exercise appears to be more specific for arterial desaturation. For 
the assessment of an exercise training programme Jones (1989) proposes 
treadmill testing is the most appropriate form of test if the training is based on 
walking. Additionally, Casaburi (1993) states it is important the exercise 
testing modality utilises the same muscles which were trained during the 
rehabilitation programme, since performance will be improved only in those 
muscle groups which undergo training. 
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Since exercise capacity is difficult to predict from resting measurements of 
pulmonary function (Jones 1971, Wasserman 1993 ), standardised methods 
of laboratory testing enables the exercise capacity to be quantified in terms 
of V02peak, V Epeak' HRpeak and peak work rate, and the subjective response to 
be qualified. Additionally the subjective response, in terms of breathlessness 
and perceived exertion, may be quantified by use of the Borg rating scales 
(appendix 5). The Borg scales correlate well with exercise intensity (Borg 
1982), are reproducible and show a similar degree of variability as V02, V E 
and HR in COPD over short periods of time (Silverman 1988). Over longer 
periods (5 weeks) the Borg ratings of dyspnoea were found to be less 
reproducible than V02 and VEin COPD (Mador 1995). Belman (1991 a) also 
found increased variability with time after the physiological response to 
exercise had stabilised in COPD, and interpreted this as a sign of 
desensitisation to dyspnoea. Mahler (1992) demonstrated ratings of 
dyspnoea overlapped (with maximal respiratory pressures and lung 
function) but were independent factors in the evaluation of patients with 
COPD. 
The reproducibility and learning effects of incremental maximal cycle 
ergometer tests were examined over a short term period (24 hours) in eleven 
patients with mild to moderate COPD (Cox 1989). Maximal work rate, 
V02peak, HRpeak and the respiratory exchange ratio (RER) all showed good 
reproducibility with less than 5% variation between tests. V Epeak' VC02peak 
and breathing frequency (fR) were slightly less reproducible, with values of 
6.6%, 6.0% and 8.3% respectively. Cox (1989) concluded there was good 
reproducibility of the test and no learning effects were apparent. However 
the study was performed in the Netherlands and the author conceded 
cycling was a common mode of transport within the population. Brown had 
published similar results in 1985 (in the USA), and in addition demonstrated 
slightly less variability between cycle tests carried out on the same day than 
the variability between days. The within-day variability of V02peak was 
approximately 4%, and the between day variability was approximately 7%. In 
a study on eight patients with severe COPD (mean FEV1 0.69 1), Mathur 
42 
(1995) measured a between-day variability in V02peak of 6.8% for an 
incremental cycle test, and 8.2% for an incremental treadmill test. 
Swinburn (1985) suggested at least 3 practice exercise tests be performed 
in patients with severe COPD prior to the evaluation of an intervention. The 
authors found wide variability between the performance (work rate) in three 
types of test carried out on four occasions in one week. Performance 
increased significantly between the 1st and 4th test, with the widest 
differences for a fixed height and rate step test, followed by an incremental 
cycle ergometer test, and least differences recorded with a 12 minute 
walking distance test. All the patients were admitted into hospital specifically 
for the performance of the study, and it may be argued there was a strong 
motivational element since each type of test was performed every day for 
three days (the 4th test was performed after 3 days of additional placebo 
treatment). 
In summary, laboratory based tests of peak exercise capacity assist in the 
establishment of a diagnosis, they allow the objective assessment of the 
cardio-respiratory response to exercise, and enable signs and symptoms to 
be quantified. In addition they may be useful in the prescription of exercise 
allowing peak heart rates and the blood lactate response to be evaluated. 
However laboratory-based tests are costly and are likely to be limited to the 
larger investigative medical centres. 
2.4.3 Field tests of exercise performance 
Whilst laboratory exercise tests enable the gold standard measurement of 
aerobic fitness - the V02max (or V02peak) to be measured directly, and assist 
in the diagnostic process, they are complex and costly, and not necessarily 
appropriate where a simple assessment of disability is required. The 12 and 
6 minute walking tests (12 or 6 MWT), are self-paced walking tests which 
measure the distance covered in the respective times, and are widely used 
clinical field tests of disability for patients with COPD. More recently a shuttle 
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walk test (SWT) has been described which incorporates a standardised and 
incremental work rate (Singh 1992). 
The 12 MWT was described by McGavin (1976). The reproducibility of the 
test, its relationship to resting lung function and maximal cycle ergometer 
performance were assessed in a group of patients with chronic bronchitis. 
The test was performed along a hospital corridor with the supervising doctor 
walking alongside, giving encouragement as necessary. The patient was 
instructed to 'walk continuously if possible but not to be concerned if he had 
to slow down or stop. The aim was to feel at the end of the test he could not 
have covered more ground in the time'. Additionally a maximal exercise test 
on a cycle ergometer and resting FEV1 and FVC measurements were 
performed. Although significant, the correlation between the distance walked 
and V02max was only moderate (r=O.52), similarly with FVC (r=0.406), whilst 
there was no significant correlation with FEV1• The authors assessed 
reproducibility over three tests and found a significant difference between 
the 1st and 2nd test, and a mean difference of +7.33 ±4.22"10 between the 
2nd and 3rd test (NS), and concluded the test should be carried out twice to 
achieve reproducible results. 
Butland (1982) compared the 12 MWT to performance during 6 and 2 minute 
versions of the test, since 12 minutes was quite a taxing length of time for 
patients with more severe impairment. Two practice 12 MWT were performed 
by all patients before entry into the study. The timing and wording of 
encouragement were standardised, and the distance covered every two 
minutes was measured. Patients walked further during the first 2 minutes 
than any subsequent two minute period, though all tests (2, 6 and 12 MWT) 
were significantly correlated. The within day reproducibility of the 2 MWT 
was assessed, and a 7.3% increase in distance was measured over four 
tests. There was a greater spread of results using the longer tests which led 
the authors to conclude these were better discriminators of exercise 
tolerance. It was concluded the 6 MWT was a suitable compromise for a 
shorter duration test. Alternatively, the greater spread of results from the 
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longer tests may also indicate a variability in the patients' ability to pace 
themselves over a longer period. The variability in pacing is borne out in a 
study by Guyatt (1984) which found a significant difference between the 
distance covered during a 2 MWT and during the first 2 minutes of a 6 MWT, 
suggesting knowledge of the test duration might influence pacing. 
The effect of encouragement on walking test performance was examined in 
a mixed group of patients (COPD and/or heart failure) (Guyatt 1984). Simple 
encouragement was found to significantly improve the 6 MWT by up to 
30.5m, whilst repeated testing with no encouragement also produced an 
improvement though of a smaller magnitude. The effect of encouragement 
was similar in magnitude to improvements previously attributed to some 
pharmacological or physiological interventions (Guyatt 1984). The authors 
suggested consistency in the conduct of the test was important, and 
recommended two practice tests because of an initial training effect. 
Similarly, Knox (1988) described a learning effect over 12 walks, with a 33% 
increase in distance walked when the tests were carried out over a short 
period of time (12 tests in 3 consecutive days), and a 8.5% increase over 4 
weeks. The authors concluded at least five practice walks were desirable 
when tests were to be performed on consecutive days, and four practice 
walks when tests were to be performed over a greater time period. 
Additionally a randomised cross-design, or a placebo group, should be 
considered for research studies as an additional control. 
Other studies have also demonstrated learning and/or motivational effects 
with repeat testing. Swinburn (1985) measured a 16% improvement over 
four 12 MWT performed during one week, and recommended at least three 
practice attempts. Mungall (1979) measured a significant improvement over 
six 12 MWT performed over a longer period of time (the level of improvement 
was not stated) and again recommended 3 practice walks. 
It is apparent the conduct of the test is important since both encouragement 
and the number of practice walks performed can significantly influence the 
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results. As Guyatt (1984) reports, a number of studies have measured 
apparent improvements following a clinical intervention, though much of the 
improvements noted may be accounted for by lack of protocol 
standardisation. The recommended number of practice walks ranges from 
one to five, with the choice influenced by the period of time over which the 
measurement is to be repeated. The number of practice attempts and the 
influence of the time period renders the test cumbersome in practice, 
reduces its simplicity, increases the cost and is more inconvenient for the 
patient. 
Other variables which have been shown to be related to the performance of 
timed walk tests include attitudes and beliefs, dyspnoea ratings and quality 
of life scores (McGavin 1978, Morgan 1983, Mak 1993, Wegner 1994). Both 
Morgan (1983) and McGavin (1978) found Borg ratings of perceived exertion 
measured post test correlated significantly to the 12 MWT (r = ·0.49 for both 
studies), and additionally patients' attitudes and beliefs concerning their 
respiratory condition and treatment accounted for a substantial proportion of 
the variance (Morgan 1983). Mak (1993) reported a strong correlation 
between the 6 MWT and perceived respiratory impairment (rated prior to 
exercise on the Medical Research Council breathlessness scale) (r=-0.520). 
Whilst there were poorer correlations with breathlessness and perceived 
exertion rated after the 6 MWT ( r= -0.35, and r = -0.30 respectively). 
Using factor analysis, Wegner (1994) found 6 MWT, dyspnoea and quality of 
life scores together acted as a significant, statistically independent variable 
on the characterisation of COPD. In contrast, quality of life measures were 
found not to relate to either a 6 MWT or a maximal cycle ergometer test in a 
study on 40 patients with COPD, whilst Borg ratings of dyspnoea at rest 
produced a significant correlation with the 6 MWT (r= -0.41) (Wijkstra 1994). 
The apparent effect of attitudes and beliefs on exercise performance would 
appear to be an important dimension for consideration during programmes 
of pulmonary rehabilitation, which aims to improve performance and 
understanding of the condition. 
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The question of what the timed walk test measures is important for its 
application and its potential sensitivity and specificity for a treatment 
intervention. The moderate relationships with measures of maximal exercise 
performance (McGavin 1976) indicate the test is more akin to a submaximal 
test than the maximal performance provoked during a conventional 
incremental test. Using a portable oxygen analyser Swinburn (1985) 
demonstrated a steady state in V02 and V E occurred after 6 minutes of a 12 
MWT, a finding which has more in common with a submaximal endurance 
test. Additionally, in the same group of patients, higher V02 and V E values 
were measured during a step test than during the 12 MWT emphasising the 
submaximal nature of the test. Singh (1992) compared the peak heart rate 
achieved during a 6 MWT and the incremental shuttle walk test, and found it 
was 9 beats higher following the shuttle test, which supports the submaximal 
nature of the 6 MWT. 
A patient's exercise performance must depend on various factors including 
motivation, endurance, respiratory function, cardiovascular fitness and 
neuromuscular function, all of which McGavin (1976) suggests govern 
'everyday disability', and therefore confer the 12 MWT with the potential to 
establish everyday disability. Steele (1996) argues that walking tests may be 
a better measure of 'functional exercise capacity', defined as the patients 
ability to undertake physically taxing activities encountered in everyday life, 
that are not reflected by conventional exercise testing. However, Spiro 
(1977) notes since day to day activities are mostly of an irregular nature with 
a steady state rarely being achieved, an increasing work rate test is more 
likely to reveal or identify the causes of exercise limitation. The counter 
argument is an individual rarely utilises maximal capacity and most normal 
activity engages only differing proportions of the maximum capacity. In 
addition, endurance capacity, which measures repeated or sustained 
performance of a task (or tasks), is an essential part of normal functioning. 
Whilst an incremental maximal test defines the limit of exercise capacity and 
with full physiological monitoring reveals abnormality of response, 
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submaximal field testing has the potential to quantify useful employment of 
that capacity. 
The self-paced nature of the timed walking tests may confer both advantages 
and disadvantages. Steele (1996) argues self-pacing is an important skill 
which is taught and needs to be measured in a naturalistic format following 
pulmonary rehabilitation and other similar interventions. Alternatively, 
Swinburn (1985) suggests self-pacing is a disadvantage which probably 
accounts for the test's dependence on attitude and motivation, and the 
effects of verbal encouragement on performance. Swinburn also questions 
the habitual nature of the walking speed adopted by the patient which may 
prevent the test from demonstrating the full beneficial effect of any treatment. 
Previous studies have demonstrated the variability in self-pacing adopted by 
patients (Butland 1982, GuyaU 1984) and this in part may be influenced by 
knowledge of the test duration. The use of self-pacing makes inter-subject 
comparison difficult, since different patients experience a different challenge 
depending on individual judgement of pace, and the adopted pace will 
reflect the employment of different relative levels of maximum capacity. Self-
pacing may also lead to decreased test sensitivity and poor intra-subject 
comparison. A patient may achieve similar distances before and after an 
intervention, but poor judgement of pace over 6 or 12 minutes may disguise 
improvements in the patient's ability to exercise at a higher capacity. 
The concerns over the use of self-paced, timed field tests have been 
discussed, however the test does possesses a number of qualities for the 
assessment of exercise performance. The simplicity and low cost of the test 
are evident, and it avoids the use of intimidating, complex equipment which 
may be daunting to the patient and lead to underperformance. The familiarity 
of the type of exercise is universal. Since walking is central to the 
achievement of normal daily functioning it is an appropriate activity to 
assess. Whilst the lack of relationship to routine measures of lung function 
may be viewed as a disadvantage, it also highlights the necessity to 
objectively evaluate exercise performance in CO PD. 
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Many of the concerns over the use of the timed field walking tests arise from 
the absence of a standardised protocol, use of self-pacing, individual 
motivation and learning effects. The development of the incremental shuttle 
walking test (Singh 1992) addressed some of the shortcomings of the 
existing field tests, whilst its purpose was to provide a standardised, 
incremental field test of symptom limited maximum performance. The test 
incorporates external pacing, therefore eliminating variability in pace and 
improving intra- and inter-subject comparison, since all patients experience 
the same set work rate. The work rate is incremental, the speed of walking is 
increased every minute, and the protocol is standardised with clearly defined 
end-points. The external pacing reduces the effect of operator 
encouragement and reproducibility is improved since it requires only one 
practice test. 
Whilst the advantages of assessing maximal capacity from an incremental 
maximal test have been examined, the evaluation of submaximal endurance 
performance with field walking tests has a place in the assessment of 
disability. The timed field walking tests, with and without the addition of 
maximal incremental tests, have been used widely as outcome measures 
following both pharmacological and rehabilitation inteNentions. Whilst 
maximum exercise capacity (V02peak) often shows minimal improvement, 
submaximal endurance tests (either field or treadmill walking, or cycle 
ergometry) have been shown to be particularly sensitive to interventions of 
exercise training (Larson 1988, Zuwallack 1991, Niederman 1991, Punzal 
1991, Goldstein 1994, Singh 1996). Thus, there are sound arguments for 
standardising the assessment of endurance capacity, and for the 
development of a field test which avoids many of the shortcomings 
associated with the existing timed walk tests. 
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3.1 INTRODUCTION 
Chapter 3 
GENERAL METHODS 
To ensure consistency throughout all procedures and measurements were 
standardised in the experimental studies undertaken. A description of the 
standard methods and equipment used is given below. 
3.2 Demographic details and subject examination 
All subjects had the following details recorded at their first visit: date of birth; 
height; body weight; current medication; and smoking history. Body weight 
was measured using a beam balance (Marsden Ltd., Model 150) and height 
was measured using the stadiometer fixed to the balance scales. Outer 
clothes and shoes were removed. Height was measured according to the 
recommendations of the British Thoracic Society and the Association of 
Respiratory Technicians and Physiologists (BTS/ARTP) (1994). Body weight 
was re-checked periodically throughout study periods. 
All subjects undergoing maximal exercise testing had a supine, standard 12-
lead ECG recorded (Nihon Kohden, Cardiofax) and resting blood pressure 
measurement (Accuson, Freestyle), as a safety precaution. Any deviation 
from normal was assessed by the study supervisor. All exercise tests were 
carried out according to local safety guidelines and the guidelines issued by 
the American College of Sports Medicine (1995). 
3.3 Lung Function Measurements 
The FEV1 and FVC were measured on a wedge-bellows spirometer 
(Vitalograph Ltd, R model), and performed according to the BTS/ARTP 
Guidelines (1994). Subjects were seated and performed a minimum of three 
technically acceptable tests, with at least a 30 second rest between 
manoeuvres. The highest value for each measurement was recorded for 
analysis (acceptability criteria: within 5% or 0.1 1 of the next highest 
measurement). If the third attempt produced the highest measurement further 
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manoeuvres were performed until a plateau was reached (attempts limited to 
five). All volumes were expressed at body temperature and pressure 
saturated with water vapour (BTPS), and read to the nearest 0.025 I. 
The accuracy and linearity of the Vitalograph was checked on a weekly 
basis using a 1 1 syringe (Vitalograph Ltd), compared to the manufacturers 
tolerence limits and adjusted if necessary. It was checked for air leaks daily. 
3.4 Heart Rate 
During the laboratory based tests (incremental threshold loading and 
treadmill exercise tests) the heart rate was monitored continuously with a 
single lead ECG signal (Graseby Medical, Cardiac Monitor 304). The 
electrodes were applied to approximate the standard chest lead V5 (mid-line 
of right clavicle and 5th intercostal space, left anterior axilla). The mon itoring 
electrodes were attached after preparing the areas with alcohol and light 
abrasion to improve electrical contact. The cardiac monitor displayed a 
continuously updated heart rate (measured from R-R wave time), a real-time 
ECG signal and a static baseline signal for comparison. 
During the field walking tests the heart rate was monitored using a short 
range telemetry device (Polar Electro, Sports Tester PE3000). The device 
consists of a transmitter on a belt worn around the chest and a receiver worn 
around the wrist. The belt has two electrodes which are placed over the 
heart. Electrical contact is achieved by wetting the electrodes. The receiver 
has a memory for storing the heart rate signal and a stopwatch facility to 
enable synchronisation between the exercise period and monitoring. The 
heart rate was monitored continuously, and the 15 second average recorded 
for data analysis. 
3.5 Respiratory gas analysis and ventilation measurement 
Measurements of oxygen consumption and ventilation were made using the 
OxyconBeta system (Mijnhardt Ltd., Holland). This is a fully computerised 
breath-by-breath exercise testing system incorporating fast-response oxygen 
51 
(paramagnetic) and carbon dioxide (infra-red) gas analysers, and a flow-
turbine mouthpiece valve which detects inspiratory and expiratory airflow. 
The subject was required to breathe through a flanged rubber mouthpiece 
attached to the flow-turbine valve. A noseclip was used and all connections 
checked for leaks prior to testing. Gas flow through the flow-turbine unit is 
measured continuously by electronic detection (photo-diodes) of the rotation 
of the turbine vanes in the mouthpiece valve. Samples of inspiratory and 
expiratory gas are diverted to the analysers for the measurement of oxygen 
and carbon dioxide concentration. 
The system required a one hour warm-up period and was calibrated for gas 
analysis (room air, and 5% CO2 in nitrogen) and volume (3 1 syringe) prior to 
each test. The system has internal temperature and barometric pressure 
sensors to enable the correct gas volume measurement, and correction to 
STPS and standard temperature and pressure dry (STPD) as appropriate. In 
order to remain consistent with clinical practice, all gas volume 
measurements were calculated to BTPS with the exception of V02 and 
\fC02 which were calculated to STPD. 
The test-retest reliability of the gas analysis measurements were assessed in 
a preliminary study with six healthy subjects (appendix 1). In addition, to 
ensure quality control of measurements over a wide operating range, one 
healthy subject (SMR) performed an incremental treadmill test (4 x 2 min test 
stages) on a regular basis during the study periods (appendix 2). 
3.6 Treadmill 
A treadmill was used throughout the studies (Jaeger LE 3000). The gradient 
and speed were adjusted from a programmable touch-pad keyboard. The 
treadmill speed was checked at the start and periodically throughout each 
study period (appendix 3). 
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3.7 Incremental Shuttle Walk Test 
The incremental shuttle walk test is an incremental, externally-paced, 
symptom limited field test described by Singh (1992). The test consists of a 
10 metre course demarcated by cones. The object of the test is to walk at a 
set-pace around the course to reach a symptom limited maximum. The pace 
is externally controlled by bleeps from a pre-recorded cassette tape. The test 
is progressive and maximal, with increments in walking speed every minute. 
There are a set of standardised instructions to the patient at the start of the 
tape, which explain the purpose of the test and how it should be performed. 
The bleeps indicate when turning should occur around the cones. The test is 
terminated for anyone of the following reasons: too breathless to continue; 
too tired; unable to keep up the set pace. 
The total distance walked was recorded, and patients asked to rate 
breathlessness and perceived exertion at the end of the test from Borg 
scales (1982). Heart rate was recorded throughout the test using the short 
range telemetry device (Sport Tester, Polar Electro, Finland). 
3.8 Blood sampling 
Samples of arterialised capillary blood were taken for the analysiS of blood 
gases and pH, and for the measurement of lactate concentration. The 
samples were taken from the earlobe following vasodilation with a 
preparatory cream (Algipan, Wyeth laboratories). All traces of the cream 
were removed and the lobe was cleaned with alcohol and thoroughly dried 
before the ear was pieced with a lancet. For blood gas measurement 100 JlI 
samples were collected in heparinised glass capillary tubes, placed on ice 
and analysed within 10 minutes on a Coming BGA machine (Coming UK). 
The machine was fully automatic with half hourly calibration cycles in 
addition to a one-point calibration following each analysis. 
For the lactate analysis duplicate samples (20JlI) were collected and 
immediately deproteinised in 100 JlI iced perchloric acid (2.5%) to arrest 
metabolism and for subsequent storage at minus 70°C. The samples were 
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analysed at a later date using the fluorometric enzymatic micro-method 
described by Maughan (1982) (appendix 4). Quality control of the technique 
included regular analysis of commercially prepared Q.C. ampoules, with 
specified tolerance limits, to assess accuracy. Precision of the technique was 
assessed from the repeat analysis of a single blood sample. A coefficient of 
variation was calculated and a value of 3.3% was obtained (appendix 4). 
3.9 Borg rating of breathlessness and perceived exertion 
The sensations of breathlessness and perceived exertion were rated by all 
of the patients. Breathlessness was rated at rest and at the end of exercise, 
in addition to perceived exertion. Patients were asked specifically to rate 
how breathlessness they felt, and to rate how difficult the exercise felt, from 
the separate Borg scales. The Borg scale for breathlessness (1982) consists 
of a series of descriptors ranging from 'nothing at all' with a zero rating to 
'maximal' rated at 10. Similarly the scale for perceived exertion has a series 
of scores from 6 to 20 and descriptors ranging from 'very, very light' to 'very, 
very hard' from which subjects choose the most appropriate (appendix 5). 
3.10 The Chronic Respiratory Disease Questionnaire (CRDQ) 
The questionnaire was used to assess the emotional and functional stability 
of patients with COPD throughout the study periods. It was administered at 
the start of any study period and repeated every two weeks. The 
questionnaire was designed to assess four areas of a patients' well-being: 
dyspnoea; fatigue; mastery (control of the disease); and emotional function 
(Guyau 1987). The questionnaire consisted of 20 questions. The first 
question assessed the degree of breathlessness experienced during five 
activities identified by the patient. The remaining questions required the 
patient to select a numbered response from a range appropriate to the 
question. A comparison of the total score for each component was made 
between sequential administrations to examine functional stability. A 
significant change was deemed to have occurred if the total score had 
increased by at least 0.5 per question (maximum potential change for each 
component: dyspnoea 2.5; fatigue 2.0; emotion 3.5; mastery 2.0). 
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3.11 Subject recruitment, consent and ethical approval 
Patients were recruited from the medical out-patient clinics or from the 
Glenfield Hospital pulmonary rehabilitation course. The study was initially 
explained to the patient and, if they expressed an interest, a date for a 
screening visit was made. They were also provided with an information 
leaflet to read in their own time. At the screening visit patients confirmed they 
had read the study information leaflet and any questions were answered. 
Signed consent was then sought with the patient fully aware of the study 
entailment, risks and benefits. It was also made clear that withdrawal from 
the study was allowed at any time without the need to express a reason and 
without jeopardy to future treatment. 
Written submissions were made to the local ethical committee 
(Leicestershire Health) and approval was granted for all the studies 
undertaken. 
3.12 Prediction values and conversion factors 
Values pertaining to normal physiological function were calculated from a 
series of regression equations derived from studies of healthy populations. 
These are termed predicted values and were calculated for V02max (Bruce 
1973), HRmax (Wasserman 1994), FEV1 and FVC (Quanjer 1993), and Plmax 
(Black 1969). V Emax was calculated from an equation developed from 50 
patients with COPD (Spiro 1975). The regression equations are reproduced 
in appendix 6. 
The traditional units for mouth pressures and other pressure measurements 
relating to changes within the thorax are cm Hp. To remain consistent with 
clinical practice and for comparison with other published data the traditional 
units are used throughout. The conversion factor from cm HP to the SI unit 
kilopascal (kPa) is 0.098 (Le. 1 cm Hp = 0.098 kPa). 
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3.13 Statistical Methods 
Parametric statistical methods were employed for data that was interval 
and/or ratio with sample sizes ;?:10. Summary data is expressed as mean 
and standard deviation (SD), unless otherwise stated. Relationships 
between variables were examined using the Pearson Product Moment 
correlation coefficient (r), and the method of least squares was used for any 
regression analysis. Multiple linear regression was used to establish the 
determinants of exercise performance where there were two, or more, 
variables significantly related to a Single factor. The Student's t-test was 
used to examine the differences between two correlated means, and 
analysis of variance (ANOVA) used for multiple comparisons (i.e. greater 
than 2). The post hoc Scheffe test was used to determine where significant 
differences occurred. To express the level of agreement between repeat 
measurements the mean difference between two variables, the standard 
error (SE) and the 95% confidence intervals were calculated according to 
the recommendations of Bland and Altman (1986). Relationships and 
differences were considered significant at the 5% level. 
Non-parametric statistical methods were used for sample sizes < 10 and for 
non-continuous data. Both mean and median values have been calculated 
to summarise data. The Wilcoxon signed ranks test was used to assess the 
difference between correlated Borg scores and Friedman analysis of 
variance for multiple comparisons. The 5% level of significance was adopted 
throughout. 
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Chapter 4 
EVALUATION OF INCREMENTAL THRESHOLD LOADING OF THE 
RESPIRATORY MUSCLES IN COPD 
4.1 INTRODUCTION 
The static measures of respiratory muscle function e.g. Plmax and PEmax make 
no account of the performance of the muscles under dynamic conditions, or 
during the increased ventilatory demands imposed by exertion. Assessment 
of the ability of the respiratory muscles to respond to such conditions is 
offered by incremental threshold loading (ITL). The method imposes a 
threshold load to inspiration which may be altered in an incremental manner 
analogous to the use of a cycle ergometer or treadmill during a whole body 
exercise test. As such, the technique also offers the potential for the 
exam ination of the metabolic and cardio-respiratory responses to 
quantifiable increases in respiratory work. 
Many existing pharmacological and exercise training interventions have the 
potential to affect both respiratory muscle and whole body exercise 
performance. In order to evaluate changes in the functional capacity of the 
respiratory muscles arising from such interventions, simple and reproducible 
tests of respiratory muscle performance are desirable. Exercise training 
interventions may also influence the development of an exercise lactic 
acidosis. This is particularly important in COPD as its occurrence will burden 
the ventilatory system further as a result of the additional CO2 and W ions 
generated during the buffering process of the acid. There is little information 
regarding the contribution of the respiratory muscles to any lactic acidosis in 
COPD. Incremental threshold loading therefore provides the opportunity to 
examine changes in blood lactate following a period of increased ventilatory 
work. 
An electronic threshold loading device utalising a solenoid valve has been 
described by Bardsley (1993). The device demonstrated a number of 
advantages over the weighted plunger method in a group of healthy 
individuals. It was found to be accurate and linear over a wide range of 
mouth pressures and was unaffected by breathing pattern. However the 
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device has not been assessed within the clinical setting in patients with 
CO PD. 
Thus the purpose of this initial study was twofold: 
1. To examine the suitability of ITL, using the electronic solenoid valve 
device, as a simple method of assessing respiratory muscle performance, 
without external constraint, in a group of patients with COPD. 
2. To assess the energetics of the task in terms of V O2, V E' heart rate 
and blood lactate concentration. 
4.2 METHODS 
4.2.1 Patients 
Twelve patients (9 men, 3 women, mean age 61 years) with COPD were 
recruited from the out-patient clinics. The recruitment procedures and 
collection of demographic data conformed to the methods described in 
chapter 3. To ensure functional stability throughout the study, the Chronic 
Respiratory Disease Questionnaire (CRDQ) (Guyatt 1987) was administered 
at the start and every alternate week. Patients were requested to refrain from 
inhaled bronchodilators 4 hours prior to testing. None of the patients were on 
oral bronchodilators or theophyllines. 
4.2.2 Study Design 
The study involved performance of an ITL test on two separate visits (mean 
time between visits 15 days). The first visit was considered a practice 
session. All visits were at the same time of day. The baseline measurements 
were the same for each visit and included FEV1 and Plmax• During the ITL test 
the breath by breath mouth pressure (Pm) was recorded in addition to the 
pressure-time product (fPdt), achieved by integrating Pm with respect to time. 
Measurements of V02 , V E and HR were made at rest and throughout the 
test, and samples of blood collected before and after the test to determ ine 
lactate concentration. To assess test repeatability seven of the patients 
performed a third test during a further visit. The remaining patients had 
previous experience of ITL with the solenoid device and were therefore 
excluded from this limb of the study. 
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4.2.3 Incremental Threshold Loading 
The solenoid valve device has been described in detail elsewhere (Bardsley 
1993). It consists of a wide bore, 24 volt DC solenoid valve which opens 
when the required negative mouth pressure is attained, and closes on 
expiration. The mouth pressure was detected by a micro-transducer (Gould 
Instruments, Bilthoven, The Netherlands, model P50) located at the 
mouthpiece (figure 4.1). The output from the micro-transducer was fed into 
an amplifier and a display and alarm module (Gould, models 13-4615-50 
and 13-4611-12). The threshold pressure can be varied and was selected 
on a digital display. When the mouth pressure reaches the value set on the 
digital display an internal relay is actuated, connecting 24V from a Farnell 
L30 power supply to the solenoid valve via a latching circuit, so holding the 
valve open. During expiration pressure in the mouthpiece rises, triggering 
the high pressure alarm which resets the latching circuit and closes the 
valve. 
The FEV, and Plmax were measured before the threshold loading 
commenced. The Plmax was measured during a maximal inspiration from 
residual volume using a hand-held electronic mouth pressure meter, which 
incorporated a small air leak to reduce buccal pressure (Precision 
Instruments, DeVilbiss UK). A noseclip was used and the pressure sustained 
for 1 second was recorded, the best of three attempts was taken. If the third 
attempt produced the highest measurement, further attempts were made 
until a plateau was reached (limited to eight attempts). For the threshold 
loading, patients were seated in a hard-backed chair, asked to wear the 
noseclip and breathe through a flanged rubber mouthpiece. This was 
attached to the solenoid device and the flow-turbine measurement head of 
the gas analysis system (figure 4.1). Patients were asked to relax and 
breathe at a comfortable rate and depth. Tidal volume (TV) and breathing 
frequency (fR) were unrestricted and expiration was not loaded. 
The initial load and size of the one minute increments were determined 
individually for each patient, based on the measurement of Plmax• The aim 
was to achieve the maximum threshold load within approximately 10 
minutes, thereby avoiding fatigue and premature cessation of the test prior to 
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Figure 4.1 Schematic diagram of solenoid valve and flaw turbine head 
the achievement of maximal workloads. Thus a patient with a low Plmax, e.g. 
55 cm H20 would start at a threshold load of 10 cm H20 followed by 5 cm H20 
increments every minute. The test finished when the patient was unable to 
reach the set threshold pressure required to open the solenoid valve. The 
peak mouth pressure achieved was taken as the highest pressure achieved 
for a full minute. Throughout the test the breath by breath Pm, and the fPdt 
were recorded on a paper-strip chart (Gould, model 13-4615-09). Patients 
were asked to rate breathlessness and perceived exertion at the start and 
end of the test from Borg scales. 
4.4.4 Cardio-respiratory and metabolic measurements 
The breath-by-breath, computerised gas analysis system (described in 
chapter 3), was used throughout. Prior to the first threshold load, patients 
relaxed for 10 minutes with the mouthpiece and nose clips, breathing 
through the unrestricted apparatus. During the last five minutes of the rest 
period measurements of VE, V02, VC02TV, fR, VC02 to V02 ratio (RER) 
and end-tidal C02 (P ETC02) were recorded, and heart rate (HR) was 
measured from a single lead ECG. The breath by breath analysis was 
averaged over the last 30 seconds of each minute. The same cardio-
respiratory measurements were made throughout the threshold loading test. 
Prior to the start of the test a small sam pie of blood (2 x 20 ~I) was collected 
from the earlobe for measurement of the baseline lactate concentration, as 
described in chapter 3. Further blood samples were collected at 4 minutes 
post-testing. Previous studies which have examined respiratory muscle 
lactate production have used shorter sampling times, therefore to examine 
the effect of time, samples were also taken at 2 minutes after the end of the 
test from six patients. The blood was stored at minus 70'C and analysed 
later according to the method described by Maughan (1982) (appendix 4). 
4.3 RESULTS 
Three patients showed a deterioration in symptoms during the study from the 
onset of common colds (change in CRDQ scores and fall in FEV,). Testing 
on these patients was suspended until they returned to baseline levels. One 
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patient was unable to tolerate the noseclip for the duration of the test and 
was therefore eliminated from the analysis. The baseline FEV" Plmax 
measurements and anthropometric details of the group are presented in 
table 4.1 
4.3.1 Performance of incremental threshold loading 
An example of the inspiratory pressure wave form and the fPdt signal from a 
representative threshold loading test is shown in figure 4.2. All patients for 
whom data are presented, found the threshold loading technique 
acceptable. The mean maximal performance is shown in table 4.2, and the 
80rg ratings of perceived exertion and breathlessness at rest and at peak 
performance are shown in table 4.3. The Pm response was found to be 
linear over the range of set threshold pressures (-S to -100 cm H20), with a 
correlation coefficient of 1.000 (figure 4.3). The fpdt increased in a regular 
manner, and there was a good correlation with the threshold pressure 
(r:0.980) (figure 4.4). 
Evaluation of the relationship between peak ITL performance and baseline 
measurements revealed a significant relationship between peak Pm and 
Plmax (r=0.6S, p=0.03, figure 4.5), but only a weak relationship with FEV" 
(r=0.42, p>O.OS), and no relationship with FVC (r=0.267, p>0.05). There was 
no significant relationship between the pressure-time product and FEV, 
(r=0.119, p>O.OS), or with Plmax (r=0.378, p>0.05). 
4.3.2 Cardio-respiratory responses to threshold loading 
The cardio-respiratory response to the threshold loading is shown in table 
4.4. There were significant increases in V O2, V CO2• V E' TV and HR, and a 
significant decrease in the P ErC02 at the end of the test (p<O.OS). The mean 
increases from resting levels for VOlp.ak' VE and HR were 118 (52) (47%) 
ml.min·" 11.4 (6.S) (89%) l.min" and 12.4 (6.0) (16%) beat.min·' respectively. 
The increase in V E was achieved primarily by an increase in the TV rather 
than any change in the fR. 
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Table 4. 1 Summary of patient characteristics. 
Mean (SD) Range 
FEV, (I) 1.28 (0.33) 0.80 • 1.78 
FVC (I) 3.21 (0.54) 2.48 • 4.60 
(FEV,IFVCx100) 40 (10) 26 • 55 
(%) 
Plmax (cm HP) 78.4 (23.5) 40.7 • 126.5 
Age (y) 61 (6.6) 50 • 71 
Height (m) 1.72 (0.07) 1.58 • 1.80 
Weight (kg) 73.1 (13.4) 54.2 • 96.0 
n=12, 9 men, 3 women 
----- -
% of predicted 
43 (12) 
86 (13) 
81 (21) 
Mean (SD) and range for baseline lung function and anthropometric details 
of the patient group. Lung function measurements are also expressed as % 
of values predicted for a normal population. 
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Table 4.2 Peak performance during incremental threshold loading 
Mean (SD) Range 
peak Pm (cm HP) 52 (23) 20 • 100 
fPdt (cm Hp.s·') 1410 (867) 400 - 2750 
% of Plmax 65 (21) 41 - 127 
Time (min) 8.5 (3.0) 4.0 - 14.0 
n=11 
Mean (SD) and range for peak performance and total test time. 
Table 4.3 Borg scores for breathlessness and perceived exertion 
Mean {SD) Median Range 
rest 1.3 (1.1) 1 0-3 
BS 
peak 4.5 (2.2) 5 0-7 
RPE peak 16.7 (2.4) 17 11 - 19 
n=11 
Mean (SD), median and range of Borg ratings for breathlessness (BS) at rest 
and at peak threshold load, and for perceived exertion (RPE) at peak load. 
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and threshold pressure (Pth). The linear regression line has been drawn. 
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Table 4.4 Cardio-respiratory measurements during incremental threshold loading 
V02 VC02 VE 1V fr PETC02 
(mLmin") (ml.min") (Lmin") (ml) (breath.min") (kPa) 
Aest 250 (24) 222 (25) 12.8 (2.6) 847 (292) 16.3 (4.2) 4.21 (0.68) 
212 - 302 186·267 9.6 - 18.5 564 • 1572 10 - 22 2.99 • 5.38 
Peak Load 367 (65)* 359 (62)* 24.2 (6.2)' 1628 (501)' 15.5 (4.9) 3.46 (O.46)' 
296 - 540 293·503 13.8 • 33.4 1078 - 2441 6 - 21 2.39 - 4.18 
n-11, ' p < 0.05 (peak c.t. rest) 
Mean (SO) and range for cardio-respiratory measurements at rest and at peak threshold load. 
AEA HA 
(beat.min") 
0.92 (0,10) 77 (15) 
0.79 - 1.02 56 • 102 
0.98 (0.13) 89 (18)' 
0.82·1.15 58 - 122 
The relationship between V02peak and peak Pm was weak with a correlation 
coefficient of 0.510, p>0.05. There was no relationship between V02peak and 
fPdt (r=0.122, p>0.05). Two patterns emerged from the individual responses 
in V02 to increasing threshold loads. Two patients had a fairly linear 
increase in V02 with increasing threshold load, whilst the more typical 
response was a jump in V02 during the initial load, followed by small and 
fluctuating increases until the peak load was reached. The mean response 
in V02 and VEto progressive threshold loads is illustrated in figure 4.6. 
4.3.3 Lactate response to threshold loading 
All patients had samples collected at 4 minutes post-loading, and six 
patients had an additional sample collected at 2 minutes post-loading to 
assess any time effect. The mean concentrations at baseline, 2 and 4 
minutes post-loading are shown in table 4.5, and the mean increases from 
baseline (Ll) are also given. There was no significant difference between the 
baseline and 4 minute measurement, however the difference between 
baseline and the 2 minute concentration was of borderline significance 
(p=0.05). There was a significant relationship between the lactate 
concentration and the peak Pm (r=0.800, p<0.05), figure 4.7. 
4.3.4 Test repeatability 
To examine the variability of the technique seven of the patients had an 
additional test on a further visit, giving a total of three tests performed on 
separate occasions (table 4.6a). Analysis of variance of repeat measures 
showed there was no significant difference between Pm, fPdt, V02peak and 
V E measured at peak threshold load on the three test occasions (p>0.05). 
The mean differences between the three tests and the 95% confidence 
intervals are shown in table 4.6b. The smallest differences for peak Pm and 
fPdt occurred between tests 2 and 3, suggesting the test repeatability 
improved following one practice test. There was a significant correlation 
between the differences in peak Pm for tests 2 and 3 and the mean of the 
measurements (r=0.765) (figure 4.8). The V02peak and V E measurements at 
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Figure 4.6 Mean (SE) V02 and VEwith increasing mouth pressure (Pm). 
o indicates the number of values at each threshold load. 
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Table 4.5 Capillary blood lactate response to incremental 
threshold loading 
Baseline 2 mins 4 mins Ll2 min 
Lactate 0.68 (0.29) 1.04 (0.29)* 0.82 (0.26) 0.32 (0.21)* 
(mmol.l"') 0.29-1.76 0.64 - 1.31 0.49-1.18 0.07 - 0.56 
2 min n=6, 4 min n-l0 * p-O.05 (post test c.f. baseline) 
Ll4 min 
0.15 (0.24) 
0.00- 0.70 
Mean (SO) and range of blood lactate concentrations at baseline, 2 and 4 
minutes post loading. The mean increases from baseline levels (Ll) are also 
shown. 
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Assessment of Test Repeatability 
Table 4.6a Peak performance during repeat incremental threshold 
loading tests 
JPdt peak Pm V02peak V E peak (cm H2O) (cm H2O.s·') (ml.min·') (I.min·') 
Trial 1 48.7 (7.6) 1646 (293) 399 (19) 26.4 (3.7) 
Trial 2 52.1 (8.2) 1473 (247) 417 (35) 24.3 (2.7) 
Trial 3 52.6 (10.0) 1363 (297) 370 (31) 22.0 (2.4) 
n=7 
Mean (SO) peak values achieved during ITL performed at three separate 
visits. 
Table 4.Gb Mean differences between repeat tests. 
JPdt Test peak Pm V02peak V E (cm HP) (cm Hp.s·') (ml.min"') (I.min·') 
2 - 1 3.4 (2.6) -173 (218) 12 (34) -1.5 (2.3) 
'2.9 - 9.8 707 - 361 "83 - 108 "8.0 - 5.0 
3-1 3.9 (3.7) -283 (225) -22 (15) -3.1 (2.0) 
"5.3 - 13.0 "833 - 268 "64 - 20 "8.6 - 2.5 
3-2 0.4 (2.3) -110 (201) -35 (37) -2.2 (1.4) 
"5.3 - 6.1 "603 - 383 "127 - 56 "2.2 - 9.8 
n-7 
Mean differences (SE) and 95% confidence intervals between repeat tests. 
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peak load show a wide variability between tests (figure 4.9 illustrates the 
differences between repeat V02peak measurements). The limits of agreement 
(Le. mean difference ± 2 sd), which provide an estimate of the widest 
deviation likely to be observed, were -233 to 163 ml.min·' for V02peak and -
9.8 to 5.41. min" for V E' for tests 2 and 3. 
4.4 DISCUSSION 
The incremental threshold loading test using the solenoid valve device was 
simple to administer and acceptable to all the patients. The one patient who 
failed to complete the test did so because of an intolerance of the noseclip 
and not as a result of the loading sensation experienced during inspiration. 
In the initial developmental study, which assessed the response of the 
solenoid valve in a group of healthy subjects, the mouth pressure response 
was found to be accurate and linear over a wide range of threshold 
pressures (Bardsley 1993). A linear response was maintained with the group 
of patients examined in this study, which presented a wide range of airflow 
obstruction from moderate to severe. The workload protocol of one minute 
increments (size of increment individually determined for each patient 
according to the baseline Plmax) achieved the maximum threshold load within 
approximately 10 minutes, thus ensuring the test did not exhaust patients 
prematurely, and was quick and simple to apply. 
The increase in V E during ITL was achieved primarily by increasing TV 
whilst fR remained unchanged. This pattern of change has also been 
reported in normal subjects (Van os 1990). However, it is in contrast to the 
findings from Kelson (1978) in a study of six patients with CO PD. A decrease 
in fA and a less than compensatory increase in TV were measured, resulting 
in an overall drop in V E and an increase in PETC02• The threshold loading 
was at a constant load of 40 cm H20 (40 to 57% of individual Plmax), and was 
maintained for at least 10 minutes. The author concluded that adequate 
ventilation may not be sustainable when high loads (relative to Plmax) were 
presented for prolonged periods of time. 
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The change in the breathing pattern during the threshold loading was 
different from that which usually occurs during either disease exacerbation 
or during whole body exercise in COPD. During exercise patients with 
COPD increase fR in addition to increasing lV (Spiro 1975), and tachypnea 
is a feature of disease exacerbation (Pride 1995). The failure to reproduce 
similar changes in the breathing pattern to those seen during naturally 
occuring instances of increased mechanical load in COPD i.e. exercise or 
exacerbation, represents a limitation of the threshold loading test. 
The protocol adopted in the current study was different from the constant-
load test employed by Kelson (1978). It was incremental, starting with low 
threshold loads which increased every minute, and the average time of the 
test was 8.5 minutes, therefore the higher loads were tolerated for shorter 
periods. Respiratory muscle fatigue has been shown to occur during the 
application of loads of 60 - 75% of Plmax in normal subjects (Roussos 1977). 
Fiz (1990) demonstrated that respiratory muscle strength (Plmax) decreased 
in patients with COPD after constant threshold loads, equivalent to 65% of 
Plmax, were applied to exhaustion. The authors suggested this reflected the 
occurrence of high frequency fatigue following the application of high 
threshold loads. 
The results from the current study demonstrate patients with COPD are able 
to increase ventilation during incremental and progressive threshold loading 
of relative short duration, however this response may change with 
endurance loading. The finding suggests patients are able to respond 
appropriately to short periods of increased mechanical load e.g. dynamic 
hyperinflation during exercise, whereas the findings from other workers 
(Kelson 1978) suggest prolonged periods of increased loading in COPD, 
e.g. as a result of infection or exacerbation of symptoms, may interfere with 
the ability to maintain adequate alveolar ventilation. 
The increase in V E is further supported by the significant fall in P ETC02 
suggesting a degree of hyperventilation. Previous reports of hyperventilation 
with threshold loading are mixed. It was recorded at low threshold loads in 
seven normal subjects, but at higher loads (>55%Pm/Plmax) there was an 
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increase in the P ETC02 (Martyn 1987). Conversely, an elevated P EP02 was 
recorded during assessments of endurance (Nickerson 1982), and during 
incremental loading, where it occurred only at the higher threshold loads 
(Eastwood 1994). Both of these studies were performed with normal 
subjects. In a study from Vanos (1990), which employed sustained threshold 
loading at four loads in normal subjects, there was a decrease in P ETC02' 
The fall was less profound at high loads, but was significant for loads of 20, 
40 and 60% of Plmax• The results from the current study have demonstrated 
hyperventilation with ITL occurs in the presence of COPD. 
Overall, the evidence to date suggests threshold loading does provoke 
hyperventilation in normal subjects and the effect is influenced by the 
relative workload. At high loads it is diminished or absent and at very high 
loads P EP02 may increase, suggesting alveolar hypoventilation. The 
present study confirms the hyperventilatory effect is preserved in COPD, up 
to threshold loads of 65% of Plmax presented for short periods of time. 
The protocol adopted for the current study did not control for end-expiratory 
lung volume (EELV). This may have changed as a consequence of the 
increased ventilation and any dynamic hyperinflation would impose an extra 
burden (additional to the external threshold load) to the oxygen cost of the 
exercise. In normal subjects ITL has been shown to cause a progressive 
decline in EELV, which approached RV at high loads (Eastwood 1994). A 
decrease in EELV places the inspiratory muscles at an advantageous 
position on the length-tension curve for the generation of greater inspiratory 
pressures (Pride 1995). Conversely, it is well documented that EELV 
increases with increasing ventilation in COPD e.g. during progressive 
exercise (Pride 1995). Therefore it may be reasonable to assume the 
increased ventilation seen during the ITL provoked an increase in the EELV. 
However there was a significant increase in TV, which suggests changes in 
diaphragm length, as a result of any increases in EELV, were minimal and 
did not effect inspiratory muscle function adversely. To determine the extent 
of any hyperinflation and its effect on performance would have required the 
imposition of more complex measurements e.g. inductance pneumography. 
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The purpose of this study was to evaluate unconstrained performance which 
allowed the development of individual responses to the task. The cardio-
respiratory changes therefore represent the resultant cost of the individual 
strategies adopted. 
The relatively small increase in 'if O2 during ITL, in comparison to the 
approximate four-fold increases recorded during whole body exercise in 
COPD (Brown 1985), reflect the small muscle mass involved in the 
performance of the task. The increased 'if02 at peak Pm was in response to 
the additional cost of the respiratory exercise over and above the 
requirements whilst resting in an upright, sitting position. Patients were 
instructed to relax, and to breathe at a comfortable rate and depth, any 
changes were the result of the strategy adopted to overcome the additional 
resistance to breathing. The magnitude of the 'if02peak was greater than the 
V02peak measured in a recent study of 7 patients with COPD who performed 
constant threshold loading (40% of Pl max for 10 minutes) (Gosselink 1995). 
The constant load test yielded a 'if02peak of 288 ml.min·', whilst at maximal 
loads a 'if 02peak of 367 ml.min·' was measured in the current study. The 
difference between the values of 'if 02peak from the 2 studies enforces the 
maximal nature of the incremental protocol. 
A similar percentage increase in 'if02 (55% vs 47% from the current study) 
was measured in normal subjects at 65% Plmax using the weighted plunger 
method and with two minute increments in load (Martyn 1987). However 
there are few data available concerning 'if02during ITL in COPD. The same 
is true for the HR response during the technique. A HR of 93 beat.min" was 
reported by Nickerson (1982) following measurement of sustainable 
inspiratory pressure using the weighted plunger device. This is slightly 
higher than the 89 beat. m in" from the current data, despite a similar 
achievement of %Plmax• However, the former measurement was in a group of 
younger subjects, therefore the % maximum HR may well be similar. 
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The mean maximal %Plmax achieved by the patients was lower than 
achieved by the group of healthy subjects using the solenoid valve (65 
versus 90%) (Bardsley 1993). Other studies on healthy subjects using the 
weighted plunger method with an incremental protocol have also achieved a 
higher %Plmax (Martyn 1987, McElvaney 1989, Eastwood 1994). In an age-
matched controlled study, 79% of the Plmax was achieved in healthy, elderly 
subjects compared to 48% in 8 patients with severe COPD (Morrison 
1989a). A similarly reduced %Plmax of 41% was also reported by van't Hul 
(1995) in 20 patients with moderate to severe COPD. 
Respiratory muscle function is compromised in COPD (Rochester 1989) and 
the reduced %Plmax was not a surprising finding of the study. Additionally, 
any increase in EELV, as a result of the additional external load, would act to 
reduce further the pressure generating capacity of the respiratory muscles. 
Normal subjects possess the capability to reduce EELV which would act to 
improve the force generating capacity of the diaphragm. However, other 
factors affecting both respiratory muscle strength and endurance capacity in 
COPD are also likely to contribute to a reduced performance. These have 
been discussed in chapter 2, and include nutritional influences, medication, 
hypoxia and hypercapnia. 
The patients from the current study managed to achieve a higher %Plmax 
compared to the findings of Morrison (1989a) and van't Hul (1995) despite a 
similar degree of airway obstruction in the patients studied. This might be 
explained by the differences in protocol and loading device used. A two 
minute incremental protocol and a weighted plunger device were used in the 
previously cited studies. The weighted plunger requires the maintenance of 
the threshold pressure throughout inspiration to hold the plunger open, 
whereas this is not a requirement with the solenoid valve. As a consequence 
greater work (JPdt) is performed with the weighted plunger for equivalent 
threshold loads (Bardsley 1993). The additional work performed throughout 
inspiration (holding the plunger against gravity), will influence the onset of 
muscle fatigue and therefore the maximum pressure achieved. Additionally, 
a two minute incremental protocol will increase the work performed and 
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energy consumed, and may lead to the premature cessation of the test, prior 
to the achievement of a true maximal pressure. 
The solenoid valve device presents a true threshold load, i.e. a load is 
applied only during the initial stages of inspiration, and is therefore more 
akin to the development of PEEPi as a result of dynamic hyperinflation in 
COPD e.g. during exercise. However, it may be argued a true threshold load 
does not entirely mimic the processes present during exercise or symptom 
exacerbation in COPD. In reality, patients with lung hyperinflation have to 
overcome a true threshold (PEEPi) as a prelude to inspiration, before the 
airways obstruction imposes a resistive load. In this respect the ideal device 
would be a combination of an initial threshold load followed by a resistive 
load. 
The Plmax measured prior to the ITL test was reduced in the patient group 
(81% predicted) and although TLC and its subdivisions were not reported, 
when corrected for lung volume Plmax is often normal or supra-normal in 
patients with COPD (Rochester 1991). However, the absolute value of peak 
Pm aChieved at the end of the threshold test was reduced in comparison to 
values from a healthy, elderly group described by Morrison (1989a) where a 
mean value of 95 cm H20 was reported. The reduced value from the group of 
patients examined was an expected finding of the study. The physiological 
consequences of COPD on the respiratory muscles are widely described 
(Rochester 1979 and 1991) and discussed in detail in chapter 2 of this 
thesis. 
The relationship between Plmax and peak Pm was significant, however it was 
only moderate (r=O.650). Plmax is a static measure which assesses maximum 
inspiratory pressure generated during a single manoeuvre, and reflects 
global respiratory muscle strength (Gibson 1989). Bellamere (1982) 
demonstrated respiratory muscle endurance was related to the force and 
duration of respiratory muscle contraction. The fraction of maximal force 
(Plmax) generated during each breath was shown to be an important factor in 
endurance capacity. Therefore, respiratory muscle strength will influence 
endurance and incremental dynamic performance, however the moderate 
relationship suggests other factors are important in the determination of peak 
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Pm. These may include: the development of respiratory muscle fatigue (this 
was possible since the critical pressure required to induce respiratory 
muscle fatigue was reached by some patients (60-75% Plmax• when using 
alinear resistances, Roussos 1977)); perception of breathlessness; general 
exhaustion; nutritional (substrate) status; and generalised muscle weakness. 
Baseline lung function (FEVl and FVC) appeared to have little effect, with 
poor and non-significant relationships with peak Pm. 
A number of studies have examined the endurance time for a particular load 
(Tllm) (McElvenay 1989) or determined the maximum load which can be 
tolerated for a specific time (Nickerson 1982, Martyn 1987). McElvenay 
(1989) reported less intra-individual variability using a two minute 
incremental test compared to an endurance test. Improved reproducibility 
and a greater maximal performance were also reported by Martyn (1987) 
using an incremental protocol, compared to the measurement of sustained 
inspiratory pressure over a 10 minute period. The purpose of the protocol 
adopted for the current study was to examine the response to quantifiable 
increases in workrate in a continuous test, and in a manner that was 
analogous to achieving a peak workload on a cycle ergometer or treadmill. 
Use of a standardised protocol with well defined end points is essential if the 
test is to be repeated at a later stage to assess the effects of an intervention, 
or to monitor progress. 
An important aspect of the protocol was the avoidance of any external 
controls for TV, inspiratory time and flow, and fA. Previous work has shown 
that breathing pattern influences the measurement of Tllm (Clanton 1985). 
However, Morrison (1989b) reported it was unnecessary to fix fR during 
incremental loading tests, following a comparison of fixed and unfixed fA. In 
a comparison of naive and experienced patients with COPD, Richardson 
(1988) reported good repeatability between incremental tests performed on 
three occasions without any external constraints on breathing pattern. The 
effect of unfixed and fixed breathing pattern was examined by Bardsley 
(1993) using the solenoid valve device. Though subjects tended to reduce fA 
and shorten the duty cycle, there was no difference between the peak Pm, 
%Plmax and fPdt achieved at the end of the tests. One of the main objectives 
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for the current study was to measure the response to increases in workload 
with the patient able to respond freely to the challenge and therefore mimic 
real life. The absence of external constraints allowed patients to develop 
their own strategy, thus reflecting a more natural response to the imposed 
task. 
The repeatability obtained for peak Pm was similar to that found by Hopp 
(1993) in patients with COPD, using the weighted plunger. The author 
recommended one practice test after finding a significant difference between 
the first and subsequent visits. This view is supported by the current findings, 
the smallest differences occurred after one practice test. Other studies have 
reported no significant differences in peak Pm and %Plmax on repeat testing 
in normal subjects (McElvenay 1989, Morrison 1989a) and in COPD 
(Richardson 1988, Morrison 1989a). The significant correlation between the 
differences of repeat peak Pm and the mean of the measurements (figure 
4.8) suggests repeatability changes with the magnitude of the measurement. 
At the extreme values of peak Pm (~ 100 cmH20) the difference between 
repeat tests represented 10% of the measurement. However for lower values 
of peak Pm, closer to group mean value, the differences between repeat 
tests equated to ±6'7'0. 
In contrast to the good repeatability of the peak Pm, there was wider 
variability in the V02peak and V E measurements. This finding suggests the 
internal work performed varied between tests e.g. extent and pattern of 
muscle recruitment, possible changes in EELV, whilst the external work 
remained consistent (Le. Pm and jPdt). This contrasts with measurements of 
whole body exercise in COPD, were good repeatability of V02peak and 
maximal work rate implies both internal and external components remain 
consistent (Brown 1985). Data from the preliminary evaluation studies of the 
gas analysis equipment revealed good repeatability of measurements 
(appendix 1) with a mean difference of 14 ml.min·' for repeat measurements 
of V02peak at maximal exercise work rates with limits of agreement (± 2 SD) 
of -148 to 121 ml.min·'. The poor repeatability of the V02peak and V E during 
ITL suggests this aspect of the test might be less useful for repeat studies. 
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Previous studies have shown blood lactate concentration peaks at 
approximately 4 minutes following whole body exercise in normal subjects 
(Astrand 1986). In this study there was no significant change in lactate at 4 
minutes post-loading. However a small and significant increase occurred at 
2 minutes post-loading suggesting a sampling time effect. This may have 
been examined further by the use of serial sampling throughout the exercise 
period, in addition to the recovery period. Because of the relatively small 
muscle mass involved in the performance of the task lactate production will 
be small and result in a low blood concentration. Lactate is rapidly broken 
down by the liver, heart and the resting skeletal muscle, and any small scale 
production is likely to have been processed rapidly. 
A number of workers have investigated several different ventilatory 
challenges, to provoke a lactate response, with mixed effect. Freedman 
(1983) found a small but significant increase in lactate (li 1.10 mmol.r') 
following sustained maximum voluntary ventilation (SMVV) in normal 
subjects but no effect from a resistive load over a period of 200 breaths. 
Conversely Cooke (1983) was unable to measure any change in blood 
lactate following SMVV manoeuvres in 5 patients with COPD. Eldridge 
(1966) was able to provoke an increase in lactate in normal subjects 
following a period of increased ventilation induced by a large dead space 
whilst breathing a reduced oxygen concentration of 15%. Again the 
increases were only small (li 0.41 mmol.r'). The results from the current 
study demonstrate an additional threshold load to breathing does provoke 
an increase in blood lactate concentration in COPD. In addition there was a 
good, positive relationship between the peak blood lactate concentration 
and the peak threshold load achieved (r=0.800). How this lactate production 
relates to lactic acid production during whole body exercise in COPD is 
examined in the second part of the study and described in chapter 5. 
In summary, the results of this study have shown firstly, ITL using the 
solenoid valve device with standardised increments of workload can be 
used to evaluate respiratory muscle performance in COPD. Without 
imposing cumbersome and artificial external regulation, the test was 
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repeatable for peak Pm and fPdt. It also required only one practice test. 
Secondly, there was a significant increase in V O2, V E and HR during the 
test. The small increase in V02 reflected the small muscle mass involved in 
the performance of the task. The technique also provoked a small increase 
in blood lactate, and there was a linear relationship with the threshold load. 
Although there were significant increases in the cardio-respiratory 
. measurements there was wide variability between repeat tests. Thus serial 
assessment of the energetics of the task, which reflect the internal work 
performed during threshold loading, would be unreliable. 
Decramer (1994) suggests the clinical relevance of assessing respiratory 
muscle performance is largely unclear. If ITL is to be used as a measure of 
performance to assess impairment, monitor progression and evaluate 
therapeutic intervention, its sensitivity to change and how it relates to other, 
conventional measures of functional capacity is an important consideration. 
The second part of this study, described in the following chapter, therefore 
addresses two issues: 1) how ITL relates to whole body exercise 
performance and 2) the effect of an inhaled bronchodilator on respiratory 
muscle performance. 
86 
Chapter 5 
THE ROLE OF INSPIRATORY MUSCLE PERFORMANCE AND 
THE EFFECT OF IPRATROPIUM BROMIDE ON MAXIMAL 
EXERCISE CAPACITY IN COPD 
5.1 INTRODUCTION 
The previous chapter demonstrated ITL was a simple and reproducible 
indicator of respiratory muscle performance in COPD. The test was capable 
of eliciting an increase in blood lactate concentration and provoked a 
significant cardio-respiratory response. This chapter describes the second 
part of the study which aimed to develop further an understanding of the ITL 
test, its clinical relevance, sensitivity to an intervention and the nature of any 
association with the exercise response in COPD. The study examined how 
ITL related to conventional measurements of whole body exercise, and 
determined the effects of an inhaled bronchodilator on both the respiratory 
muscle and whole body exercise performance. 
Several studies have investigated the relationships between static 
respiratory muscle function and exercise capacity in COPD (Mahler 1988, 
Dillard 1989, Loiseau 1989, Wijkstra 1994). In addition the effects of various 
training regimens on static respiratory muscle function and exercise capacity 
have been examined (Pardy 1981, Larson 1988, Lisboa 1994, Wanke 
1994). If respiratory muscle endurance is important in the ventilatory 
limitation to exercise, as suggested by Decramer (1994), and ITL mimics an 
increase in PEEPi, the resultant threshold load from dynamic hyperinflation, 
then the question of how ITL relates to whole body exercise performance 
arises. Specifically, this study addressed whether dynamic indices of 
respiratory muscle performance, namely peak Pm and fPdt, were associated 
with the maximal exercise response in COPD. 
Inhaled bronchodilators are commonly used in the treatment of COPD. The 
anticholinergic agent ipratropium bromide (IB) is frequently used either 
singly or in combination therapy with B2-agonists. However many patients 
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show a variable and often poor spirometric response to bronchodilators 
though symptomatic relief is reported (Guyatt 1988, Chrystyn 1988). In 
addition, several studies which have demonstrated clinically trivial changes 
in lung function, report significant improvements in exercise tolerance and 
the subjective response to exercise (Chrystyn 1988, Hay 1992, Grove 1996). 
The mechanisms by which bronchodilators might improve exercise tolerance 
are not fully elucidated, though evidence suggests a reduction in dynamic 
hyperinflation and changes in airway resistance reduce the mechanical 
load, and lead to reduced exercise breathlessness (Belman 1996). Thus the 
question arisies, if bronchodilators lead to a reduction in the mechanical 
load is there a concurrent improvement in respiratory muscle performance 
detectable by ITL? 
This study had the following aims: 
1) To examine how ITL relates to measurements of whole body exercise 
performance. 
2) To evaluate the sensitivity of ITL to an inhaled bronchodilator. 
3) Compare changes in whole body exercise performance and ITL 
following an inhaled bronchodilator. 
5.2 METHODS 
5.2.1 Patients 
The same 12 patients (mean FEV, 1.32 1, age 62) described in chapter 4, 
attended for an additional 5 visits to complete this part of the study. All the 
patients (9 men, 3 women) had COPD as the primary diagnosis, had 
reported symptomatic relief from inhaled bronchodilators and had shown 
some improvement of spirometric indices on a previous occasion. Seven 
patients were using inhaled steroids, 9 an inhaled B2-agonist, and 6 inhaled 
lB. Patients were requested to refrain from their inhaled bronchodilators 4 
hours prior to testing. The CRDQ was administered every two weeks to 
assess functional stability. Patients with co-existent cardiac disease or 
locomotor disorders were excluded. 
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5.2.2 Study Design 
On separate days, and following practice sessions for each test (performed 
at a previous visit), patients performed a maximal treadmill exercise test, an 
incremental shuttle walk test and an ITl test. The order of testing was 
randomised, and followed the administration of nebulised IB (250 Ill), or 
normal saline placebo (P), in double-blind, randomised, cross-over manner. 
The FEV, and FVC were measured before and 30 minutes after the 
nebulised solutions. The Plmax was measured on the ITl test days following 
nebulisation. All tests were performed at the same time of day. 
Measurements of V O2, V E and HR were made throughout the ITl test and 
the treadmill exercise tests. lactate was measured from arterialised earlobe 
blood samples at rest and following each of the test conditions. Patients 
were asked to rate breathlessness and perceived exertion from Borg scales 
at the start and end of each test. 
5.2.3 Incremental Threshold Loading 
The technique and solenoid valve have been described in detail in chapter 
4. Prior to the commencement of the test Plmu was assessed as described in 
chapter 4. The peak Pm achieved was taken as the highest pressure 
achieved for a full minute. 
5.2.4 Treadmill Test 
This was an incremental, symptom-limited test. A brisk walking pace was 
determined initially for each patient during a practice test. The walking pace 
remained constant throughout. The gradient was increased every 2 minutes 
by 2.0% from an initial setting of zero. The aim was to achieve a symptom 
limited maximum performance within 8 to 10 minutes. A single-lead ECG 
was monitored throughout. All the patients were encouraged to give 
maximum effort, and to indicate when they were unable to continue because 
of breathlessness, fatigue or for any other reason. 
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5.2.5 Shuttle Walk Test 
The test was performed as described in chapter 3. The heart rate was 
monitored and the total distance walked recorded. 
5.2.6 Cardia-respiratory and Metabolic measurements 
The V02 and V E were measured during the treadmill exercise and the ITL 
test using the computerised gas analysis system (described in chapter 3). 
Prior to testing patients relaxed for 10 minutes with the mouthpiece in and 
with the noseclip on. During the last 3 to 5 minutes of the rest period the gas 
analysis and HR measurements were recorded. The breath by breath 
analysis was averaged over the last 30 seconds of each minute. 
Arterialised capillary blood samples were collected from the earlobe (2 x 20 
Ill) at rest and 4 minutes post testing for the measurement of lactate 
concentration. The technique and analysis was described in chapter 3. 
5.3 RESULTS 
Three patients showed a deterioration in symptoms during the study, from 
the onset of common colds, (fall in CRDQ scores, and in baseline FEV1). 
Testing on these patients was suspended until they returned to baseline 
levels. One patient was unable to tolerate the noseclip during the ITL test, 
but was able to complete the treadmill and the shuttle walk tests. The mean 
time between visits was 7.4 (5) days. The anthropometric details and 
baseline lung function were as shown in table 4.1 (chapter 4). 
There was a minor degree of breathlessness at rest (prior to the 
commencement of any testing) with a mean Borg score of 1.5 (1.2) (median 
score 1.0) for all visits. Most patients had some improvement in spirometric 
measurements following IB, though the response was variable. The FEV1 
response to IB and P is shown in table 5.1. The V02pe .. , V E and HR at peak 
treadmill exercise were compared to predicted values and shown in figure 
5.1. 
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Table 5.1 FEV, pre· and post-nebuliser at six different test visits 
p 
18 
n=12 
pre 
post 
pre 
post 
Treadmill 
1.32 (0.12) 
1.25 (0.11) 
1.33 (0.10) 
1.52 (0.14) 
Shuttle 
1.28 (0.09) 
1.28 (0.11) 
1.32 (0.12) 
1.49 (0.16) 
ITL 
1.32 (0.10) 
1.28 (0.10) 
1.32 (0.12) 
1.56 (0.14) 
Mean (SO) FEV, (I) pre- and post-placebo (P) and ipratropium bromide (IB) 
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Figure 5.1 Peak treadmill achievement expressed as mean % of 
predicted values (±SE) (P) 
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5.3.1 Effect of ipratropium bromide 
The mean ventilatory, gas exchange and heart rate responses at peak 
workload for each of the test conditions following both treatments are given 
in tables 5.2 - 5.4. With the exception of the shuttle walk test there was a 
tendency for higher values following IB, though the differences between 
treatments only reached significance for peak V Epeak (ITL and the treadmill 
test). There were no significant treatment effects on the peak work rates 
achieved (treadmill time, peak Pm, fPdt, shuttle distance). The differences 
between treatments for the treadmill V02peak and HRpeak showed borderline 
significance (p values were 0.053 and 0.055 respectively). 
The blood lactate concentrations increased significantly from resting values 
following the treadmill and shuttle walk tests for both treatment conditions. It 
reached significance during ITL following IB only (p=0.03). Following IB, 
treadmill exercise provoked a significantly greater change from baseline 
levels (t. lactate) than the shuttle walk test. However there were no 
significant differences between the peak lactate concentrations following the 
treadmill and the shuttle walk test. A summary of the lactate analysis is given 
in table 5.5. 
There were no treatment effects on the subjective rating of breath lessness 
and perceived exertion for all of the test conditions. However breathlessness 
was rated significantly higher following the treadmill test compared to the ITL 
and shuttle walk test. Perceived exertion was significantly lower following 
the shuttle walk test compared to the treadmill and ITL. The mean and 
median results for both sensations are given in table 5.6. 
5.3.2 Relationships between test variables 
The peak Pm correlated significantly with treadmill V E peak' (figure 5.2) and 
with treadmill V02peak following IB (table 5.7). The correlation with treadmill 
time and shuttle walking distance was poor (r=0.502 and r=0.529 
respectively, p>0.05). There was a significant correlation with Plmax (r=0.794, 
p<0.01, and r=0.650, p<0.05 following IB and P respectively), but not with 
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Table 5.2 Peak performance and cardio-respiratory response to incremental threshold loading 
Plmax Peak Pm % Plmax jPdt V02peak V Epeak (cm HP) (cm H2O) (cm Hp.s·') (ml.min·'.kg·') (I. min") 
p 78.5 (7.1) 52 (7) 65.3 (6) 1410 (261) 5.1 (0.3) 24.2 (1.9) 
41 - 127 20 - 100 41 - 127 400 - 2750 3.5 - 6.4 13.8 - 33.4 
IB 78.1 (7.8) 53 (7) 67.8 (4) 1876 (337) 5.6 (0.5) 27.3 (1.9)' 
42 - 126 30 - 109 42 - 126 640 - 4240 3.7 - 8.9 18.4 - 38.6 
n=11, * p<0.05 for differences between treatments 
Mean (SE) and range of peak performance and cardio-respiratory response to ITL following placebo (P) and 
ipratropium bromide (18) 
V02peak expressed as mJ.min·': P 367(20), 18390(30) 
HR peak 
(beat.min·') 
89 (5) 
58 - 122 
89 (6) 
64 - 121 
Table 5.3 
Time 
(min) 
p 9.1 (0.6) 
5.5 - 12 
18 10.1 (0.8) 
6 - 14 
Cardio-respiratory response to symptom-limited 
treadmill exercise 
V02peak V E peak HRpeak 
{ml.min·1.klt} (l.min·1} (beat.min·
1) 
18.4 (1.3) 42.2 (3.8) 127 (6) 
12 - 27.6 24 - 67.1 87 - 170 
19.8 (1.6) 48.3 (4.7)- 131 (7) 
9.6 - 30.1 27.8 - 87.7 87 - 175 
n=12 - p<0.05 for differences between treatments 
RER 
0.90 (0.03) 
0.75 - 1.05 
0.92 (0.03) 
0.78 -1.06 
Mean (SE) and range of exercise time and cardio-respiratory response to 
peak exercise following placebo (P) and ipratropium bromide (18). 
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Table 5.4 Shuttle walk test performance and heart rate response 
Distance HRpeak ( m) (beat.min-1) 
p 372 (32) 121 (5) 
190 - 540 86 - 148 
368 (27) 122 (5) 
210 - 530 92 - 148 
18 
n=12 
Mean (SE) and range for distance walked and peak heart rate during shuttle 
walk test following placebo (P) and ipratropium bromide (18) 
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Table 5.5 Capillary blood lactate response to exercise 
Baseline post exercise ~ 
+4 min 
p 0.45 (0.08) 1.81 (0.46) 1.36 (0.42) 
0.14 - 1.05 0.23 - 5.77 0.09 - 5.09 
Treadmill 
IB 0.46 (0.07) 2.12 (0.52) 1.67 (0.51)* 
0.10 - 0.84 0.27 - 7.01 0.17 - 6.52 
P 0.68 (0.09) 0.82 (0.08) 0.15 (0.07) 
0.29 - 1.76 0.49-1.18 0.02 - 0.46 
ITL 
IB 0.57 (0.08) 0.77 (0.07) 0.21 (0.08) 
0.21 - 0.96 0.46 - 1.16 0.04 - 0.79 
P 0.85 (0.12) 1.53 (0.20) 0.68 (0.18) 
0.28 - 1.48 0.50 - 2.67 0.01 - 1.92 
Shuttle 
IB 0.68 (0.09) 1.27 (0.16) 0.59 (0.13) 
0.17-1.21 0.4 - 2.42 0.09 - 1.36 
n=12 except ITL where n=11 
* p<0.05 cf shuttle IB (satistical comparison between treadmill and shuttle) 
. Mean (SE) and range of blood lactate concentrations (mmol.r1) at baseline, 
4 min post exercise and A (difference from baseline), following placebo (P) 
and ipratropium bromide (lB). 
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Table 5.6 Borg ratings of breathlessness (8S) and perceived exertion (RP E) 
Treadmill ITL Shuttle 
SS APE SS RPE SS APE 
p 
mean (SE) 6.7 (0.6) 16.6 (0.4) 4.5 (0.6) 17.0 (0.7) 5.0 (0.6) 14.B (0.9) 
median 7.0 17.0 5.0 17.0 4.6 14.6 
18 
mean (SE) 7.1 (0.6) 16.5 (0.6) 5.0 (0.8) 17.0 (0.4) 4.1 (0.6) 14.4 (O.B) 
median 7.0 16.5 5.0 17.0 3.6 14.2 
Mean (SE) and median 80rg scores rated at the end of all three test conditions following placebo (P) and 
ipratropium bromide (18). 
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Table 5.7 Relationships between test variables 
V02peak VEPeak 
P IB P IB 
peak Pm 0.498 0.671" 0.702" 0.793" 
FEV1 0.592' 0.479 0.651" 0.671" 
Shuttle distance 0.678" 0.708" 0.595' 0.620' 
. p<:: 0.05, .. p<:: 0.025 
Correlation coefficients (r ) of peak Pm, FEV1 and shuttle walk distance 
with V02 and V E at peak treadmill exercise 
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FEV, (r=0.574, p>0.05). There were no significant relationships between fPdt 
and treadmill V02peak, treadmill V Epeak or shuttle walk distance. 
There was no relationship between the absolute values of V02peak attained 
during ITL and the treadmill test. However there was a significant 
relationship between the ITL V02peak expressed as a percentage of the total 
available V02 i.e. treadmill V02peak (r=0.752, p<0.05, figure 5.3). The 
relationship remained unaltered following IB (r=0.749). The V Epeak achieved 
during the ITL test was 60 (19)% of the V Epeak achieved during maximal 
treadmill exercise, and the V02peak during ITL was 30 (10) % of that achieved 
during exercise. These values did not change substantially following lB. 
There were no significant relationships between the static measure of 
respiratory muscle function, Plmax, and any of the exercise variables 
(treadmill time, treadmill V02peak' V Epeak and shuttle walk distance). Both the 
shuttle walking distance and the FEV, correlated significantly with treadmill 
V02peak and V Epeak. Generally IB tended to strengthen the relationships 
between variables. A summary of the correlation coefficients and the 
treatment effect is given in table 5.7. 
There was a moderate relationship between the absolute blood lactate 
increases following ITL and treadmill exercise (r=0.677, p<0.05). However 
one outlying data point influenced the relationship. It was not significant 
when this was removed. However, there was a significant relationship 
between the ITL blood lactate response, expressed as a percentage of the 
total lactate response, and the whole body exercise concentration (r=0.729 
(P), p<0.05) (figure 5.4). The blood lactate increase following ITL (at 2 and 4 
min), expressed as a mean percentage of the increase following treadmill 
exercise was 41 (25)%. This did not change substantially following lB. 
The variables which had shown significant correlations with treadmill V02peak 
and V Epeak were entered into a multiple linear regression analysis (computer 
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programme Microsoft, Statview 512). The strongest correlations occurred 
following IB and these were used in the analysis. The analysis revealed 
shuttle walking distance, peak Pm and FEV1 together explained 63% of the 
variance in the treadmill V02peak' with R=O.860, p<O.025. However only 
shuttle walking distance appeared as a significant, individual determinant of 
V02peak (r=O.708, p<O.05). The same three variables also explained 71% of 
the variance in treadmill V Epeak' with R=O.892, p<O.01. None of the variables 
appeared as significant individual determinants of V E peak. 
5.4 DISCUSSION 
Exercise capacity is commonly reduced in COPD and a reduced ventilatory 
capacity is generally considered the main limiting factor. The exercise 
capacity of this group of patients was markedly reduced in terms of the 
V02peak achieved (66% of the predicted normal value). The predicted values 
for exercise ventilation were calculated from a regression equation derived 
from a group of patients with COPD (Spiro 1975). The attainment of 88% of 
the predicted value suggests a peak exercise response was achieved. There 
was a moderate heart rate reserve (79% of the predicted heart rate achieved 
at peak exercise) which suggests a ventilatory limit to exercise. 
During ITL the respiratory muscles were stressed in a continuous manner 
with progressive increments in work load, similar to the incremental and 
progressive demands placed on the respiratory musculature during the 
whole body exercise test. As with a whole body exercise test patients were 
allowed to respond to the task without any external constraints on breathing 
rate or depth, thus developing their own natural response to the additional 
inspiratory load. A good relationship between the whole body exercise 
V Epeak and peak Pm was demonstrated. This has not been examined 
previously, and extends the range of associations between respiratory 
muscle function, assessed by static and semi-static methods, and exercise 
performance. 
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Peak Pm reflects both respiratory muscle strength and endurance, and 
generally those patients who achieved greater inspiratory threshold 
pressures were able to achieve higher levels of ventilation during the whole 
body exercise. However multiple linear regression analysis did not select 
peak Pm as a significant independent determinant of V Epeak' Thus respiratory 
muscle performance alone does not explain fully the ventilatory limit to 
exercise. Other variables are important, and respiratory muscle performance 
acts in combination with these in the determination of peak exercise 
ventilation. 
The static indices of respiratory muscle function already identified with 
exercise performance include Plmax and oesophageal pressure (PlmaxPoes)' In 
a large study of 113 patients with COPD, Loiseau (1989) demonstrated a 
strong relationship between maximal cycle work rates and Plmax and 
respiratory impedance (p 0./ VtfTi). Wijkstra (1994) assessed a wide range of 
indices including inspiratory pressures, quality of life measures and Borg 
ralings of dyspnoea, and their relationship 10 exercise performance in 
COPD. Amongst the variables examined, transfer factor (TLco) and PlmaxPoes 
were found to be significant determinants of the 6 minute walk test and 
maximal cycle work rate. However, in the current study no significant 
relationships were detected between the measures of respiratory muscle 
performance (peak Pm, Plmax and fPdt) and the indices of maximal exercise 
work rate, i.e. treadmill time and shuttle distance. Methodological differences 
may partly explain this finding. The choice of the treadmill protocol may have 
influenced the exercise time achieved by the patients (the increments were 
deliberately chosen to achieve a symptom limited maximum performance 
within 10 minutes) and this may have affected its relationship with other 
variables. The shuttle walk test utilises an incremental protocol in contrast to 
the 6 MWT test, which is more akin to a submaximal endurance test. This 
operational difference may explain the absence of a relationship between 
the respiratory muscle performance and the shuttle walk distance. 
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The correlation coefficient ( r) of 0.702 (and 0.793 post 18) for peak Pm and 
treadmill V Epeak was of similar magnitude to that determined by Dillard (1989) 
for Plmax and V Epeak (r=0.765), in a study of 20 patients with COPD. Dillard 
(1989) assessed the relationships between a range of lung function 
variables (FEV" FVC, TLco), inspiratory muscle strength (Plmax), age and 
maximal exercise performance. The Plmax was found to constitute a 
significant determinant of V02peak, and this was additional to the effects of 
TLco and V Epeak in a multiple regression analysis. In a study from Mahler 
(1988), which sought to determine the non-exercise variables which could 
be used to reliably predict V02peak in COPD, a significant correlation 
between Plmax and V02peak was demonstrated. However the author was 
unable to detect any predictive power. 
The current study was unable to detect any relationship between the static 
measure of respiratory muscle function, Plmax and treadmill V02peak and 
V Epeak' unlike the studies cited above. One reason for the absence of a 
significant correlation may be the differences in study populations. There 
was a greater degree of airflow obstruction in the present study group 
compared to the two former studies, were the mean FEV, values were 1.72 
and 1.65 litres respectively. In addition, the mean V02peak of the patient 
group from Dillard (1989) was greater than the measurement in the current 
study (23 vs 19.8 ml.min".kg"), and the study from Mahler (1988) (19.9 
ml.min".kg·'). In moderately severe airflow obstruction respiratory muscle 
strength will be compromised as a result of increased gas trapping and 
hyperinflation. In addition, dynamic hyperinflation occurs during exercise, 
and there is usually a marked reduction in exercise capacity and V02peak' It is 
possible these changes, and other factors associated with more severe 
impairment, lead to a breakdown in the relationship between the static 
measures of respiratory muscle strength, Plmax, and the exercise 
performance. In contrast, peak Pm, reflecting the dynamic response of the 
respiratory musculature, remained associated with the whole body V02peak 
and V Epeak despite the degree of impairment. This suggests both respiratory 
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muscle endurance and the whole body performance may be similarly 
affected by the changes associated with COPD and exercise. 
The relationship between Plmax and peak Pm improved following lB. 
However in this group of patients, with moderately severe airflow obstruction, 
the peak Pm remained more closely associated with the incremental 
treadmill variables than the static measure of respiratory muscle strength, 
PlmaJc This finding would support a hypothesis in which the dynamic 
measures of respiratory muscle performance are more closely associated 
with indices of whole body exercise performance than static measures of 
respiratory muscle function in more severe COPD. 
The relationship between peak Pm and V Epeak was significant and improved 
following inhaled lB. However the relationships between fPdt and V Epeak, and 
fPdt and V02peak, were poor and non-significant. This was a surprising 
finding of the study since fPdt is an index of the external work performed by 
the respiratory muscles during loaded breathing (Collett 1985) and may 
reflect the response mounted to maximal exercise stress. However there was 
wide variability in fPdt between patients, reflected in the large standard 
deviation, which suggests a range of strategies were developed in response 
to the increased threshold load. The variability of the measurement will 
influence its relationship with other variables. 
Although the spirometric response to IB was weak and variable, the 
bronchodilator tended to strengthen the relationships between the treadmill 
exercise variables and peak Pm. The absolute values of V Epeak and V02peak, 
during both ITL and whole body exercise, also improved following lB. The 
relationships between variables were sensitive to the changes induced by 
the inhaled bronchodilator, suggesting an improved coupling between 
different aspects of the exercise performance e.g. the mechanical changes 
and respiratory muscle performance and the resultant exercise ventilation 
and gas exchange. This finding suggests the application of additional 
interventions aimed at improving functional capacity, e.g. respiratory muscle 
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training and general exercise training, may be capable of maximising the 
improved ventilatory capacity, and the associations between components of 
the exercise response. 
Many patients with COPD fail to demonstrate spirometric improvement 
following inhaled bronchodilators, and some patients show only a minimal 
response or partial reversibility (Calverley 1995). The benefits associated 
with small and often variable changes are difficult to evaluate, and several 
studies have investigated exercise tolerance and symptom scores to 
examine the functional benefits from bronchodilators in COPD. However 
evidence for the role of inhaled bronchodilators and improvements in 
exercise performance in COPD is conflicting. A number of studies have 
measured increases in maximal work rate, or distance walked, following 
either B2-agonist or anticholinergic type inhalers, or both, whilst some 
reports have demonstrated changes in subjective measurements only. The 
message is confounded by the choice of drug, dosage, acute and chronic 
effects and not least the type of exercise employed. 
Early recommendations suggested the B2-agonist salbutamol should be the 
drug of choice when improvements in exercise tolerance were sought in 
chronic bronchitis (Le itch 1978). It provoked a significant increase in 12 
MWT where IB did not (Leitch 1978). However only a low dose of IB (40/1g) 
was used in the study from Leitch (1978), and in a recent study Ikeda (1996) 
has shown higher doses of 18 (;::160/1g) are necessary to demonstrate 
improvements in exercise capacity in COPD. 
Oxitropium bromide (OB), (an anticholinergic agent similar to IB), was shown 
to increase the 6 MWT, with significant improvements in exercise 
breathlessness in COPD (Spence 1993). Additionally it improved V Epeak and 
V02peak during cycle exercise with corresponding decreases in symptom 
scores. Improvements in the 6 MWT following OB were unrelated to changes 
in spirometric indices (Hay 1992, Spence 1993). The long acting B2-agonist 
salmeterol had no effect on the cardio-respiratory responses to a 
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progressive cycle test, or on 6 MWT, following both acute and chronic 
dosage, however perceived exertion was less during the walk test (Grove 
1996). 
In the current study the patients had a small and variable spirometric 
response to IB, however there were significant improvements in 'if Epeak. and a 
tendency for higher 'if02peak values during treadmill exercise and ITL. The 
improvements in the ventilatory and gas exchange response did not 
translate to significant improvements in peak work rates i.e. treadmill 
exercise time, shuttle walk distance, fPdt or peak Pm, suggesting 
mechanisms additional to the ventilatory impairment were contributing to the 
exercise limitation. There is now strong evidence the systemic musculature 
has a significant role in the limitation of exercise in COPD. Recently, 
Gosselink (1996) has demonstrated the existence and importance of 
peripheral muscle weakness in the limitation of exercise in COPD. This was 
additional to the contribution from respiratory muscle and resting lung 
function to exercise performance. 
Further evidence of the effect of general deconditioning in the limitation to 
exercise was demonstrated by Killian (1992). In a large study of 97 patients, 
patients with moderate and severe COPD reported leg fatigue as frequently 
as control subjects, for the primary reason for exercise termination, rather 
than breathlessness. The results from the current study demonstrate, despite 
small and variable changes in the FEV1 following IB, changes induced by the 
bronchodilator were amplified during exercise with significant improvements 
in exercise 'if Epeak' However improving the ventilatory response in isolation 
did not produce significant improvements in exercise capacity. This finding 
supports the evidence that additional factors have an important role in the 
limitation of exercise in COPD. 
The subjective ratings of breathlessness and perceived exertion showed 
little change following lB. This contrasts with the findings of Belman (1996) 
from a study of 13 patients with moderate to severe COPD (FEVl 1.20 1), 
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where maximal cycle exercise was performed following an inhaled B2-
agonist and following a placebo inhaler. The authors measured a reduction 
in dynamic hyperinflation and a concurrent reduction in the Borg 
breathlessness score during exercise (4.5 to 3.1) following the active inhaler. 
Other workers have also found reduced subjective ratings of breathlessness 
(Spence 1993) and perceived exertion (Grove 1996). In the current study the 
effects of a single treatment dose of IB were examined. The effects of a 
period of pre-treatment were not examined and this may have lead to 
additional benefit. The presence of a mouthpiece and noseclip may also 
have influenced the Borg ratings for the laboratory based tests, since these 
were higher than the ratings for the field test. Additionally, the subjective 
ratings for the shuttle walk test had a tendency to fall following IB, though the 
differences failed to reach significance. Any element of anxiety with the 
laboratory based tests may have acted to mask the effect of IB on the 
subjective sensations. 
There was a minimal increase in the blood lactate concentration following 
ITL, and a more appreciable change following the whole body exercise tests, 
reflecting the greater muscle mass involved. The treadmill exercise provoked 
a greater increase in lactate than the shuttle walk test, and this was 
significant following lB. With the exception of the first two minutes, patients 
walked at an increasing gradient during the treadmill test compared to 
walking on the level throughout the shuttle test. Previous studies (Cockcroft 
1985, Mathur 1995), have demonstrated exercise modality influences the 
magnitude of the lactate response in COPD, with cycle exercise producing a 
greater increase than treadmill walking. During cycling the emphasis of 
muscular work differs from that in walking exercise. Similarly, the muscular 
activity involved in walking along a gradient differs from walking on the flat. 
Thus differences in muscle recruitment on the inclined treadmill may explain 
the differences in blood lactate concentration between the two walking tests. 
Levison (1968) measured an increased oxygen utilisation by the respiratory 
muscles during exercise in COPD. In a study which compared the oxygen 
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cost of volitionally increased ventilation during exercise between control 
subjects and patients with COPD, Levison (1968) noted a disproportionate 
increase in the oxygen utilisation of the respiratory muscles in COPD (9.3 
mLr' vs 4.2 mLr' of ventilation). This accounted for approximately 35·40% of 
the maximum oxygen consumption. The author proposed there was likely to 
be significant competition between limb and respiratory muscles for the 
available O2 in COPD during exercise. A point may be reached where any 
benefits of increasing ventilation may be offset by the additional energy cost 
incurred to the respiratory muscles. In the current study the oxygen cost of 
the ITL test equated to 30% of the V02peak measured on the treadmill. If ITL 
imposes similar ventilatory loads as those encountered during exercise in 
COPD, the oxygen cost of the respiratory musculature will amount to a 
substantial proportion of the V 02peak. 
Once oxygen demand exceeds oxygen delivery anaerobic pathways are 
engaged, and the lactic acid load then becomes an important limiting factor 
of exercise (Astrand 1986). How the increased energy cost of breathing 
might influence the lactic acid load during exercise in COPD was examined 
by Engelen (1995) in 8 patients with COPD. The patients performed an 
incremental exercise test (lWR) and constant work rate tests (CWR). During 
one of the CWR tests patients increased ventilation volitionally to levels 
achieved during the IWR test. Though the volitional increase in ventilation 
provoked an increase in blood lactate, the end exercise concentrations 
following the CWR tests were not significantly different (0.11 mmol.r'). 
Additionally, much larger increases were measured following the IWR test. 
The authors concluded the respiratory muscles were unlikely to have an 
important influence on the blood lactate levels achieved during maximal 
exercise in COPD. 
The 8 patients studied by Engelin (1995) were selected on the basis of a 
significant blood lactate response to exercise (mean peak lactate 5.3±2.8 
mmol.r'). Many patients with more severe COPD show a reduced and less 
than significant increase blood lactate concentration during exercise 
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(Selman 1993). How respiratory muscle lactate production influences 
exercise tolerance in these patients is unclear. In the current study 6 patients 
had < 2 mmol.r' increase in blood lactate following treadmill exercise (IS). 
The ITL blood lactate response expressed as a proportion (%) of the 
individual lactate response, measured after the treadmill exercise, gave a 
mean value of 40 (10)% for the whole group. Thus the question of whether 
respiratory muscle lactic acid is more important in patients with severe 
impairment warrants further investigation. Engelin (1995) noted the more 
severely obstructed patients demonstrated higher rates of respiratory muscle 
lactate production per unit increase in ventilation. The author suggested 
further studies were required to explain why many patients with COPD 
experience a blood lactate response at relatively low work rates. 
The mean change in the blood lactate concentration provoked by the 
respiratory muscle exercise during the ITL test (0.15 mmol.l"', following 
placebo) was similar to that reported by Engelen (1995). The change was 
achieved at much lower levels of ventilation (24 vs 48 l.min"'). However, 
during ITL additional static work is required to overcome the imposed 
threshold load. The changes in blood lactate following IS were greater, and 
probably reflect the higher ventilation levels achieved. Again the changes 
were at lower levels of ventilation compared to the study from Engelin (1995) 
(27 vs 48 l.min·'). This suggests the work rate imposed during the ITL test 
represents a similar challenge to the respiratory muscles to that imposed by 
a volitional increase in ventilation during exercise, as described by Engelin 
(1995). 
There was a strong relationship between the distance walked during the 
shuttle walk test and the V02pe .... This has been shown previously in a study 
which validated the shuttle walk test against a symptom limited maximal 
incremental treadmill test (Singh 1994a). There was also a significant 
relationship between the distance walked and V Epeak. These findings support 
the use of the shuttle walk test as a valid measure of functional capacity 
which provokes an incremental and maximal performance in COPD. 
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In summary, this study has demonstrated: 1) a good relationship between 
peak Pm and whole body exercise V Epeak. However, unlike previous reports, 
there was no relationship between the static measure of respiratory muscle 
function, Plmax, and whole body exercise performance. This may be 
explained by the greater degree of airflow obstruction in this patient group, 
and suggests dynamic indices of respiratory muscle performance (peak Pm) 
are more closely associated with exercise ventilation in moderately severe 
impairment; 2) peak Pm, FEV1 and shuttle distance explained 71 % of the 
variance in the treadmill V Epeak. None of these variables were selected as 
independent determinants of the ventilatory response. The three variables 
also explained 63% of the variance in V02peak' and shuttle distance was a 
significant individual determinant V02peak; 3) There was a significant 
improvement in exercise ventilation following lB. Additionally, IB improved 
the relationships between variables. This suggested a closer coupling of the 
events contributing to the exercise performance e.g. respiratory muscle 
performance and the ventilatory response. However, the improvements in 
V E and V02 were not accompanied by improvements in work rate, which 
suggests the exercise limitation in COPD cannot be explained fully by the 
abnormal ventilatory response. 
The findings from this study suggest the respiratory and systemic 
musculature is likely to play an additional role in the exercise limitation in 
COPD. This component may be reduced by exercise training. An 
intervention of exercise training may also maximise the improvements in the 
relationships between whole body exercise performance and the respiratory 
muscle contribution. In order to examine exercise training in this patient 
group appropriate and sensitive methods of assessment are necessary. This 
aspect is addressed in the following chapter. 
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Chapter 6 
THE DEVELOPMENT OF A FIELD TEST OF WALKING 
ENDURANCE CAPACITY 
6.1 INTRODUCTION 
The previous experiments in this thesis demonstrated a reduced respiratory 
muscle performance in COPD, and a high oxygen cost of the ITL exercise. 
Whilst the relationship between ITL and the ventilatory response to exercise 
was strengthened following an inhaled bronchodilator, and peak exercise 
V E and V02 improved, there were no significant changes in the peak work 
rates achieved. These findings suggested improving the ventilatory capacity 
in isolation does not improve exercise capacity in COPD. They also support 
the contention that other factors, such as generalised muscle weakness and 
deconditioning, are important in the exercise limitation in COPD. In order to 
maximise the improvements achieved by conventional inhalation therapy it 
was suggested additional therapeutic interventions, such as exercise 
training, could be introduced for this patient group. 
A number of studies of pulmonary rehabilitation have demonstrated 
substantial improvements in endurance capacity, in addition to more modest 
improvements in maximal exercise capacity, in COPD (Chester 1977, Ries 
1987, Niederman 1991). As everyday activities rarely, if ever, engage 
maximal capacity, assessment of submaximal endurance capacity in this 
group is important, especially if training interventions aim to improve 
performance of everyday activities. It is unlikely the factors which produce a 
ventilatory limit to maximal exercise will improve following exercise training 
and rehabilitation. Thus the assessment of submaximal performance may 
prove more sensitive to training induced changes in fitness, co-ordination 
and strength. 
Field walking tests are commonly used for the assessment of disability and 
as an outcome measure following rehabilitation in patients with COPD. The 
12 and 6 minute walk tests are self-paced tests which measure the distance 
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covered in a set time (McGavin 1976, Butland 1982). The non-standardised 
nature of the tests contributes a degree of variability in the performance of 
the test (Guyatt 1984, Knox 1988). The incremental shuttle walk test (ISWT) 
(Singh 1992) is standardised with external pacing, and pre-determined 
increments in walking speed. The incremental nature of the protocol has 
been shown to produce a maximal response in patients with COPD (Singh 
1994a). However a standardised field test of endurance capacity, using 
constant walking speeds, external regulation of pace and where all patients 
experience the same relative level of exercise intensity, does not exist for 
use with this patient group. For practical reasons a standardised field test of 
endurance capacity would be desirable for the routine assessment of 
patients with COPD. As external regulation of walking speed has already 
been aChieved with the ISWT, use of a similar format in the development of a 
standardised, constant-paced endurance test would complement its use, 
enabling both endurance and maximal capacity to be assessed along the 
same walking course. 
The purposes of this study were: 
1) To develop a standardised field test with a constant walking pace, and 
which complemented the shuttle walk test, to assess endurance capacity in 
patients with COPD. 
2) To assess a range of exercise intensities to ensure the test was 
applicable for use within the clinical and pulmonary rehabilitation 
environment. 
6.2 METHODS 
6.2.1 Patients 
Ten patients (9 men) with moderate and severe COPD were recruited to 
examine the response to the three field endurance tests (mean FEV, 
1.01 (0.36)1, age 63.7(5.5) ). Six of the patients had participated in previous 
studies, and 4 had attended the hospital pulmonary rehabilitation course. 
The CRDQ (Guyatt 1984) was administered at the start and every alternate 
week, and the FEV, was measured at every visit. Height and weight were 
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measured at the first visit and weight was rechecked at intervals throughout 
the study. Nine patients were using inhaled B2 agonists, 7 an inhaled 
steroid, 4 ipratropium bromide and one patient was using oral theophyllines. 
There were no alterations to prescribed medications although patients were 
instructed to use their inhaled bronchodilator within 1 hour of testing. 
6.2.2 Study Design 
The patients attended on 4 separate occasions. At the first visit two ISWT 
were performed (described in chapter 3). The first test was considered a 
practice, and the 2nd test was performed after a rest period of 45 minutes. 
The predicted V02peak was calculated from the greatest distance walked 
(Singh 1994a). The endurance shuttle walk tests (ESWT) were performed 
during the 3 subsequent visits, each at a different walking speed. The 
exercise intensities for the ESWT related to 75"10, 85"10 and 95"10 of the 
V02peak predicted from the ISWT performance. The level of exercise intensity 
for each visit was randomised. All tests were performed at the same time of 
day. Heart rate was monitored throughout the walking tests and 
breathlessness and perceived exertion rated from Borg scales. 
6.2.3 Endurance shuttle walk test 
The endurance walk test had a similar format to the ISWT i.e. the same 10 m 
course demarcated by cones and pre-recorded bleeps from a cassette 
player to regulate walking speed. The test objective was to measure the 
duration of exercise at the set endurance walking pace. The basic 
requirements of the test were a constant walking speed, and the avoidance 
of a lengthy test duration if the test was to be applicable in the clinical 
environment. At the start of each endurance test there was a 2 minute warm-
up period at a slower pace. This was followed immediately by the set 
endurance pace, externally controlled by bleeps from a cassette and which 
remained constant throughout the remainder of the test. The bleeps 
indicated when the patient should be turning around a cone at either end of 
the course. Patients walked up one side of the course and returned down the 
opposite side, turning around the cone at each end of the course. To allow 
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for turning the actual straight line distance between cones was 9.0 m, thus 
allowing 0.5 m for turning (figure 6.1). To avoid the possibility of some 
patients walking for very long periods, a time limit of 20 minutes was 
imposed. However, all the patients remained unaware of this time limit to 
avoid target setting. 
Initially a variety of suitable endurance walking speeds were identified and a 
series of cassette tapes pre-recorded with a range of bleep frequencies. The 
choice of walking speeds was achieved in two ways: 1} identification of the 
maximum walking speeds, and distances, most frequently achieved during 
the ISWT. Results were analysed from 36 patients with COPD referred to the 
pulmonary rehabilitation service at the Glenfield Hospital; 2} from the 
construction of a graph of V02peak values predicted from the ISWT 
[regression equation V02peak = 4.19 + (0.025xdistance), Singh 1994a] and 
the corresponding shuttle walking speeds (figure 6.2). From the graph 15 
endurance walking speeds were selected which covered a range of 
predicted V02peak values from 4.9 to 16.9 ml,min·'.kg'\ The V02 values were 
deemed representative for this type of patient, following the examination of 
test results from 36 patients referred to the pulmonary rehabilitation service. 
The graph relating speed and V02 (figure 6.2) was subsequently used to 
determine the endurance speeds for the patients entered into the study. 
To regulate the walking speed around the 10 m shuttle course the bleep 
frequencies were calculated (table 6.1). The cassette tape recordings were 
undertaken by the Audio-Visual Service of the Loughborough University. A 
one minute calibration signal, and a set of standardised instructions to the 
patient, were also recorded at the start of each tape (appendix 7). 
The 10 m course was inside the hospital on a quiet, flat corridor. The pre-
recorded test instructions were played to each patient prior to their first 
performance of the endurance walk. Patients were instructed to walk at the 
constant speed (the 'endurance' speed) for as long as possible, until they 
were too breathless, too tired or could no longer keep up the set pace. The 
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10 metres • 
I~ _________ V 
... 9.0 metres 
Figure 6.1 Shuttle course 
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Table 6.1 Range of pre·recorded walking speeds 
Level Warm·up speed Endurance speed Time/ 10 m 
(km.h·') (km.h·') shuttle (s) 
1 1.44 1.80 20.00 
2 1.44 2.06 17.50 
3 1.44 2.40 15.00 
4 1.44 2.67 13.50 
5 1.44 3.00 12.00 
6 1.44 3.27 11.00 
7 2.40 3.60 10.0 
8 2.40 3.89 9.25 
9 2.40 4.24 8.50 
10 2.40 4.50 8.0 
11 2.40 4.80 7.50 
12 2.40 5.14 7.00 
13 2.40 5.33 6.75 
14 2.40 5.76 6.25 
15 2.40 6.00 6.00 
Duration of warm·up speed 2 minutes, and 20 minutes for endurance speed 
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first 2 minutes of the walking signal was at a slower, warm-up pace. At the 
end of the warm-up period the following taped message occurred 'at the next 
triple bleep increase your walking speed'. The endurance pace lasted for 
twenty minutes, therefore the maximum possible exercise time was 22 
minutes including the warm-up period. Throughout the operator remained 
silent at the edge of the course and recorded the time walked at the 
endurance speed. Heart rate was recorded using the telemetry device. 
The test was symptom limited and terminated for the following reasons: 
patient request (e.g. too breathless to continue or leg fatigue); patient 
completed 20 minutes of the endurance pace; stopped by the operator when 
the patient was unable to keep up the set pace. If the patient was 0.5 m, or 
more, away from the next cone at the sound of a bleep, the patient was 
encouraged to catch up on the next lap. If the patient was still beyond 0.5 m 
from a cone at the next bleep the test was terminated. 
Determination of endurance walking speeds 
The V 02peak was predicted for each patient from the total distance covered 
during the ISWT, (Singh 1994a). Three target V02 values were calculated 
which related to 75%, 85% and 95% of the predicted V02paak' From the 
graph of V O2 vs walking speed (figu re 6.2) the corresponding speed for 
each V02 value was determined. Tapes closest to each speed were 
selected from the bank of 15 pre-recorded cassettes. 
6.3 RESULTS 
All patients completed the study and the average time between visits was 
10.0 (4) days. Two patients had an exacerbation of symptoms (not related to 
participation in the study) and testing was suspended until they returned to 
baseline levels. A further two patients had significant changes in 3 aspects of 
the CRDQ on one occasion, and one patient had changes in two aspects. 
The measurements of FEV1 did not change during these periods. On direct 
questioning the patients were able to identify specific causes for the changes 
and did not recognise any general deterioration in condition. As a result they 
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continued in the usual manner. The lung function at the first visit, the 
percentage of predicted normal values and anthropometric details of the 
group are presented in table 6.2. Eight patients identified some 
breathlessness at rest at each visit, whilst 2 patients identified some 
breathlessness at rest on two visits. The resting Borg scores and FEV1 
values for each visit are given in table 6.3. 
The peak performance during the ISWT is shown for each patient in table 
6.4. All the patients identified breathlessness as the main reason for the 
termination of exercise. The Borg ratings for breathlessness and perceived 
exertion are summarised in table 6.8. 
The endurance capacity was defined as the exercise duration at the set 
endurance speed. The endurance walking speeds for each patient were 
derived from their peak performance during the ISWT and are shown in table 
6.5. The time achieved by each patient and the reason for terminating the 
endurance exercise is shown in table 6.6. Three patients completed 20 
minutes during the 85% test and 4 during the 75% test. One patient 
completed 20 minutes during all 3 endurance tests. As a precaution this 
patient repeated the ISWT to ensure a peak performance had been 
achieved during the initial test. The results from the repeat test were identical 
to the results from the initial test. 
A summary of the endurance times and peak heart rate responses for the 
group are shown in table 6.7. The individual heart rate responses to each 
endurance test are illustrated in figure 6.3. There was a progressive 
decrease in the endurance times as the exercise intensity increased, though 
individually some patients (n=3) achieved the maximum time (20 minutes) 
for both the 75% and 85% exercise intensities. Analysis of variance revealed 
the endurance time achieved during the 95% test was significantly different 
from the 85% and 75% tests (p<0.05). There was no significant difference 
between the 75% and 85% times. The 95% HR was significantly different 
from the 75% HR (p<0.05), but it was not significantly different from the 85% 
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Table 6.2 Summary of patient characteristics 
Mean (SD) Range % of predicted 
FEV, (1) 1.01 (0.36) 0.6 - 1.65 35 
FVC (1) 2.92 (0.55) 2.03 - 3.9 81 
% FEV,IFVC 34 (6) 25 - 42 
Age (y) 63.7 {5.5} 54 - 72 
Height (m) 1.69 (0.07) 1.56 - 1.77 
Wei9ht (k9) 69.7 (12.6) 55.5 - 99 
n=10, 9 men, 1 woman 
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Table 6.3 FEV, and Borg ratings (BS) for breathlessness at rest 
Visit ISWT 75%ESWT 85%ESWT 95%ESWT 
FEV, (1) 1.05 (0.29) 1.02 (0.27) 1.06 (0.33) 1.07 (0.33) 
0.55 - 1.5 0.65 - 1.5 0.6 - 1.68 0.6 - 1.75 
BS mean 1.1(0.8) 1.5(1.1) 1.3(0.9) 1.2(0.9) 
0-3 0-3 0.5 - 3 0.5 - 3 
BS median 1.0 1.2 1.2 1.0 
Mean (SD). median (BS only) and range for baseline FEV, and Borg ratings 
of breathlessness at rest at each visit 
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Table 6.4 Incremental shuttle walk test performance 
Subject Distance HRpeak max. walking predicted V02feak 
(m) (beat.min·') speed (km.h") (ml.min:' kg' ) 
1 250 126 4.25 10.32 
2 320 125 4.86 12.03 
3 330 102 4.86 12.30 
4 120 111 3.03 7.13 
5 360 134 5.47 13.01 
6 280 115 4.86 11.05 
7 420 146 5.47 14.48 
8 360 84 5.47 13.01 
9 240 146 4.25 10.1 
10 450 136 6.08 15.22 
mean (SO) 313 (96) 123 (20) 4.86 (0.86) 11.87 (2.35) 
Total distance walked, HRpeak' maximum shuttle walking speed attained, and 
V02peak predicted from the distance achieved. 
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Table 6.5 Individual endurance walking speeds 
"". -
Subject 75% ESWT 85% ESWT 95% ESWT 
1 3.27 3.60 3.89 
2 3.89 4.24 4.50 
3 3.89 4.24 4.50 
4 2.06 2.67 3.00 
5 4.24 4.50 4.80 
6 3.62 3.89 4.24 
7 4.50 4.80 5.33 
8 4.24 4.50 4.80 
9 3.27 3.60 3.89 
10 4.50 5.14 5.33 
Mean (SO) 3.76 (0.72) 4.12 (0.71) 4.43 (0.71) 
Walking speeds (km.h·') for 3 levels of endurance intensity 
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Table 6.6 Individual endurance times (min) and reason for terminating 
exercise 
75% 85% 95% Ex. level 
Subject min I reason min I reason min I reason 
1 3.4/C 2.4/C 1.5 I C 
2 14.2 I 6 12.6 I 6 7.5/6 
3 17.6 I LF 13.0 I LF 5.5 I 6 
4 7.8/6 3.4/6 1.2 I 6 
5 201- 20.0 1- 5.3/6 
6 5.0/6 2.8/6 1.8 I 6 
7 20.01- 20.01- 4.216 
8 3.4/C 2.7/C 3.0/C 
9 20.0 1- 20.01- 20.01-
10 20.0 1- 5.3/C 3.4/6 
Time completed at each exercise intensity and the reason for terminating 
exercise. 
6 breathless 
LF leg fatigue 
C combination of breathlessness and leg fatigue 
completed 20 minutes of endurance walking speed 
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Table 6.7 Endurance shuttle walk test performance and heart rate 
response 
Time (min) 
75% ESWT 
13.1 (2.3) 
3.4·20 
118 (5) 
86 - 146 
85% ESWT 
10.2 (2.5) 
2.4 - 20 
121 (6) 
82 - 148 
95% ESWT 
5.3 (1.7) 
1.1 - 20 
127 (8) 
82 - 159 
Mean (SE) and range for endurance time completed and peak heart rate 
during the three endurance tests (ESWT) 
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Figure 6.3 Individual heart rate response to 3 endurance shuttle walk tests (includes warm·up speed) 
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HR. There was no significant difference between the 75% and 85% HRpeak· 
The Borg ratings of breathlessness and perceived exertion for both the ISWT 
and the ESWT are summarised in table 6.8. There was a trend for the Borg 
ratings of breathlessness to increase as the endurance intensity increased, 
however there were no significant differences between the scores. The same 
was true for the ratings of perceived exertion. 
There was no relationship between the FEV, and the endurance times. 
There was a moderate and significant relationship between the 75% and the 
85% times (r=0.827, p<0.05, figure 6.4). There was no relationship between 
the 95% time and the two lower intensities. 
6.3.1 Comparison of endurance and incremental field tests 
The mean time spent walking during the ISWT was 343 (75) s. There were 
no relationships between the ISWT and ESWT times. Seven patients 
achieved a higher HR following the 95% test, and 4 patients following the 
85% test, compared to the HRpeak following the ISWT. However the 
differences in HRpeak between endurance tests and the ISWT did not reach 
significance. There were no significant differences between the Borg ratings 
for the ISWT and the ESWT. The reasons for terminating exercise differed 
markedly. Breathlessness was the main reason for all patients during the 
ISWT and for 7/10 of the patients during the 95% test. Whilst more leg 
fatigue, either singularly or in combination with breathlessness, occurred 
during the 85% and 75% tests. 
6.4 DISCUSSION 
Although a variety of field tests for the assessment of endurance capacity are 
available for healthy individuals, this is not the case within the clinical 
environment where there is little choice of field test, and an absence of a 
standardised endurance test. The adaptation of the ISWT format to provide 
an externally paced endurance field test has shown standardisation of 
walking pace is achievable, and the walking speeds may be individually 
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Table 6.8 Borg ratings for breathlessness and perceived exertion 
75%ESWT 85% ESWT 95%ESWT ISWT 
BS mean (SE) 3.9 (0.4) 
range 2-7 
median 3.7 
RPE mean (SE) 13.5 (0.6) 
range 11 - 17 
median 13.4 
4.6 (0.6) 
2-9 
4.3 
13.6 (0.9) 
9 - 19 
13.4 
5.0 (0.5) 
4-9 
4.8 
14.3 (0.7) 
13 - 19 
14.1 
4.9 (0.6) 
3-9 
4.6 
13.3 (0.6) 
11 - 17 
13.2 
Borg ratings for breathlessness (BS) and perceived exertion (RPE) rated 
following the ESWT and the ISWT 
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Figure 6.4 Relationship between 75% and 85% endurance times 
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determined from the peak performance measured during the ISWT. 
The advantages of a standardised field test for the assessment of endurance 
capacity include ease of use and simplicity for operator and patient, and the 
avoidance of expensive laboratory equipment and time. Additionally the 
provision of a standardised walking pace improves intra- and inter-subject 
comparisons. The ESWT is based on a familiar activity and employs only 
minimal equipment. In the rehabilitation setting where there is often a large 
throughput of patients, a quick and simple assessment of endurance 
capacity, which is not confined to one area, is desirable. The determination 
of the walking speeds from a graph increased the complexity of the test, 
however this may be simplified by the production of a table or formula which 
related ISWT performance to suitable endurance speeds. The actual 
endurance speeds determined for each patient were similar to the relative 
percentages of maximum ISWT speed achieved. Therefore a simple 
percentage calculation, involving the maximum ISWT speed, may provide an 
alternative approach. 
The range of pre-recorded endurance speeds was wide to accommodate a 
variety of exercise tolerances. However some of the faster speeds were 
unused, whilst some of the moderate and slower speeds were used 
repeatedly. A greater variety of walking speeds in the moderate range would 
improve selection for those patients who achieve only 1 or 2 shuttles at their 
final, maximum ISWT speed, i.e. a reduction in the increment size between 
the endurance speeds. To avoid the requirement for a large number of pre-
recorded tapes the unused faster speeds might be removed without 
detriment to the versatility of the test in similar patients. 
Any new instrument for patient assessment should be sensitive to change 
and possess good repeatability. A number of studies have demonstrated 
endurance capacity is sensitive to change following exercise training in 
patients with COPD (Chester 1977, Ries 1987, Niederman 1991, Singh 
1996). Therefore it would be appropriate to assess the sensitivity of the 
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ESWT following pulmonary rehabilitation. The issue of sensitivity and 
repeatability is addressed in the final experimental chapter of this thesis. 
The 75% and 85% endurance tests did not provoke significantly different 
responses in HR, time and subjective ratings. However the endurance time 
achieved during the 95% endurance test was significantly less than the 75% 
and 85% tests. A short test is desirable in terms of practical application and 
for the wider margin it leaves for change following an intervention. A number 
of patients completed the full 20 minutes of the lower intensity endurance 
tests therefore for these patients the 95% test may be more suitable for the 
demonstration of change following intervention. Alternatively, some patients 
achieved very short times during the 95% test, and also tended to achieve 
shorter times during the 75% and 85% tests. This is consistent with the 
findings of Singh (1996) where some patients have short endurance times, 
even at 50% of predicted V02peak, but achieve large improvements following 
exercise training and rehabilitation. 
There was a moderate and significant relationship between the 75% and 
85% endurance times, whereas the relationship between the 95% time and 
the 75% and 85% times were poor and did not reach significance. There are 
two possible influences which may explain these findings. Firstly, a time limit 
of 20 minutes was imposed on the test thus artificially influencing the 
endurance time achieved by some patients. A large proportion of patients 
were stopped by the 20 minute limit during the 85% and the 75% tests (30% 
and 40% respectively). Secondly, the 95% test produced a maximal 
performance in some patients, as evidenced by the HR response, and this 
may have influenced the relationship with endurance time. 
The lack of a relationship between the maximal performance and endurance 
capacity is further supported by the absence of an association between the 
ISWT time and the endurance times. This finding suggests endurance 
capacity may be related to other factors rather than the constraints wh ich 
limit maximal exercise in COPD. This contention is supported by the 
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contrasting reasons for the termination of exercise during the incremental 
and endurance tests. Breathlessness was the reason identified by all 
patients during the ISWT and by 7/10 patients during the 95% endurance 
test. However leg fatigue, either singly or in combination with 
breathlessness, was identified more often during the 85% and 75% 
endurance tests, where longer exercise times were achieved at the lower 
intensities. This would suggest deconditioning, skeletal muscle changes and 
possibly depletion of local energy stores are also important factors of 
endurance capacity in COPD, and these are additional to the ventilatory 
abnormalities. The finding would support the case for endurance type 
training in this patient group. 
In the current study the walking speed was externally paced and patients 
were given no indication of how long they had been walking. In addition they 
were not informed of the 20 minute time limit of the test. In this sense the 
ESWT was open ended, in contrast to the 6 or 12 MWT which are time 
limited and self-paced. Previous studies which have examined timed 
walking tests in detail have demonstrated that patients pace themselves 
according to the duration of the test. Bernstein (1994) examined the 
distances covered in each 2 minute interval of the 12 MWT. The distance in 
the first 2 minutes was slightly higher than the distances walked in the other 
5 intervals. However there were no significant differences between distances 
and the correlation coefficients were highly significant. These findings were 
similar to those of Butland (1982) who also examined the distances covered 
in the 2 minute segments of a 12 MWT. Additionally 2,6, and 12 minute tests 
were compared and the distances were highly correlated. However the 
author did not extrapolate the shorter test distances. When multiplied the 2 
minute distance would be greater than the distance achieved during the 12 
minute test, suggesting the pace was different for each test. Guyatt (1984) 
demonstrated a highly significant difference between the distance covered 
during a 2 minute test and the distances during the 2 minute intervals of a 6 
minute test. All three studies concluded patients do pace themselves 
according to the duration of the test. These findings emphasise the non-
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standardised nature of the timed walk test which relies on individual 
judgement of pace and a self imposed work rate. Any variability in work rate 
was avoided with the ESWT where the walking speed was externally 
imposed. 
All the patients in the study group had moderately severe to severe airflow 
obstruction. They all had some breathlessness at rest and reported 
symptoms of breathlessness to a wide variety of daily activities e.g. dressing, 
washing, housework etc. All the endurance times were below 8 minutes 
during the 95% test with the exception of one patient, whilst there was wider 
variation at the 75% and 85% tests. This may reflect greater random 
variation, or is possibly an indication that lower intensity exercise may be a 
better discriminator of exercise tolerance in a fairly homogeneous group of 
patients. Previous studies of field test performance in patients with COPD 
have shown a wider spread of results with longer tests. Butland (1982) 
measured greater variance with a 12 MWT compared to the 6 and 2 MWT, 
although the differences were not large. However, in the routine clinical 
situation responsiveness to treatment is usually more important than the 
ability to discriminate between patients, hence a shorter test which is 
sensitive to change is likely to be more desirable. 
The 95% endurance test provoked a higher mean heart rate than the ISWT, 
and the 85% test provoked a higher heart rate in 4 patients. There are two 
possibilities which may explain this finding. Firstly patients did not give 
maximum effort during the incremental test. All reasonable precautions were 
taken to minimise this possibility - patients received the standardised 
instructions recorded at the start of the ISWT tape, and patients were 
reminded to continue walking until too breathless or exhausted to continue 
i.e. to attain a symptom limited maximum. A practice test was always 
performed, and on the second test patients were encouraged to catch up 
with the bleeps if they slowed down. In the one patient in whom the ISWT 
was repeated the results were identical to the previous test which supports 
the correct conduct of the ISWT. 
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Secondly, a high intensity constant work rate test may provoke a higher 
heart rate in some patients than an incremental test. During the progressive 
test a steady state is unlikely to be attained in the shorter time available at 
each work rate. However when the object of the progressive exercise test is 
to measure 'iJo2mox' increases in work rate should continue until the 'iJ02 
reaches a plateau. In the clinical situation the 'iJ 02mox is rarely attained, and 
the symptom limited 'iJ02mox or 'iJ02Poak is measured i.e. the highest values 
are recorded in the absence of a plateau. The absence of a steady state 
during the peak work rate may lead to an underestimation of the maximum 
heart rate. In the current study the work rate remained constant throughout 
(following the slower warm-up period) and more time was available to attain 
a steady state at a high work rate. This is supported by the graphs of 
individual heart rate response where a plateau occurred during the higher 
work rates in some patients. As a consequence higher heart rates were 
recorded than during the ISWT. 
A number of studies have shown a similar peak effect with the use of 
constant high work rate and steady state tests. Matthews (1989) recorded 
higher heart rates in both a control group, and in patients with moderate 
COPD, during a constant workload test at 75% of maximum workload. Whilst 
Cotes (1969) measured higher heart rates at equivalent work rates during a 
steady state test compared to progressive exercise, in both healthy subjects 
and, in a subsequent study, subjects with asbestos-related lung disease 
(King 1987). 
The 95% test provoked a peak response in some patients whilst the 75% 
and 85% tests demonstrated patients with COPD can sustain relatively high 
work rates. This is consistent with previous studies which have found 
patients are able to exercise at relatively high work rates approaching, or in 
some cases exceeding, maximal performance (Ries 1987, Punzal 1991). An 
additional use of the ESWT may be as a training aid within the hospital 
rehabilitation setting. The rehabilitation programme at the Glenfield Hospital 
includes brisk walking as part of the exercise training, thus periodic use of 
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the tapes and the 10 metre course with individual patients may provide the 
opportunity to reinforce the prescribed training intensity. 
There are a number of outcomes from this initial developmental study and 
several issues which require further investigation. External pacing of a field 
test for endurance capacity is achievable and the test can be relatively short 
which is both practical for the operator and not to onerous for the patient. 
Walking speed and hence the exercise intensity can be determined from the 
peak performance achieved during the ISWT. The lower intensity tests 
elicited longer exercise times and a greater incidence of leg fatigue. This 
finding supports deconditioning as an important limiting factor during 
endurance exercise in COPD. 
The endurance shuttle walking test has the potential to be used as a quick 
and simple field test to assess disability, monitor progression and evaluate 
the outcome of therapeutic interventions. However to become a reliable 
method of assessment it is necessary to examine its relationship with the 
laboratory assessment of endurance exercise, and this issue is addressed in 
the following chapter. The repeatability of the test also requires investigation. 
Finally the test will only be worthwhile if it is sensitive to change. This would 
be most suitably assessed following an intervention of pulmonary 
rehabilitation with exercise training. These aspects are examined in the final 
experimental chapter of the thesis. 
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Chapter 7 
THE CARDIO-RESPIRATORY AND METABOLIC RESPONSE TO 
ENDURANCE EXERCISE IN COPD 
7.1 INTRODUCTION 
The previous chapter described the development of a standardised field test 
of walking endurance and examined three levels of exercise intensity in 10 
patients with COPD. However to be accepted as a reliable method of 
assessment the shuttle endurance walking test has to be both valid and 
repeatable. 
Conventional laboratory based tests, using a treadmill or cycle ergometer, 
enable the assessment of the cardio-respiratory and metabolic responses to 
standardised work rates. A number of studies have related field and 
laboratory exercise performance. McGavin (1976) compared the 12 MWT 
test with maximal cycle performance and demonstrated a significant, though 
moderate relationship, with V02peak (r=O.52). Bernstein (1994) examined the 
correlation between V02peak and the distance walked during each 2 minute 
interval of a 12 MWT test. The highest correlation (r=O.71) occurred with the 
distance walked during the 6 to 8 minute interval. Singh (1994a) 
demonstrated a strong relationship between incremental shuttle walk test 
distance and V02peak (r=O.88). The cardio-respiratory response to constant 
work rate exercise in COPD has been examined previously in terms of the 
ventilatory and gas exchange kinetics and the establishment of steady state 
(Nery 1982). Other studies have compared the cardia-respiratory responses 
to both high and low intensity steady state cycle exercise in COPD and 
normal control subjects (Matthews 1989). 
The aims of this study were as follows:-
1} To examine the relationship between the shuttle endurance walk test 
performance and endurance performance on a treadmill at the same relative 
levels of exercise intensity i.e. 75%, 85% and 95% of V02peak' 
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2) To describe the cardio-respiratory and metabolic response to 
endurance exercise in COPD. 
7.2 METHODS 
7.2.1 Patients 
The same ten patients (9 men, 1 woman), who had participated in the field 
test study, attended for an additional 6 visits. The demographic details, 
administration of the CRDQ, baseline lung function measurements and 
instructions regarding medications were the same as described in chapter 6. 
7.2.2 Study Design 
Patients performed six treadmill exercise tests during separate visits. All 
visits were repeated at the same time of day. The first test was a practice 
incremental test to familiarise patients with the equipment and walking on 
the treadmill. The second test was a symptom limited incremental test to 
measure V02peak. The third test was a steady state test to determine the 
relationship between V02 and walking speed. A regression equation was 
derived relating the steady state walking speeds and the corresponding 
V02• From the equation 3 endurance speeds were calculated which related 
to 75%, 85% and 95% of the V02peak. For the endurance tests patients 
walked at each of the calculated speeds on separate occasions and in 
randomised order. 
Visit 1 Visit 2 Visit 3 Visit 4 Visit 5 Visit 6 
practice incremental steady state endurance endurance endurance 
.. VISit 4-6, level of exertion randomlsed 
7.2.3 Incremental and Steady State Exercise Tests 
The incremental test was performed to determine the V02peak. A brisk 
walking pace was determined for each patient from performance during the 
practice test. The treadmill gradient was increased by 2.0% every two 
minutes from an initial setting of zero. Patients were instructed to indicate 
when they could no longer continue because of breathlessness, fatigue or 
any other reason. They were encouraged to give maximum effort. The test 
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was symptom limited and performed according to the safety criteria 
described in chapter 3. 
The steady state test was performed to determine the relationship between 
walking speed and V02 for each patient. Patients walked for four minutes at 
three different speeds, with a period of recovery between each speed. Low, 
medium and medium high speeds were determined from the peak 
performance during the incremental test. The average V02 during the final 
minute of each walk was plotted against the walking speed, and a linear 
regression line fitted by a computer graphics programme (Microsoft, Cricket 
Graph Ill, version 1.5). The derived equation was used to calculate the 
endurance walking speeds corresponding to 75%, 85% and 95% of the 
V02peak measured during the incremental test. 
7.2.4 Endurance Tests 
The endurance walking speeds were presented in randomised order over 
three visits. Patients walked for two minutes at a slower warm-up pace 
followed immediately by the endurance pace. Patients were instructed to 
walk until they fell too breathless or tired to continue. They were not informed 
of any time limit, and discouraged from asking or estimating how long they 
had been walking. All clocks were turned out of sight from the patient. A time 
limit of 20 minutes was imposed where there was an absence of symptoms 
and where there were indications the patient would continue comfortably for 
some time (i.e. Iow Borg ratings, subjective confirmation of state, visual 
assessment of patient by operator, appearance of steady state V02 and HR 
on the exercise computer screen). Otherwise the test was conducted 
according to the safety criteria described in chapter 3. 
7.2.5 Measurements 
The FEV1 was measured prior to exercise, and breathlessness rated from 
Borg scales whilst seated and resting. The following measurements were 
made during a 5 minute rest period and throughout the exercise periods:-
V02 and V E measured using the Oxycon system, a single lead ECG for HR 
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and oxygen saturation (%Sp02) using an earlobe probe pulse oximeter 
(Ohmeda Biox 3700e). At the end of exercise patients rated specifically how 
breathless they felt, and rated the difficulty of the exercise, from separate 
Borg scales. Exercise time was recorded throughout and the reasons for 
exercise termination noted. Earlobe capillary blood samples were collected 
for the measurement of blood gases, pH and lactate concentration. Blood 
gases and pH were measured at rest and during the final minute of the 
incremental test and the 85% endurance test. Blood lactate concentration 
was also measured at rest and 4 minutes post exercise during the 
incremental and the 85% endurance test. 
7.3 RESULTS 
All patients completed the study, the mean time between visits was 9.8 (4.8) 
days. The lung function at the inital visit, the percentage of predicted normal 
values and anthropometric details were presented in table 6.2, chapter 6. 
Nine patients identified some breathlessness at rest at each visit, and one 
patient reported breathlessness on rest on 4 occasions. The breathlessness 
scores at rest and FEV, measurement at each visit are given in table 7.1. 
7.3.1 Incremental exercise to measure V02peak 
The mean exercise time was 8.3 (2.4) minutes. The reasons for exercise 
termination were breathlessness in 3 patients, leg fatigue (2 patients) and a 
combination of both symptoms (5 patients). The mean ventilatory, gas 
exchange, HR response and Borg ratings of perceived exertion and 
breathlessness at peak exercise are presented in table 7.2. Figure 7.1 
illustrates the percentage of predicted values for V02peak, V E and HR. 
Nine patients had a fall in %Sp02 during exercise. In 6 patients the fall was 
<: 4 percentage points (p.p.), and in 2 patients it was only 1 p.p. The mean 
(SD) %Sp02 at rest was 95.4 (1.5)% and at peak exercise was 91.5 (2.4)%. 
The mean fall was 3.9 (2.6)%. There was a corresponding fall in Pa02 and a 
slight fall in pH. Four patients had a slight increase in PaC02 though it 
remained within normal limits for all cases. Only 2 patients had an absolute 
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Table 7.1 Borg ratings for breathlessness at rest and mean baseline FEV, 
values for all visits 
Visit 
FEV, (1) 
BS 
mean(SD) 
range 
Inc. Test 
SS 
Inc. test 
1.01 (0.36) 
1.7 (1.0) 
0.5 - 3 
75%, 85%, 95% 
SS 75% 
1.00 (0.29) 1.02 (0.32) 
1.6 (1.0) 1.6(1.3) 
0.5 - 3 0-4 
incremental test visit 
steady state test visit 
endurance test visits 
85% 95% 
~ ...... ~ ..... 
0.98 (0.29) 1.00 (0.45) 
1.6 (1.1) 1.4 (0.9) 
0-3 0.5 - 3 
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Table 7.2 Cardio·respiratory measurements and Borg ratings during symptom limited incremental exercise 
V02peak V Epeak HRpeak Vt fA RER BS RPE 
(ml.min·'.kg·') (1. min·') (bt.min·') (ml) (breath.min·') 
mean (SO) 15.5 (3.9) 42.1 (12.8) 120 (20.1) 1614 (499) 28.2 (5.6) 0.91 (0.06) 5.5 (1.5) 15.4 (2.0) 
range 9.7 - 21.2 25.9 - 64 86 - 151 897 - 2484 20.4 - 37 0.84 - 1.01 4 - 9 13 - 19 
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increase in lactate concentration exceeding 2 mmol.1 '1, and one of these had 
a concentration> 4 mmol.l .1. A summary of the capillary blood gas, pH and 
lactate measurements is presented in table 7.3. An anaerobic threshold (AT) 
was detected in 5 patients using the V-slope method (Sue 1988) (figure 7.2). 
Only one of these had a lactate response> 2 mmolJ '1, whilst the remaining 4 
patients had minor increases in blood lactate concentration of 0.35, 0.52, 
0.38 and 0.28 mmolJ ,1. 
There was no relationship between the incremental V02peak and baseline 
lung function (FEV1), treadmill time, the end exercise %Sp02 or the fall in 
%Sp02' There was no relationship between the incremental treadmill time, 
the FEV1 and fall in %Sp02' 
7.3.2 Steady State Exercise 
A graph of the three steady state walking speeds and the corresponding 
V02 was plotted for each patient and the regression lines fitted. The mean 
regression coefficient (r2) was 0.965 (range 0.906 to 1.000). The regression 
equations were used to calculate the endurance walking speeds which 
related to 75%, 85% and 95% of the V02peak for each patient. The derived 
walking speeds are given in table 7.4. 
7.3.3 Endurance Exercise 
The endurance capacity was defined as the duration of exercise at the set 
endurance walking pace. The mean times for the three tests of endurance 
were 16.2 (6.6),12.3 (7.2) and 8.1(6.8) minutes for the 75%,85% and 95% 
tests respectively. The exercise times for each patient and the reasons for 
the termination of exercise are given in table 7.5. The 60r9 ratings for 
breathlessness and perceived exertion increased progressively as the level 
of exertion increased. The differences reached significance between the 
95% and 75% tests for perceived exertion only. Table 7.6 summarises the 
80rg ratings for breathlessness and perceived exertion. 
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Table 7.3 Blood gases and lactate concentrations following incremental 
and endurance exercise 
PaO. (kPa) PaCO. (kPa) pH lactate (mmol.l .,) 
Ine Base 9.88 (0.32) 4.84 (0.06) 7.423 (0.007) 0.39 (0.14) 
7.94 - 11.24 4.51 - 5.23 7.393-7.455 0.04 - 1.21 
peak 8.03 (0.24) 4.87 (0.18) 7.391 (0.012) 1.22 (0.52) 
6.88 - 9.17 4.10 - 5.62 7.349-7.484 0.21 - 4.88 
85% Base 10.42 (0.44) 4.74 (0.10) 7.426 (0.007) 0.41 (0.12) 
7.6 - 11.95 4.16 - 5.16 7.387 - 7.460 0.11 - 1.18 
peak 8.50 (0.42) 4.92 (0.13) 7.386 (0.009) 1.34 (0.56) 
6.76 - 10.95 4.14 - 5.51 7.345-7.432 0.12 - 4.67 
Mean (SE) and ranges for capillary blood gases, pH and blood lactate 
concentrations during incremental exercise (inc) and during the 85% 
endurance test. Values are for baseline (base) and peak exercise, except 
for blood lactate concentration which was at 4 mins post exercise. 
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Figure 7.2 Incremental exercise 
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Table 7.4 Walking speeds for treadmill endurance tests 
Subject 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
mean (SO) 
75% 
1.4 
3.9 
4.5 
2.7 
4.4 
2.5 
3.5 
4.1 
2.6 
4.0 
3.36 (1.0) 
85% 
1.8 
4.4 
5.3 
3.5 
5.4 
3.2 
4.1 
4.8 
3.2 
4.7 
4.04 (1.1) 
95% 
2.3 
4.9 
6.1 
4.4 
6.3 
3.9 
4.7 
5.5 
3.9 
5.4 
4.70 (1.2) 
Walking speeds (km.h·') for 3 intensities of endurance exercise. 
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Table 7.5 Endurance times and reasons for termination of exercise 
Test 75% 85% 95% 
Subject min / reason min / reason min / reason 
1 13.8/ LF 12.3/ GF 9.8/ LF 
2 20 / - 20 / - 17.2/ B 
3 20 / - 9.0/ C 2.9/ C 
4 4.7/ B 2.3/ B 2.0/ B 
5 20 / - 20 / - 3.6/ C 
6 20 / - 8.3/ B 4.5/ B 
7 20 / - 20 / - 20 / -
8 3.9/ C 3.1 / C 2.1 / C 
9 20 / - 8.2/ C 4.7 I GF 
10 20/ - 20 / - 14.5/ LF 
mean (SE) 16.2 (2.1) 12.3 (2.3) 8.1 (2.2) 
Time completed for each test and reason for the termination of exercise. 
B breathless 
LF leg fatigue 
GF general fatigue 
C combination of leg fatigue and breathlessness 
completed 20 minutes of endurance walking speed 
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Table 7.6 Borg ratings for breathlessness and perceived exertion 
Endurance test 75% 85% 95% 
BS mean (SE) 4.1 (0.7) 4.5 (0.5) 5.9 (0.7)' 
range 1 - 9 3 - 7 3 - 10 
RPE mean (SE) 13.2 (0.9) 14.3 (0.8) 15.3 (0.7)' 
range 10 - 19 11 - 17 13 - 18 
, significantly different from 75% test only (p<0.05) 
Breathlessness (BS) and perceived exertion (RPE) rated at the end of each 
bout of endurance exercise. 
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The end of test mean values for V °2, V E and HR showed a progressive 
increase at each level of exercise intensity (table 7.7). However there was 
wide variability in the pattern of the V02 response to the endurance 
exercise. Four patients attained a steady state in V02 during the 75% test 
(L\ V02, (terminal - 3 min) equal to zero, or negative (Wasserman 1994)), and 
2 patients had a peak response at this level (final V02 2': V02peak)' Five 
patients had a peak response during the 95% test. The pattern of the V02 
response during the endurance exercise is illustrated in figure 7.3. Examples 
of the steady state response and the peak response of V 02 V E and HR are 
illustrated in figure 7.4. The percentage of V02peak attained during the third 
and the final minute of exercise at each level of exertion is illustrated in 
figure 7.5. The mean (SD) % of V02peaK achieved at the end of each 
endurance test was 97 (11)%, 88 (13)%, and 84 (16)% for the 95%, 85% and 
75% tests respectively. 
The 95% test provoked a peak response in V02 in some patients (n=5). 
therefore the gas analyses for these tests were also examined for evidence 
of an AT. An AT (V-slope) was detected in 3 of the patients. Two of these also 
demonstrated an AT during the peak incremental test. An AT (V-slope) was 
not detected during any ofthe 85% and 75% endurance tests. The presence 
of a gas exchange AT during the incremental and 95% endurance tests is 
summarised in table 7.8. 
Analysis of variance, and post-hoc Scheffe test, revealed the 95% 
endurance test provoked significantly greater levels of V °2, V E and Vt 
compared to the 75% test. The HR during the 95% test was also significantly 
higher than the HR during the 85% and 75% tests. There were no significant 
differences between the fR at the end of each bout of endurance exercise. 
Thus differences in the ventilatory response were achieved primarily by 
changing VI. 
154 
Table 7.7 
Endurance 
test 
75% 
85% 
95% 
Cardia-respiratory measurements at the end of endurance exercise 
; I 
\1 0 2peak \lE HR Vt fA 
(ml.min·'.kg·') (L min"') (bt.min·') (ml) (breath.min·') 
11.8 (0.4) 33.4 (3.1) 112 (7) 1287 (104) 26.6 (2.1) 
9.4-14.0 22.4 - 51.3 80 - 157 981 - 1792 12.5 - 33 
13.5 (0.9) 37.2 (4.2) 113 (6) 1394 (126) 26.8 (1.7) 
9.4 - 19.9 23.7 - 65 82 - 153 900 - 2211 16.5 - 33 
15.0 (1.0)* 40.5 (3.4)* 122 (7)+ 1444 (103)* 28.5 (2.1) 
11.1-21.2 27.0 - 58.9 83 - 157 906 - 2045 20 - 40.8 
RER 
0.87 (0.01) 
0.82 - 0.96 
0.90 (0.02) 
0.78 - 0.99 
0.92 (0.02) 
0.82 - 1.01 
* significantly different from 75% and 85% tests (p<0.05) + significantly different from 75% test only (p<0.05) 
Mean (SE) and range for cardio-respiratory measurements during the final minute of each endurance test 
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Figure 7.3: Number of patients who attained a 
steady state, gradual drift or peak response in V02 
during endurance exercise 
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Table 7.8 Anaerobic threshold (AT) during incremental and 
endurance exercise 
Subject AT V-slope method 
Incremental 95% Endura nce 
Exercise Exerc ise 
_____ ... _ ._. __ ( 1. m i~J. (% L _ _ ...... 0.:.rT]in.J ... __ _ 
1 NF NF 
2 1.26 (93) NF 
3 1.12 (68) 1.30 
4 NF NF 
5 NF 1.25 
6 NF NF 
7 0.83 (83) NF 
8 0.92 (72) 0.90 
9 NF NF 
10 0.93 (80) NF 
Anaerobic threshold' detected by the V-slope method during incremental 
and 95% endurance exercise. (NF - not found) 
• Expressed as Lmin"' and percentage ( ) of V02peak measured during 
incremental exercise 
NB The AT was not detected during the 85% or 75% tests 
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There was a fall in the mean value of %SpOz at all levels of exertion with the 
greatest fall occurring during the 95% test (figure 7.6). The PaOz and the pH 
fell during the 85% test (table 7.3) (blood samples were not collected during 
any other endurance test). Two patients had an increase in lactate 
concentration> 2 mmoi.l ., from baseline values. The blood gas and lactate 
analyses are summarised in table 7.3. 
There was no relationship between the baseline FEV, measurements and 
endurance times, or between the FEV, and the V O, at the end of each 
endurance test. However there was a significant relationship between the 
fall (Ll) in %SpO, and the 85% endurance time (r value 0.717, p<0.025), 
(figure 7.7). The relationship with the 75% endurance time showed 
borderline significance (r = 0.620, p=0.056) . 
7.3.4 Comparison of incremental and endurance exercise 
Analysis of variance revealed there were no significant differences between 
the peak incremental response and the end of test responses during the 
95% and 85% tests for VO
" 
V E' HR, (illustrated in figure 7.8), and for RER, 
Vt and fR. Additionally the peak incremental HR, R, Vt and fR were not 
significantly different from the 75% endurance response. There were no 
significant differences between the end of test values of %SpO, and no 
differences between Ll%SpO" There were no significant differences 
between the incremental and endurance tests for the Borg ratings of 
breathlessness. Similarly Borg ratings of perceived exertion were not 
significantly different with the exception of the 75% test. The exercise times 
achieved for the 95% test and the incremental test were not significantly 
different. The incremental test time was significantly less than the 85% and 
75% endurance times (figure 7.9). 
There was a significant but moderate relationship between the incremental 
test V O,peak and the 85% treadmill endurance time (r=0.663, p<0.05). There 
was no relationship between the incremental VO'Peak and the 95% and 75% 
endurance times. 
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7.3.5 Comparison of the field and treadmill endurance responses 
Although patients tended to walk for longer on the treadmill than around the 
shuttle course at all exercise intensities, there were no significant differences 
between the endurance times (figure 7.10). However there were wide 
differences in some patients and subsequently there were no significant 
relationships between the treadmill and field test times except for the 75% 
level (r=0.681, p<0.05). However this was strongly influenced by the number 
of patients who attained the 20 minute ceiling during both tests. 
There were no significant differences between the end of test heart rate 
responses, or between the Borg scores for breathlessness and perceived 
exertion at comparative field and treadmill endurance levels. The reasons for 
terminating exercise on the treadmill and during the field test matched for 6 
patients at both the 75% and 85% levels, and for 5 patients at the 95% level. 
More patients identified breathlessness as the reason for terminating 
exercise during the 95% ESWT (n=7) than for the 95% treadmill test (n=3). 
There were significant relationships between the end of test field and 
treadmill heart rates (r values 0.901,0.761 and 0.731, p<0.025, respectively 
for 95%,85% and 75% endurance levels), figure 7.11. 
There was a significant relationship between the V02peak predicted from the 
incremental shuttle walk test and the V02peak measured during the 
incremental treadmill test (r=0.751, p<O.025). However the predicted V02peak 
tended to underestimate the measured value. There was a significant 
relationship between the V02peak measured during the incremental treadmill 
test and the 75% field endurance time (r=0.742, p<0.05), but no significant 
relationship with the 85% and 95% field endurance times. 
7.4 DISCUSSION 
The aim of this experiment was to describe the cardio-respiratory and 
metabolic response to endurance exercise in COPD, and to examine the 
relationship between the field and treadmill endurance performances. To 
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produce the same relative level of stress in all patients (% of V02peaJ the 
walking speeds for each endurance test were calculated from the individual 
maximal performances and steady state exercise responses. The rationale 
for choosing the high work rates was based on three precepts: 1) the 
evidence that patients with COPD are able to sustain exercise at relatively 
high work rates; 2) endurance capacity measured at high work rates in 
COPD is sensitive to an intervention of exercise training (Ries 1988, Punzal 
1991); 3) the necessity to develop a field test which is practical and avoids 
lengthy testing periods. 
The group demonstrated a reduced exercise capacity. The V02peak achieved 
during the symptom-limited incremental test was only 55% of the value 
predicted for a normal population. There was also a moderate heart rate 
reserve at peak exercise which is consistent with a ventilatory limit to 
exercise. The equation to calculate the predicted V Epeak at maximal exercise 
was derived from a group of patients with COPD (Spiro, 1975). The high 
percentage of the predicted value supports the attainment of maximal 
exercise capacity in this group of patients. 
One of the aims of this study was to examine the cardio-respiratory and 
metabolic response to endurance exercise in COPD. Leidy (1994) described 
functional capacity as an individuals maximum potential to perform activities, 
and equated it to the measurement of V02m fD( in the laboratory. Functional 
performance describes the corporeal activities of normal daily living, and 
functional capacity utilisation as the extent to which capacity is called upon 
in the selected level of performance. Thus, although performance is 
ultimately constrained by functional capacity, everyday fitness may relate 
more accurately to endurance capacity, or the ability to sustain exercise, 
rather than to the maximum exercise capacity. In this study endurance 
capacity was defined as the duration of exercise at the set intensity 
(% V02peak)' The endurance capacity varied depending on the intensity of 
exercise, whilst there was a wide range of endurance times within the COPD 
group studied. 
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The range of endurance times were not significantly correlated with lung 
function or maximum exercise capacity (V02peak)' A lack of correlation 
between these two variables and endurance capacity has been 
demonstrated in patients with cystic fibrosis (Freeman 1993). This finding 
supports the results from the field test study (chapter 6) where there was no 
relationship between the time walked during the ISWT and the times 
completed during the endurance tests. In the current study there was a 
moderate relationship between incremental treadmill V02peak and the 85% 
treadmill endurance time (r=0.663), and between the incremental treadmill 
V02peak and the 75% field endurance time (r=0.742). However there were no 
relationships between the V02peak and any of the other endurance times 
(field or treadmill). This finding suggests endurance capacity may be related 
to other factors rather than the constraints which limit V02peak' Astrand (1986) 
states, for healthy subjects, the V02max is important for strenuous activity 
lasting approximately 5 - 30 minutes, whilst for prolonged energy demanding 
activities the maximal aerobic power is less important for performance. 
Peripheral factors, including muscle glycogen stores and muscle blood flow, 
and the level of pre-training are important for endurance performance. 
A sub-optimal nutritional status is likely to affect both stored muscle glycogen 
and exogenous glucose levels. Although nutritional status was not 
evaluated, and there was no evidence of low body weights in the present 
study, previous work has demonstrated elevated resting energy expenditure 
in both normally nourished and malnourished patients with COPD (Lanigan 
1990, Donohoe 1989), and this is likely to effect energy stores. Other studies 
have found changes in peripheral muscle strength and endurance (Newell 
1989, Gosselink 1996b) and differences in muscle fibre types (Jakobsson 
1990). Gosselink (1996b) examined quadriceps and handgrip force in a 
group of younger patients (mean age 58), and with slightly better lung 
function than the current study (FEV1 % of predicted was 43%). Reduced 
peripheral strength was demonstrated in addition to reduced respiratory 
muscle strength. 
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In the study from Jakobsson (1990) skeletal muscle metabolites and fibre 
types were compared in two groups of patients with severe COPD, one 
group had respiratory failure. Both groups had a reduced percentage of type 
1 fibre types (high oxidative capacity, low glycogenolytic capacity) (17% and 
22%) compared to a control group (% not given). The respiratory failure 
group also had significantly reduced concentrations of glycogen and 
creatine phosphate. The authors found a significant correlation between the 
arterial Pa02 and muscle glycogen, and between Pa02 and the type 1 fibres, 
for both groups. There were some abnormalities in Pa02 in the present study 
group. How this, and other abnormalities associated with the chronic 
condition, influenced muscle strength, energy stores, enzyme systems and 
the measured endurance capacity cannot be confirmed. However changes 
in peripheral muscle strength and energy stores, and their subsequent 
influence on endurance capacity, cannot be ruled out in this patient group. 
In the current study there was no evidence of hypercapnia, however there 
was a significant correlation between the 85% endurance time and the fall in 
%Sp02 (r=0.717), and a weaker relationship with the 75% endurance time 
(r=0.620, p=0.056). There was no relationship between the fall in %Sp02 
and the incremental exercise time. Two studies which examined the effects 
of oxygen supplementation on exercise performance in COPD (Bye 1985) 
and in interstitial lung disease (ILD) (Bye 1982) found endurance capacity 
was substantially improved (113% and 263% respectively) with O2, However 
there was no effect on the incremental exercise performance (measured in 
the patients with ILD). The author suggested a mechanism of improved O2 
delivery and utilisation of O2 by the tissues and limb muscles. Additionally, 
there was a delay in the onset of EMG evidence of diaphragm fatigue in the 
COPD patients, which suggested there were improvements in the respiratory 
muscle performance. 
In a recent study which examined the effect of O2 supplementation on the O2 
deficit and V02 kinetics during exercise in COPD, Palange (1995) measured 
improved phase two "02 time-constants, reduced O2 deficit and steady state 
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ventilation during constant work rates in hypoxaemic patients. The author 
concluded O2 supplementation accelerated "it02 kinetics, and enhanced 
aerobic metabolism, in the skeletal muscles in COPD. Although the results 
from the current study do not demonstrate a causal effect, they support a 
relationship between the fall in %Sp02 and endurance exercise capacity. 
They do suggest further investigations for the role of %Sp02' and the 
influence of ambulatory oxygen and endurance exercise. 
Since everyday activity is more likely to relate to endurance capacity, levels 
of habitual activity, deconditioning, and motivation are likely to influence 
tests of endurance capacity. All the patients in the current study were retired 
from regular work, and though not quantified, qualification of daily activities 
revealed a wide range of levels. Resting lung function did not explain the 
wide range in endurance times. In the field test study (chapter 6) there was a 
marked contrast between the reasons for exercise termination during the 
ISWT and the 95% ESWT, (main reason - breathlessness), and the reasons 
indentified for the lower intenSity endurance tests (leg fatigue and 
combination of symptoms). This suggested deconditioning was an important 
determinant of endurance capacity, whilst breathlessness remained the 
principal symptom limiting the shorter 95% and the incremental test (lSWT). 
The reasons for exercise termination in the current treadmill study differed 
slightly from those identified during the field exercise. A greater incidence of 
leg fatigue was identified during the incremental and the 95% treadmill tests 
than for the corresponding field tests. The incremental treadmill test may 
have provoked more peripheral muscle fatigue than the incremental field 
test, since patients walked up an increasing gradient. Additionally, patients 
tended to walk for longer during the 95% treadmill endurance test, with 
greater incidence of leg fatigue, than during the comparative field test. The 
incidence of leg fatigue suggests there may have been deconditioning in 
some patients. Whether deconditioning was an important factor in the 
exercise limitation of this patient group requires further investigation. 
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It has been suggested the respiratory muscles may contribute importantly to 
the exercise limitation in COPD (Dodd 1984), and ventilatory muscle training 
has been shown to increase submaximal exercise performance in some 
studies (Pardy 1981, Larson 1988). This was discussed in some detail in the 
previous chapters. Gallagher (1994) suggests inspiratory muscle function 
influences endurance exercise time in some patients, since unloading the 
respiratory muscles with the use of continuous positive airway pressure led 
to significant improvements in endurance capacity in some patients 
(O'Donnell 1988). 
The purpose of the steady state exercise tests (3 x 4 minute stages at 
different walking speeds) was to establish the relationship between walking 
speed on the treadmill and V02 for each patient. This allowed individual 
walking speeds to be determined for the endurance tests, to provoke a given 
percentage of the V02peak' This model was largely successful for the 95% 
and the 85% tests, however there was a wide scatter in the % V02peak 
achieved, indicated by the large standard deviations. The V02 achieved at 
the end of the 75% test was much higher (mean value 84%) than the target 
level. This latter finding is consistent with a study from Matthew (1989) where 
the application of a cycle ergometer work rate, equivalent to 75% of the 
maximal work rate, provoked a maximal V02 response in both a COPD 
group and an age-matched control group. 
The finding of a high V02 at the lower exercise level (75%) raises a number 
of issues. The relatively slower walking speeds on the treadmill provoke a 
high V02 in this patient group. The maximal exercise capacity may be so 
reduced that lower intensity exercise will engender a higher proportion of the 
maximal capacity, and even minimum exertion will elicit a relatively high 
energy expenditure. However 75% of V02peak is a relatively high level of 
exercise, even if in absolute terms the walking speeds might be considered 
slow or moderate. The energy requirement for walking on the level at 2 mph 
is between 2 - 4 kcal.min·" or less than 1 l.min·l of O2 (Astrand 1986). This 
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oxygen consumption is close to the V02peak measured in most of patients in 
this study. However, despite the high V02 there was a graduated response 
in endurance times and the endurance capacity (length of time walked at 
each level) varied according to the imposed exercise intensity. The ability of 
patients to exercise at relatively high intensities supports the findings of 
others (Toshima 1990, Punzal 1991), where high intensity exercise training 
and testing regimens have been used as part of a rehabilitation programme. 
At the 95% level of exertion 4 patients exceeded their V02peak and 6 patients 
exceeded their HRpeak. Submaximal exercise V02 and HR values which 
exceed peak values in patients with moderate and severe COPD has been 
shown elsewhere (Matthews 1989, Punzal 1991). This finding suggests the 
incremental test may not always be the best method to obtain the highest 
value of V02 for some patients. A similar response for HR was found during 
the field test study and was discussed in chapter 6. It is likely the shorter 
work stages during the incremental test did not allow the physiological 
variables sufficient time to stabilise. Thus peak values were not achieved 
prior to the termination of exercise. During the 95% endurance test the work 
intensity was high and persisted long enough for peak values to occur. A 
study which compared the ventilatory and gas exchange time constants 
between patients with COPD, and an age-matched control group, 
demonstrated patients had significantly longer phase 2 time-constants prior 
to the attainment of a steady state (Nery 1982). Additionally Wasserman 
(1994) reports considerably delayed steady state time with exercise above 
the AT. 
The 95% endurance test provoked a peak response in 4/10 patients, and a 
gas exchange AT in 3 patients. The lactate response following the 85% test 
was not significantly different from the incremental response. One of the 
patients with a gas exchange AT during the 95% endurance test did not 
demonstrate an AT during the incremental test. These findings further 
support the usefulness of a high intensity constant work rate test to provoke a 
maximal response in some patients. At present there is no consensus 
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regarding the most appropriate exercise test for patients with respiratory 
disease. A test duration of 8 - 12 minutes for the measurement of \/02peak has 
been recommended. The work rate increments should be tailored to the 
individual, taking into account habitual activity, clinical details and the results 
of any prior respiratory function tests (Wasserman 1994). The results from 
the present study indicate the use of a constant work rate, of high intensity, 
may provoke a higher \/02peak compared to an incremental test in some 
patients. 
The increases in \/02 between 3 and 6 minutes (11\/02 (6-3)) of a constant 
work rate test were related to changes in lactate concentration in both 
normal subjects, and patients with heart failure (Wasserman 1994). The 
author suggested where the work rate was above the AT, the \/02 will 
continue to rise, and only when the work rate was below the AT will the \/02 
assume a steady state. Using the same criteria in the current study, the 95% 
and 85% endurance tests were below the AT for the 2 patients who achieved 
a \/02 steady state, and the 75% level was below the AT for 4 patients. 
However, due to the variable lactate response, and the absence of serial 
measurements, the relationship between changes in \/02 and the blood 
lactate concentration cannot be confirmed in this group. 
There was wide variation in the pattern of the \/°2 response at the same 
relative levels of exercise (% of \/02peak). Some patients achieved a steady 
state \/02 at 2, or more, exercise intensities, whilst others had a rapid rise in 
. . 
V02 and attained or exceeded their V02peak. Finally some patients had a 
gradual increase in the \/02 throughout the endurance exercise. Roston 
(1987) suggested a continual slow increase in \/02 was associated with 
increased blood lactate concentration. The occurrence of a steady state \/°2 
. in the current study could not be explained by the baseline lung function 
(FEV,). 
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The results of the treadmill endurance tests from the present study 
substantiate the field test findings, that this group of patients with moderately 
severe COPD can tolerate exercise at relatively high work rates. The findings 
are consistent with previous studies which have examined patients prior to 
exercise training programmes and have demonstrated exercise of a 
relatively high intensity can be sustained. Punzal (1991) found patients who 
did not reach an AT were able to train at a higher percentage of maximum 
exercise capacity than patients who had reached an AT. Casaburi (1991) 
compared high and low intensity training in patients with moderate COPD, 
pre-selected on the basis of a detectable metabolic acidosis, and found 
patients were able to sustain and improve endurance exercise at 90% of the 
work rate associated with an AT. The present study has demonstrated both 
types of patients (with and without evidence of an AT), are able to exercise at 
high levels of V02• 
The group achieved longer endurance times walking on the treadmill with 
slightly lower heart rates compared to walking around the shuttle test course. 
The shuttle and corresponding treadmill speeds were different for some 
patients, however there are additional reasons which may explain this 
finding: 1) lower energy expenditure on the treadmill as a result of the belt 
assisting the backward movement of the foot before advancing to the next 
step; 2) differences in shoe to ground friction and step impact; 3) higher rate 
of energy expenditure as a result of turning the corners of the shuttle course 
compared to walking in a straight line on the treadmill. The heart rate 
responses provoked by the field test were comparable to those achieved on 
the treadmill, with significant relationships between the same levels of 
endurance. This finding supports the use of the field test to provoke similar 
cardiac responses to those provoked on the treadmill. 
There was a strong correlation between the V02peak predicted from the ISWT 
and the V02peak measured during the incremental treadmill test. The ISWT 
tended to underestimate the actual V02peak' however the endurance walking 
speeds derived from the predicted V02peak provoked similar HR responses, 
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and similar Borg ratings to those achieved on the treadmill. The shuttle 
endurance speeds were different from the treadmill walking speeds, and this 
reflects the differences between treadmill walking and walking around the 
shuttle circuit, and the differences between the predicted and the measured 
V02peak. However the similarities between the treadmill and field test 
responses validates the use of the ISWT to determine suitable endurance 
speeds for the field test. 
The gas exchange response to the incremental exercise revealed 5 patients 
with an AT determined by the modified V-slope method (Sue 1988). The 
absence of a gas exchange AT, or a metabolic acidosis, in patients with 
moderately severe to severe COPD is not uncommon. Sue (1988) was 
unable to detect an AT in 8 of 22 patients studied using the gas exchange 
method, and in 7 of the patients using the standard bicarbonate method i.e. 
fall in plasma standard bicarbonate at onset of metabolic acidosis. Belman 
(1992) detected only 7 patients from 29 with a metabolic acidosis (fall in 
bicarbonate> 2 meq.n during incremental exercise, whilst Wanke (1993) 
was unable to detect an AT in 12 of 30 patients with COPD using the same 
method. 
In the present study patients who demonstrated a gas exchange AT (n=5) 
tended to have higher FEV1 and V02peak values (mean values, 1.25 vs 0.79 I, 
and 17.2 vs 13.8 ml.min·1.kg·1 respectively). This is consistent with previous 
reports where differences between study populations has led a number of 
workers to suggest disease severity may influence the appearance or 
absence of an AT. In the study from Sue (1988), which described the use of 
the V-slope gas exchange method in patients with COPD, the subjects who 
developed metabolic acidosis had milder airways obstruction compared to 
those who did not. Wanke (1993) found significantly higher airways 
resistance (Raw) in patients who did not develop an AT, and Punzal (1991) 
found higher FEV1 values in patients who developed an AT (FEV1 1.96 vs 
1.07 1). Spiro (1975) documented mean lactate concentrations of 3.63 and 
2.56 mmol.r1 following maximal exercise in moderate (mean FEV1 1.45 I) 
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and severe COPD respectively (mean FEV, 0.62 I). However the findings 
from Sue (1988) and Wanke (1993) led both authors to conclude that resting 
pulmonary function alone is a poor predictor of individual patients who do or 
do not develop metabolic acidosis during exercise. In the current study the 
small number of patients that displayed an AT make firm conclusions difficult. 
However since the application of exercise training may, in some pulmonary 
rehabilitation centres, rely on the development of an AT, the relationship 
between disease severity and the development of an AT is worthy of further 
investigation. 
The patients who demonstrated the gas exchange AT had a longer mean 
incremental exercise time compared to the rest of the group (mean (SO) 
exercise time 9.3 (3.3) vs 7.7 (1.6) min). A reduced exercise capacity, which 
precluded the development of metabolic acidosis, may additionally explain 
the absence of an AT response in some patients. Previously it had been 
contended most patients with moderate and severe COPD did not develop 
an AT as a result of premature peak exercise levels (Belman 1986). 
However more recent work indicates a lactic acidosis can occur at low work 
rates in some patients, and the peak response is reduced in comparison with 
normal control subjects (Sue 1988, Casaburi 1991). Singh (1994b) 
demonstrated a markedly reduced blood lactate response in 10 patients with 
COPD (only 2 patients had an increase >2mmol.r'), and detected an AT by 
the gas exchange method in 6 patients. A gas exchange AT and significantly 
higher lactate concentrations were detected in 10 age·matched control 
subjects. The control group achieved longer exercise times (9.5 minutes) 
compared to the patient group (7.6 minutes). In the current study the small 
number of patients in the AT and non-AT groups make it difficult to draw 
reliable conclusions concerning the influence of exercise time. However it is 
likely a reduced exercise capacity, and termination of exercise prior to any 
significant increase in blood lactate concentration may explain the absence 
of an AT in some of the patients. 
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There was only one patient with a gas exchange AT and an increase in 
blood lactate concentration> 2.0 mmol,r'. The remaining patients with a gas 
exchange AT (n=4) had minor increases « 1 mmol,r'). The proposed linking 
mechanism between the rise in blood lactate concentration and the sharp 
increase in CO2 production, relative to V02, is the release of additional CO2 
from the dissociation of carbonic acid. Hydrogen ions, released from the 
dissociation of lactic acid, are buffered by bicarbonate ions, forming carbonic 
acid which subsequently dissociates to form CO2 and water (Na+ + HC03' + 
W + La' f-t Na+ + La' + H2C03 (f-t Hp + CO2) (Astrand 1986)). Both CO2 and 
increases in the hydrogen ion concentration stimulate the respiratory centre 
via the carotid bodies (Wasserman 1993). 
The absence of a blood lactate increase, despite the presence of a gas 
exchange AT, in 4 of the patients suggests two possible mechanisms: 1) the 
ventilatory response in some patients may be triggered by very small 
increases in the W ion, or CO2 concentration, and this is possible since 
some patients are extremely intolerant of small fluctuations in PaC02 
(Wasserman 1993); 2) the ventilatory and metabolic anaerobic thresholds 
may only be coincidentally and not causally linked. This hypothesis was 
argued by Loat (1993) in a review article which examined the relationships 
between the ventilatory, gas exchange and the lactate thresholds during 
exercise. The authors argued several points for a coincidental relationship 
and these included: i) patients with McArdles disease (deficiency of muscle 
phosphylase) demonstrate a normal hyperventilatory response to exercise 
despite the failure to produce lactic acid; ii) studies involving the comparison 
of the ventilatory and lactate thresholds during exercise in the normal and in 
glycogen depleted states demonstrated the two thresholds could be 
manipulated independently; iii) studies have shown the two thresholds 
respond differently to a training stimUlUS. 
The findings from the current study cannot confirm the mechanisms for the 
gas exchange AT response to exercise. However they demonstrate that 
some patients may not manifest a conventional blood lactate response to 
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exercise (Le. > 2mmol.r' increase or an absolute value > 4 mmol.r') in the 
presence of a gas exchange AT. Additionally, the results would support a 
contention that the blood lactate increase following maximal exercise in 
COPD is reduced in comparison to a healthy population. There are a 
number of possible mechanisms for this finding, including reduced exercise 
times, or work rates, the premature termination of exercise due to symptoms, 
and reduced muscle bulk 
A number of studies have shown the mode of exercise can influence the 
lactate response in patients with COPD. In a comparison of cycling and 
treadmill exercise in 8 patients with severe COPD, Mathur (1995) found 
cycling provoked the greatest increase in post exercise lactate concentration 
(mean increase for cycle ergometer 1.44 vs 0.41 mmol.r' for treadmill 
exercise). Cockcroft (1985) reported considerably higher lactate and 
ventilatory responses in 9 patients with COPD during cycling exercise 
compared to treadmill exercise at equivalent levels of V O2 , The author 
suggested the smaller muscle mass involved with cycling exercise may 
account for the differences, since the mean metabolic rate per unit of 
contracting muscle is greater than for the equivalent treadmill work and thus 
is likely to engage anaerobiosis at a lower level of V O2, Similar findings 
have also been demonstrated in healthy individuals (Koyal 1976, 
Hermansen 1969). The use of treadmill (walking) exercise in the present 
study may have additionally influenced the size of the blood lactate 
response in this group of patients. 
One patient without evidence of a gas exchange AT had the largest increase 
in lactate concentration of the group (post exercise value 4.88, and 1:1 3.67 
mmol.l"). This is consistent with the study from Sue (1988) which concluded 
the modified V-slope method was satisfactory for 'most individual exercise 
studies'. In a study which examined the reliability of the non-invasive 
methods of detecting an AT in COPD, Belman (1992) detected a gas 
exchange AT (using the V-slope method) in only 417 patients who had 
demonstrated a change in standard bicarbonate> 2 mmol.r'. The authors 
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describe wide inter- and intra-observer variability with the V-slope method in 
moderate and severe COPD. A study presented in abstract form only 
(Maltais 1993) has questioned the utility of the V-slope method in detecting 
an AT in severe COPD. A gas exchange AT was detected in only 2 patients 
whilst significant increases in lactate were measured in the whole group 
(n=15). 
The results of the blood lactate analysis and the detection of a gas exchange 
AT during the incremental test were consistent with a number of previous 
reports, and, in summary, the findings were: 1) the more severely affected 
patients (lower FEV1 and exercise capacity) appear not to produce a 
conventional increase in blood lactate (increase> 2, or absolute value of > 4 
mmol.rl) upon maximal exercise; 2) there are inconsistencies between the 
occurrence of the gas exchange AT and the metabolic response. The 
reliability of detecting a gas exchange AT in moderate to severe COPD has 
been questioned, whilst changes in the blood lactate concentration may be 
minimal. 
To summarise the findings of this study: 1) the heart rate response recorded 
from the treadmill endurance tests was similar to that measured during the 
field endurance tests described in chapter 6. There were also no significant 
differences between the Borg ratings from the field and treadmill tests. These 
findings support the use of the ISWT to derive suitable walking speeds for 
the field endurance test; 2) the treadmill endurance tests provoked a wide 
range of variation in the pattern of the V02 response, ranging from a steady 
state to a peak response and this could not be predicted from the baseline 
lung function tests; 3) there were no substantial relationships between the 
peak incremental response and the endurance times for both the treadmill 
and the field tests (ESWT). This finding suggests endurance capacity in 
COPD may be related to additional factors rather than the constraints which 
limit V02peak' The more frequent occurrence of leg fatigue during the longer 
tests suggested the possibility of deconditioning in some patients. 
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The results from the current study show patients with moderate and severe 
COPD are able to tolerate exercise at high levels of V02 and this supports 
the use of relatively high work rates in a clinical field test. The 95% test 
provoked a peak response in some patients, whilst half of the patient group 
completed 20 minutes of the 75% test. Thus the performance of an 
endurance test at 85% of maximum intensity is likely to be practical Le. not 
too onerous for the patient, or time consuming for the operator, and it would 
possess a suitable margin for improvement following an intervention. 
However, the sensitivity and repeatability of a high intensity endurance test 
is as important as the practicality of the test. These two issues are addressed 
in the next chapter. 
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Chapter 8 
THE RESPONSE OF THE ENDURANCE SHUTTLE WALK TEST 
TO AN INTERVENTION OF PULMONARY REHABILITATION 
8.1 INTRODUCTION 
In order to become a reliable method of exercise evaluation the ESWT must 
possess both sensitivity, and repeatability. The studies reported in chapters 
6 and 7 suggested an endurance test at 85% of V02peak was well tolerated 
by the patients examined and would provide a practicable test in terms of 
duration and opportunity for improvement. In this study the repeatability of 
the ESWT was assessed and the sensitivity of the test was examined 
following an intervention of pulmonary rehabilitation. 
The number of practice walks recommended for the timed walk field tests 
varies from one to five (McGavin 1976, Knox 1988). An examination of the 
repeatability of the ISWT demonstrated the test required only one practice 
walk (Singh 1992). The 12 and 6 MWT have been shown to improve 
significantly following a period of pulmonary rehabilitation in patients with 
COPD (McGavin 1977, Cockcroft 1981, Niederman 1991). However Guyatt 
(1984) suggested the magnitude of change reported in some studies may 
represent test-retest variability and poor conduct of the test. Additionally a 
number of studies have failed to incorporate a control group or period, an 
important factor recommended by Knox (1988) where a timed walk test is 
used as an outcome measure. 
The aims of this study were formulated as follows: 
1) To assess the between day repeatability of the ESWT. 
2) To assess the sensitivity of the ESWT to an intervention of 
comprehensive pulmonary rehabilitation following a control period of 
similar duration. 
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8.2 METHODS 
8.2.1 Patients 
Thirty-three patients were entered into the study (16 women, 17 men). All the 
patients had been referred to the Hospital pulmonary rehabilitation service 
following routine attendance to the out-patient respiratory clinics. All the 
patients had COPD as a primary diagnosis, though some patients had 
additional clinical problems. These were not considered contra-indications 
to regular exercise and were stable at the time of referral. The additional 
ailments were renal impairment (1), cardiac valve disease (1), old 
myocardial infarction (1), gastric ulcer (2), hypertension (4). Patients were 
contacted by letter after they had received an appointment for their initial 
rehabilitation assessment. In the majority of cases there was a delay of 6 to 8 
weeks between referral and commencement of rehabilitation and this acted 
as the control period for the study. Height and weight were measured at the 
start, and weight was re-checked at intervals throughout the study. FEV, was 
measured at every visit, and the degree of breathlessness at rest assessed 
from a Borg scale. There were no alterations to any medications, although 
patients were instructed to use their inhaled bronchodilator within one hour 
of their appointment time in order to ensure maximum bronchodilation prior 
to exercise. 
8.2.2 Study Design 
Patients attended on four separate occasions. At the first visit, two ISWT and 
one practice ESWT were performed. The endurance walking speed was 
related to 85% of the V02peak predicted from the ISWT, and was calculated 
as described in chapter 6. The ESWT was performed during all the 
subsequent visits. The second visit occurred within 7 days of the initial visit, 
and was considered the start of the control period (no change in treatment). 
The third and final visits occurred at the start and end of the 7 week 
pulmonary rehabilitation course. In addition to the ESWT, patients also 
performed an ISWT at the start and end of the rehabilitation course. In order 
to examine the repeatability of the ESWT, 11 patients performed an 
additional endurance test at the start of the control period (visit 2a). 
183 
Rehabilitation 
Visit 1 2 2a Control period 3 4 
(repeat study) 5 -7 weeks Start End 
Test ISWT ESWT ESWT ISWT ISWT 
ESWT ESWT ESWT 
8.2.3 Endurance Shuttle Walk Test 
A number of modifications to improve the ESWT, and the recorded cassette 
tapes, were identified. These were: the inclusion of an additional moderate 
speed (table 8.1); alterations to the taped message at the start of the tapes; 
recording the complete test onto a smaller number of tapes. Four endurance 
walking speeds were recorded onto one 90 minute tape i.e. 2 x 20 minute 
tests on each side. Previous experience with the ESWT tapes during the 
developmental study (chapter 6), had suggested the standardised 
instructions recorded at the start of the tape were superfluous. All patients 
listened to the standardised instructions at the start of ISWT, and the 
instructions for the ESWT were very similar. There were two minor 
differences i.e. instructions concerning the 2 minute warm-up period, and the 
constant walking pace. Thus the instructions at the start of the ESWT tapes 
were removed. The one minute calibration signal remained, in addition to 
the following taped message at the start of each test:-
'walking test level_. The walking speed for the first 2 minutes is fairly slow, 
so don't go too fast. The test will start in 10 seconds, so get ready at the start 
now. The test starts with a triple bleep after a 4 second count-down.' 
A short piece of music was also recorded at the end of each endurance test 
to make it immediately obvious to the operator when the full 20 minutes of 
the endurance bleeps had finished. In addition it also acted as an audio 
marker for the end of one test and the start of the next test, recorded on the 
same side of the tape. 
The ESWT was performed as described in chapter 6. The walking speed 
was determined in the manner described in chapter 6, and related to 85% of 
the V02peak' predicted from the ISWT. The heart rate was recorded 
throughout using the telemetry device. Breathlessness and perceived 
exertion were rated from Borg scales and the reason for the termination of 
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Table 8.1 Modified Endurance Walking Speeds 
Level Warm-up speed Endurance speed Time/10 m shuttle 
(km.h·') (km.h·') (s) 
1 1.44 1.78 20.25 
2 1.44 2.09 17.25 
3 1.44 2.44 14.75 
4 1.44 2.72 13.25 
5 1.44 3.00 12 
6 2.40 3.27 11 
7 2.40 3.60 10 
8 2.40 3.79 9.5 
9 2.40 4.11 8.75 
10 2.40 4.36 8.25 
1 1 2.40 4.65 7.75 
12 2.40 4.97 7.25 
13 2.40 5.14 7.0 
14 2.40 5.54 6.5 
15 2.40 5.76 6.25 
16 2.40 6.00 6.0 
Duration of warm-up speed 2 minutes, and 20 minutes for the endurance 
speed 
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exercise was recorded. 
8.2.4 Incremental Shuttle Walk 
The ISWT was performed according to the description in chapter 3. Oxygen 
saturation was checked at rest and at the end of the test using the finger 
pulse oximeter. Where there was a fall in %Sp02 to <86% patients 
performed all subsequent walk tests with ambulatory oxygen (flow: 2 l.min·'). 
The oxygen was administered via nasal cannulae, and the portable cylinder 
was carried by the test operator (SMR) walking behind the patient. Care was 
taken to walk some distance behind the patient to avoid influencing 
performance of the tests. 
8.2.5 Pulmonary Rehabilitation Course 
During the 7 week out-patient course patients attended the Hospital 
Physiotherapy Department for 2 hour classes, twice weekly. The course had 
educational and exercise components. The educational component 
consisted of inter-active talks covering a variety of topics e.g. effective cough, 
relaxation, control of breathing, drugs, doses and devices, pathology of 
COPD and current therapies, nutrition, energy saving devices, keeping well, 
benefits agency and lung function measurements. Patients received a folder 
containing notes of the talks for future reference. 
The exercise training programme consisted of a circuit of flexibility and 
strength type exercises in the physiotherapy gym, and a home walking 
programme. The prescribed walking intensity related to 50% of the V02peak 
predicted from an ISWT performed during the initial rehabilitation 
assessment. The prescribed time of continuous walking was determined 
individually from performance during a treadmill endurance test, at the 
derived speed. Patients were instructed to walk every day if possible and to 
gradually increase the length of continuous walking at the prescribed speed. 
They were given a diary sheet to record the minutes of continuous walking 
completed and a 80rg scale to rate breathlessness. Patients who 
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demonstrated oxygen desaturation < 86% during the initial assessment 
performed the exercise training with portable oxygen. 
The pulmonary rehabilitation course was conducted by other dedicated 
Hospital personnel and has been in operation for a number of years. There 
were no alterations to the standard course. Although the investigator (SMR) 
tutored some exercise classes, the main part of the rehabilitation intervention 
was performed by other staff. 
8.3 RESULTS 
The mean (SO) duration of the control period was 5 (1.5) weeks. The study 
was conducted during late autumn and winter, and coincided with very low 
ambient temperatures and the usual increased prevalence of winter viral 
infections. As a result a number of patients had chest infections during the 
control periods, and during the rehabilitation course. Additionally several 
patients failed to complete the rehabilitation course due to severe 
exacerbation of symptoms, and for other reasons. 
Four patients had exacerbation of symptoms and chest infections during the 
control period and were treated with antibiotics. In addition one of the 
patients received a short course of oral prednisolone. Two of the patients 
recovered in time for the start of the rehabilitation, and two of the patients 
had the start deferred for 2 - 3 weeks. Three patients were treated with 
antibiotics for chest infections during the rehabilitation course and had a 
break from the course for 1 - 2 weeks. One patient suffered from cystitis and 
did not attend for 3 weeks. Ten patients failed to complete the rehabilitation 
course for a variety of reasons. These were: severe exacerbation of COPO 
and chest infection (3); Baker's cyst on the left knee (1); exacerbation of 
cardiac valve disease (1); exacerbation of renal impairment (1); minor stroke 
(1); motivational problems (2); sciatica (1). 
The data for 19 patients are presented. Three patients had not completed the 
course at the time of writing. An additional patient, not referred to the 
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rehabilitation course, was recruited for the repeatability section of the study. 
The measurements from this patient are included in the repeatability section 
only. 
All patients were on regular inhaled bronchodilator and steroid treatment. 
Two patients were receiving low dose oral steroids (prednisolone). Eleven 
patients were on diuretic therapy. Two patients were receiving domiciliary O2 
therapy for at least 15 hours per day, and 6 patients were using O2 for 
symptomatic relief only. 
The anthropometric details of the group, baseline and predicted lung 
function at the time of the initial visit are shown in table 8.2. The mean FEV1 
and resting Borg breathlessness values at each visit are shown in table 8.3. 
Three patients had a fall in oxygen saturation to <86% during the initial ISWT 
and received ambulatory oxygen for all subsequent tests. In addition these 
patients also received ambulatory oxygen during the exercise training 
component of the rehabilitation programme. The mean resting %Sp02 for the 
whole group was 94.5 (1.5)%. AI the end of the initial ISWT the %Sp02 was 
90.7 (3.9) and the mean fall was 3.8 (3.0). Individual values are illustrated in 
figure 8.1. 
The endurance walking speeds were determined from the peak ISWT 
performance and calculated by the graphical method described in chapter 6 
(fig. 6.2). The individual endurance walking speeds are shown in table 8.4. 
The endurance capacity was defined as the exercise duration at the set 
endurance speed of the ESWT. To enable comparison with the ISWT, the 
distance walked during the endurance test was also calculated, and 
included where appropriate. There was no significant change in the ESWT 
over the control period, the mean difference (SE) in time spent walking was 
4.1 (9.9) s, and for distance walked was 4.7 (8.1) m, p>0.05. Similarly there 
was no significant change in the ISWT (mean difference 2.6 (9.2) m). 
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Table 8.2 Summary of patient characteristics at initial visit 
Mean (SO) Range % of predicted 
FEV, (I) 0.80 (0.19) 0.50 - 1.20 35 (8) 
FVC (1) 2.06 (0.90) 0.95 - 3.7 68 (20) 
FEV/FVC (%) 45 (17) 15 - 78 
Age (y) 69 (6.6) 56 - 77 
Height (m) 1.64 (0.07) 1.53 - 1.79 
W~ght (kg) 70.8 (15.1) 53 - 106 
....... , ............... .. ....... " " . 
... __ 7 ...... 
..... ............ , 
n=19; 9 men, 10 women 
Table 8.3 Borg rating for breathlessness at rest, and baseline FEV, at 
each visit. 
~ 
Visit 1 2 3 4 
practice start control start rehab. end rehab. 
FEV, (I) 0.80 (0.19) 0.82 (0.19) 0.84 (0.23) 0.85 (0.21) 
8S 
mean (SO) 1.3(1.0) 1.9 (1.0) 2.3 (1.3) 2.0 (1.3) 
range 0-3 0-3 0-4 0-4 
median 1.4 1.8 2.1 1.9 
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100 
95 
90 
85 
80~-----r-----------.------
Rest Peak Ex. 
(n.b. several points overlaid) 
- indicates mean 
Figure 8.1 Pulse oximetry (%Sp02) at rest and 
at peak exercise (n=19) 
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Table 8.4 Individual endurance walking speeds 
Patient 85% Endurance speed 
(km.hr1) 
1 3.00 
2 2.72 
3 4.11 
4 3.60 
5 2.09 
6 3.79 
7 2.72 
8 3.00 
9 4.36 
10 3.60 
11 3.00 
12 3.00 
13 2.44 
14 1.78 
15 3.00 
16 2.09 
17 4.36 
18 3.00 
19 3.00 
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All the patients, with the exception of one (patient 10), had an improvement 
in the ESWT at the end of the rehabilitation course. Prior to rehabilitation the 
maximum time achieved by any single patient during the ESWT was 709 s 
(11 min 49 s). Following rehabilitation 3 patients completed 1200 s (20 
minutes), and 4 patients achieved> 17 minutes. The response to the ISWT 
was more variable, 9 patients had an improvement of ;:: 30 m ( i.e. greater 
than the test-retest variability (Singh 1992)) and 10 patients attained the 
same distance or less than at the start of rehabilitation. Analysis of variance 
revealed there were significant improvements in both the ESWT and ISWT 
for the whole group. The mean percentage improvement in endurance 
capacity was 160%, and for the ISWT was 32%. A summary of the walking 
test results for both the ESWT and ISWT pre- and post- rehabilitation are 
shown in tables 8.5 and 8.6 (and fig. 8.2). The individual values are 
illustrated in figure 8.3. 
The mean differences and 95% confidence intervals for the changes in both 
tests are shown in table 8.7. One patient died suddenly 3 weeks after 
completing the rehabilitation course (patient 10). This was the only patient 
without an improvement in the ESWT. A slight decrease in the endurance 
capacity was measured (start rehabilitation 436 s, end 399 s). To eliminate 
the possibility of a spurious result the post-rehabilitation ESWT was 
repeated at a separate visit. The results were within 4 seconds (399 and 395 
s). Additionally there was only minimal improvement in the ISWT. 
There were significant improvements in the Borg ratings for breathlessness 
and perceived exertion following rehabilitation for both the ESWT and the 
ISWT. The improvements occurred in addition to the significantly longer 
exercise times measured during the ESWT. Tables 8.5 and 8.6 summarise 
the Borg ratings for both tests. 
The reasons for the termination of endurance exercise did not change 
appreciably during the control period. Following the ESWT most patients 
identified breathlessness, and a combination of breathlessness and leg 
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Table 8.5 Endurance shuttle walk test performance 
Start control Start rehab. End rehab. 
Time (s) 283 (36) 287 (33) 706 (162) 
81 ·681 100· 564 200· 1200 
Distance (m) 247 (32) 252 (33) 601 (82) 
40·548 49·582 116· 1455 
HRpe• k (beat.min·') 113 (4) 112 (4) 116 (4) 
78· 145 78·136 81 . 146 
BS 4.4 (0.3) 4.2 (0.3) 3.6 (0.3) 
[4.1 J [4.1 J [3.5J 
2·7 3·7 2·7 
RPE 12.7 (0.4) 12.2 (0.3) 11.5 (0.4) 
[12.6] [12.1] [11.4] 
9·16 11 • 15 7·15 
n:: 19 
Mean (SE) and range for endurance time and distance, HRpeak' Borg ratings 
for breathlessness (BS) and perceived exertion (RPE) at the start of the 
control period and the start and end of the rehabilitation course. 
[ ] indicates the median scores for the BS and RPE. 
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Table 8.6 Incremental shuttle test performance 
Start control Start rehab. End rehab. 
Distance (m) 182 (18) 184 (22) 223 (22) 
60 - 330 40 - 340 70 - 400 
HRpeak (beats.min·l ) 111 (4) 106 (3) 109 (3) 
79 - 143 77 - 123 77 - 130 
SS 5.1 (0.4) 4.4 (0.3) 3.7 (0.3) 
[4.9] [4.1] [3.5] 
3-9 2-7 2-7 
RPE 12.6 (0.3) 13.8 (0.5) 12.1 (OA) 
[12.5] [13.6] [12.0] 
11 - 17 11 - 18 7 - 14 
Mean (SE) and range for ISWT distance, HRpeak' Borg ratings for 
breathlessness (BS) and perceived exertion (RPE) at the start of the control 
period and the start and end of the rehabilitation course. 
[ ] indicates the median scores for the SS and RPE. 
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Figure 8.2 Mean (SE) distance walked during the 
endurance and the incremental shuttle tests 
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Table 8.7 Mean differences between walking test performances 
Control Rehabilitation % change 
visit 4·2 visit 5·4 visit 5 • 4 
ESWT time (s) 4.1 (9.9) 419(70.7) 160 (26) 
·16.8·24.9 271 ·568 106·214 
ESWT distance (m) 4.7(8.1) 349 (62) 160 (26) 
·12.3·21.8 218 - 480 106 - 214 
ISWT distance (m) 2.6 (9.7) 38.4(13.1) 32.0 (12.4) 
·17.8·23.1 10.8·66.0 6.0 - 58.0 
n=19 
Mean (SE) and 95% confidence intervals for the differences between the 
start and end of the control period (visit 4 - 2), and the start and end of 
rehabilitation (visit 5 • 4). 
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fatigue, as the main reasons for exercise termination during the control 
period. Following rehabilitation breathlessness was identified less often and 
more patients identified tiredness as the main symptom following the ESWT. 
The test was terminated by the operator for 3 patients who completed 20 
minutes of the test. The frequency of the different reasons for exercise 
termination are illustrated in figure 8.4. The main reason for termination of 
the ISWT was breathlessness. This remained unchanged following 
rehabilitation. 
There were no significant changes in the peak heart rate response following 
both the ESWT and the ISWT during the control period, and following 
rehabilitation. The mean (SE) heart rate response at equivalent endurance 
times pre- and post-rehabilitation were 111 (4.0) and 111 (3.9) respectively. 
The heart rate data is summarised in table 8.5 and 8.6. 
8.3.1 Relationships between variables 
There was evidence that patient 10 was different from the rest of the group. 
The sudden death shortly after completing the course suggested there were 
additional, active medical problems, and these possibly acted to negate any 
effect of the rehabilitation. Therefore, it was considered reasonable to 
exclude the data set of this patient from an examination of the relationships 
between variables. 
There was a significant relationship between the FEV, and the absolute 
increase in ESWT. The relationship was strongest for the baseline FEV, 
measured at the start of rehabilitation (r=0.662, p=0.0028) (figure 8.5). There 
was also a significant relationship between the FEV, and the ESWT post-
rehabilitation (r=0.685, p =0.006) (figure 8.6). There was no relationship 
between the FEV, and the control (pre-rehabilitation) ESWT, or between the 
FEV, and the percentage increase in ESWT following rehabilitation. There 
was a significant, positive relationship between the pre-rehabilitation ESWT 
and the absolute increase in the ESWT post-rehabilitation (r=0.570, 
p=0.014) (figure 8.7). 
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Figure 8.5 Relationship between the absolute increase in 
ESWT time and baseline FEV1 (n=18) 
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There was no relationship between the Borg breathlessness scores (actual 
score, and the change in score (.~)) and the increase in ESWT post-
rehabilitation (absolute and percentage increase). There was no relationship 
between the %Sp02 at peak incremental exercise (lSWT) and the post-
rehabilitation ESWT, or with the increases in ESWT. There were no 
relationships between the fall (il) in %Sp02 and the post-rehabilitation 
ESWT. 
8.3.2 Repeatability of the ESWT 
A summary of the ESWT results for the 11 patients entered into the 
repeatability leg of the study is presented in table 8.8a. The 3 ESWT were 
completed within 15 days for all the patients. All patients showed an 
improvement in the ESWT performance after one test and 8 patients had an 
improvement after 2 tests. The was a strong relationship between tests 2 and 
3, (r=0.995, figure 8.8). ANOVA revealed there were no significant 
differences between tests 2 and 3. The mean differences and 95% 
confidence intervals are shown in table 8.8b. The differences between tests 
2 and 3 are illustrated in figure 8.9. 
8.4 DISCUSSION 
The key findings of this study were: the ESWT was sensitive to an 
intervention of pulmonary rehabilitation for patients with COPD; following 
one practice walk the test possessed good repeatability The magnitude of 
improvement in the ESWT following the intervention was far greater than the 
improvement in the ISWT. This supports previous studies which have 
demonstrated endurance capacity possesses greater sensitivity to change 
than maximum capacity in patients with COPD (Holle 1988, Niederman 
1991, Singh 1996). 
The current study incorporated a control period were there was no change in 
overall clinical management of the patients. During this period there was no 
significant change in functional capacity. Thus the patients acted as their 
own control. The study design may be criticised for not recruiting a separate 
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Table B.Ba Test- retest for the endurance shuttle walk (n=11) 
Visit 1 2 3 
~--'-"""'-"'-
FEV1 (I) 0.75 (0.21) 0.79 (0.19) 0.82 (.24) 
ESWT Time (s) 251 (120) 310 (171) 325 (158) 
ESWT Distance (m) 214 (101) 262 (137) 274 (130) 
HApeak (beat.min·1) 108 (17) 107 (16) 103 (16) 
SS 4.6 (2.0) 4.4 (1.6) 4.5(1.7) 
[4.3] [4.1] [4.2] 
RPE 12.7 (1.9) 12.6 (2.1) 12.9 (2.7) 
[12.6) [12.4) [12.7] 
Mean (SO) for FEV1, time, distance, HRpeak' Sorg breathlessnes rating and 
perceived exertion for 3 ESWT repeated over an 15 day period. 
[ ] indicates the median ratings for SS and PE. 
Table B.Bb Differences in endurance time and distance between tests 
TIME 
Test 2 vs 1 (s) 
Test 3 vs 1 (s) 
Test 3 vs 2 (s) 
DISTANCE 
Test 2 vs 1 (m) 
Test 3 vs 1 (m) 
Test 3 vs 2 (m) 
... .r"" 
* p < 0.05 
Mean difference (SE) 
59.5 (22.4)' 
74.3 (18.8)* 
14.8 (6.3) 
47.5 (18.4)* 
60.3 (16.2)' 
12.8 (4.9) 
..... , ........ " -
95% Cl 
9.7 - 109.2 
32.5 - 116.1 
0.6 - 28.9 
6.6 - 18.4 
24.1 - 96.5 
1.9 - 23.6 
Mean differences (SE) and 95% confidence intervals between tests 
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control group, and conducting a randomised, cross-over designed study. A 
number of rehabilitation studies with such a design have been reported 
(Cockcroft 1981, Weiner 1992, Wijkstra 1994), and have shown significantly 
greater improvement in exercise tolerance in the active groups. 
One of the aims of the current study was to examine the short term 
repeatability of the ESWT. Use of the control period additionally provided the 
opportunity to examine the medium term stability of the ESWT. Although the 
control period was not tightly regulated, since its purpose was to act as a 
control for the intervention, the ESWT showed good repeatability over this 
timescale (mean duration 5 (1.5) weeks). The mean difference between tests 
at the start and end of the control period was 4 s, which contrasted 
favourably with the short term repeatability of 15 s. However, there was 
greater individual variability over the medium term, reflected in the wider 
confidence intervals (42 vs 28) and the wider limits of agreement for the 
range of differences between repeat tests (-82 to 90 seconds vs -27 to 57 
seconds). 
The short term repeatability demonstrated a positive improvement in ESWT 
with each successive performance of the test, and suggested a diminishing 
learning effect in the test performance. The third test improved the ESWT 
duration by an average of only 15 s, compared to an increase of 60 s 
following the first test. Thus the results suggested one practice walk was 
sufficient to establish good test repeatability. The greater variability in the 
medium term repeatability suggested the learning effect on test performance 
was lost after several weeks. The difficulties in conducting this study over a 
long period of time, in patients with severe, chronic respiratory disease, and 
during the winter months, have been highlighted by the incidence of disease 
exacerbations and the susceptibility to other ailments. If the situation 
encountered during the current study was a fair representation of patients 
with severe impairment, it may be argued the unregulated control period was 
reasonable for the examination of the medium term test repeatability in this 
patient group. However, further examination of the stability of the test over 
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longer periods may be warranted. The purpose of the control period was to 
examine functional capacity over a similar time span to the rehabilitation 
intervention. However the control period was shorter than the average length 
of time spent at rehabilitation (5 vs 7 weeks). The failure to adhere to similar 
time periods was the result of the difficulties experienced with patient illness, 
recruitment and retention. 
The main exercise training component of the rehabilitation programme 
comprised of a home walking programme. The target for each patient was to 
increase continuous walking at a pace which related to approximately 50% 
of the V02peak, predicted from the ISWT. Both Jones (1988) and Casaburi 
(1993) state it is important to assess the effects of exercise training utilising a 
similar mode of exercise. This argument supports the ESWT as an 
appropriate testing mode for the current rehabilitation programme. The 
intensity of the ESWT (85% of the predicted V02peak) was in excess of the 
intensity of the training prescription. However, the majority of patients 
achieved large improvements in endurance capacity at this higher intensity. 
This finding raises two important issues: firstly a low intensity training 
programme improves overall endurance capacity in this patient group; 
secondly, would re-calibration of the training intensity result in additional 
improvements? 
A number of studies have demonstrated benefits from high intensity exercise 
training in both mildly affected patients (Casaburi 1991) and patients with 
more severe impairment (Ries 1987, Carter 1988, Punzal 1991, O'Oonnell 
1995). Recently Maltais (1997) has demonstrated most patients do not 
achieve higher levels of exercise training. The study assessed training 
intensity accurately over a 12 week period, in patients with severe 
impairment (n=42, FEV1 38% of predicted). The patients were prescribed 
high intensity training, with 30 minutes at 80% of the maximal cycle work rate 
as the target intensity. Few patients achieved this level, and though the 
training intensity gradually increased, at the end of the programme the mean 
intensity achieved was 60% of the Wma>.' some 20% lower than the 
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prescribed level. However, there were significant improvements in exercise 
tolerance and evidence of a physiological adaptation to training (increased 
V02peak and reductions in V E and lactic acid concentration for a given work 
rate). The study from Maltais (1997), the current study and others 
(Niederman 1991, Clark 1996), would suggest useful improvements can be 
achieved with more moderate training intensities, and lower intensity training 
is successful in patients with moderate to severe COPD. 
A number of reports suggest gradually increasing the training intensity 
(Belman 1986, Ries 1990). Whether further gains would be made by re-
calibrating the training intensity in the current rehabilitation programme may 
warrant further investigation. Although the prescribed exercise intensity was 
at 50% of the predicted V02p.ak' regular checks on walking speed were not 
undertaken. However the duration of walking was monitored closely with 
new targets for continuous walking set weekly. The results reported in 
chapter 7 suggested slow to moderate walking constituted a high 
percentage of the V02peak in this patient group, where V02peak is often 
severely reduced. As patients improved during the programme walking 
speed may have increased insidiously, though this cannot be confirmed. 
Informal, qualitative assessment by observation suggested the training pace 
adopted by patients was less than the intensity of the ESWT pace at which 
they were assessed. Additionally, all the patients confirmed the ESWT pace 
was faster than they would normally walk. The incorporation of increasingly 
higher intensities of exercise into the programme may be disadvantageous 
where it brings discomfort by way of extreme breathlessness, and the 
possibility of muscle and joint pain, and even injury. In such situations 
compliance with the training programme may be reduced. 
The improvements in the ESWT demonstrated the changes in endurance 
capacity were not confined to the training level of exercise intensity. This 
pattern of response was demonstrated in a study which compared training 
above and below the lactate threshold in a group of healthy, elderly subjects. 
A constant-paced high intensity treadmill test (>75% V02peak) was used to 
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assess both low (53% of V02peak) and high intensity training (82% of V02peak) 
(Belman 1991b). Both programmes produced similar changes, with 
significant reductions in HR, VE and V CO2 during the treadmill assessment. 
The author suggested low intensity walking was an adequate aerobic 
stimulus for producing modest gains in aerobic power, in previously 
sedentary, elderly subjects. In the current study there was a significant 
improvement in the ISWT which suggested an increase in the maximal 
capacity and V02peak for some patients. However, there were substantially 
greater gains in the submaximal exercise performance, despite assessment 
at the higher intensity. Thus the training was more effective at improving 
overall endurance capacity in this patient group, where the pathophysiology 
of cOPD is likely to limit improvements in the maximal capacity. 
Following rehabilitation, three of the patients attained the 20 minute limit of 
the endurance test, and 4 patients achieved more than 17 minutes. Only 3 of 
these patients had significant improvements in the post-rehabilitation ISWT. 
This finding reinforces the arguments for a limit to the improvements which 
may be gained in maximal capacity, and for the sensitivity of endurance 
capacity to training. Whether post-training assessments should be 
conducted at pre-training intensities is an important question, and forms a 
natural adjunct of further research to the current study. In the case of patients 
achieving the 20 minute limit, simply re-assessing at the next endurance 
walking speed on the ESWT tape requires further investigation. 
The mechanisms which contribute to endurance capacity in this patient 
group have been discussed in some detail in the previous chapter. However 
it is worthwhile considering the possible mechanisms of improvement 
following pulmonary rehabilitation. A number of factors are likely to 
contribute to the improvement in exercise tolerance and several workers 
have suggested one or a combination of the following: improved aerobic 
capacity and muscle strength, mechanical efficiency and enhanced skeletal 
muscle enzyme activity; increased motivation and confidence; 
desensitisation to the sensation of breathlessness; improved ventilatory 
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muscle function; improved co-ordination and technique of performance; 
reduced ventilatory requirement; improved tolerance to the physical and 
sensory requirements of exercise; (Holle 1988, Casaburi 1995, Belman 
1993, O'Donnell 1995, Maltais 1997). 
The results from the current study support a hypothesis of desensitisation 
and/or reduced breathlessness, and improved subjective tolerance of 
exercise, as important components of the training-induced improvements. 
There were significant improvements in the Borg ratings for breathlessness 
and perceived exertion following the assessment of endurance and maximal 
capacity. The majority of patients achieved substantial improvements in 
walking duration with similar, or reduced, ratings of breathlessness and 
perceived exertion, compared to the pre-training levels. This was 
substantiated further by the change in the reasons for the term ination of 
endurance exercise. The symptom of breathlessness was identified less 
often following rehabilitation, whilst there was an increase in 'tiredness' 
reported from those patients who were walking for much longer periods of 
time. 
The results from the current study cannot differentiate whether there was 
desensitisation to breathlessness, or a genuine reduction in breathlessness, 
as a result of a lower ventilatory requirement and improved respiratory 
muscle performance. A simple, qualitative assessment by observation, 
revealed signs of breathlessness were reduced during, and following, the 
test for some patients. Whilst for others, there appeared to be less 
breathlessness during the test, whereas the end-test levels appeared to be 
similar to pre-training levels. These observations would suggest the 
mechanism may vary amongst patients, and in some cases there may be a 
combination of desensitisation and a reduced ventilatory requirement. 
A possible mechanism of a reduced ventilatory requirement was described 
by Casaburi (1995), following a study which identified a reduced blood 
lactate concentration during exercise, as a result of high intensity training in 
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patients with mild to moderate COPD. The consequence of a reduced lactate 
concentration is a lower W ion load, leading to a reduced ventilatory 
requirement for the maintenance of pH. Recently, some evidence has 
emerged of a similar mechanism of improvement in patients with severe 
impairment. In a study involving 11 patients with severe COPD (mean FEV, 
36% of predicted), post-training skeletal muscle biopsy samples revealed 
increased activity in two oxidative enzymes and reduced blood lactate 
concentration during exercise (Maltais 1996b). These changes were 
accompanied by improvements in V02peak and peak cycle work rate, and 
reduced ventilatory and heart rate response at equivalent pre-training work 
rates. The training schedule consisted of high intensity cycle exercise, upper 
extremity exercises and self-paced walking. 
The evidence of metabolic improvements in the study from Maltais (1996b) 
contrasts the findings of Belman (1981). In a group of 15 patients with severe 
COPD, Belman (1981) found no changes post-training in muscle enzyme 
activity, despite increases in endurance capacity. Additionally, there was no 
evidence of a cardiovascular training response. There was no data 
concerning the blood lactate concentrations in the study. The training 
intensity was lower in the study from Belman (1981), and Maltais (1996b) 
cites large inter-individual variability in the skeletal muscle adaptation to 
training. The variability in the blood lactate response in patients with severe 
COPD has been discussed in previous chapters, and is supported by data 
presented in this thesis. Thus, the available evidence concerning a reduction 
in the ventilatory requirement, as a result of blood lactate changes in severe 
impairment, is scarce, and does not explain adequately the changes in 
breathlessness and improved exercise tolerance for all patients with severe 
COPD. 
An improved mechanical efficiency has been proposed by O'Donnell (1995), 
and by Holle (1988), as the mechanism of improvement following 
rehabilitation. In a study which incorporated a non-intervention control 
group, O'Donnell (1995) utilised a 6 week training programme in 30 patients 
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(FEV1 42% of predicted), and related the relief of breathlessness to a fall in 
the ventilatory demand, as a result of enhanced mechanical efficiency 
(reduced VO/work rate and V CO/work rate slopes). Additionally, 
significant improvements in resting inspiratory capacity suggested a 
decrease in EELV, and therefore a possibility of improved inspiratory muscle 
function as a result of decreased elastic loading. Holle (1988) measured 
improved peak work rates and endurance capacity in 44 patients with severe 
COPD. The author proposed an enhanced mechanical efficiency as the 
mechanism of improvement, rather than an improved aerobic capacity, or a 
cardiovascular training effect, since there was no change in the HRmax or 
V Epeak' and only a small improvement in V02peak. In the current study a 
change in HR pre- and post-training was not observed which suggests the 
absence of a cardiac training effect. However the large improvements in 
endurance capacity, and lowered sense of perceived exertion, wou Id 
support a hypothesis of enhanced mechanical efficiency. 
Further evidence of an enhanced mechanical efficiency was suggested by 
the variable changes in the maximal capacity. Overall there was a 32% 
improvement in the ISWT, which suggested there was an increase in the 
aerobic capacity post-training for some patients. However, without direct 
measurement of the V02peak this cannot be confirmed. Additionally some 
patients did not show an improvement in the ISWT. These findings would 
suggest changes in the maximal aerobic capacity were only one possible 
contributing factor to the improvements in some patients. Improved skill of 
performance and co-ordination will lead to improved effiCiency and have a 
sparing effect on oxygen consumption. Such a mechanism would suggest 
more efficient use of existing capacity, and may partly explain why many of 
the patients in the current study showed increased endurance capacity 
without concurrent improvement in the maximal capacity. Belman (1993) 
states improved skill of performance has been found in a number of studies 
and cites a study from Paez (1967), which demonstrated treadmill walking 
improved with repeated attempts. Casaburi (1995) has suggested improved 
efficiency in the breathing pattern in severe COPD, with the adoption of a 
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slower and deeper respiratory pattern following training. This strategy would 
have a deflationary effect on the lungs, and lead to O2 sparing. 
An improvement in the skill of walking (and therefore mechanical efficiency) 
was suggested by the changes in the short and long term repeatability of the 
ESWT. As discussed previously there was an indication of a learning effect 
when the ESWT was repeated over a short period of term. However this was 
lost over the longer, non-intervention period. If this effect transfers to walking 
in general, a training effect in the skill of walking may have occurred during 
the rehabilitation period. 
There was only one patient who did not demonstrate an improvement in 
endurance capacity (patient 10) following the rehabilitation. A fall in the 
ESWT was recorded at the end of the rehabilitation period (t. 37 s). As 
indicated in the results section, the patient died within a few weeks of 
completing the course. Details of the sudden death indicate there was no 
evidence of a chest infection or deterioration in respiratory (emphysema) 
problems. The circumstances of the death were unusual for patients with 
uncomplicated emphysema and suggested other, unidentified clinical 
problems. The clinical notes indicated there were no other significant health 
problems. The lack of improvement from the rehabilitation contrasted with 
the other participants in the study, therefore a repeat test was performed to 
eliminate the possibility of a erroneous result. The difference between repeat 
tests was only 4 seconds, thus confirming the absence of an improvement. 
The lack of improvement suggests other, covert clinical problems e.g. 
cardiac disease, which may have acted to negate any therapeutic effects. If 
the ESWT is able to identify those patients who fail to improve following 
rehabilitation it might be used to indicate additional investigations, such as 
cardiac screening. There were consistent improvements in endurance 
capacity for the other participants, whilst the ESWT was sensitive to the lack 
of improvement, and also detected a slight deterioration in endurance 
capacity in patient 10. This finding contrasts with the situation for the ISWT, 
where there was a variety of responses post-rehabilitation, and therefore the 
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absence of a change in the ISWT would be unlikely to signal additional 
problems. 
The influence of the disease severity (FEV,) on the response to the 
rehabilitation is revealed in figures 8.5 and 8.6. Patients with the lower 
values of FEV, tended to gain the most benefit from the exercise training and 
had the greatest absolute change in endurance capacity (fig 8.5). The 
relationship between FEV, and endurance capacity changed following the 
pulmonary rehabilitation. Prior to rehabilitation there was no relationship 
between FEV, and endurance capacity. Following rehabilitation there was a 
moderate (negative) and significant relationship between the two variables 
(r=O.685, p<O.01, figure 8.6). This relationship demonstrates patients with 
more severe airways disease (lower FEV,) achieve greater levels of 
endurance, post rehabilitation, than patients with slightly less severe airways 
obstruction. 
The changes in endurance capacity and the relationship with disease 
severity raises a number of issues for clinical practice: how can the patients 
who are likely to be most responsive to rehabilitation be identified, when is 
the best time to introduce rehabilitation, and what is the most effective mode 
of management for those patients who are less responsive? The lack of a 
relationship between FEV, and the baseline (pre·rehabilitation) endurance 
capacity, emphases FEV, as a poor indicator of functional capacity prior to 
exercise training. Additionally, there was a wide range in the absolute 
change in ESWT, some patients had a small absolute change in endurance 
capacity, however this represented a large percentage improvement. 
Finally, patients with a higher baseline endurance capacity tended to 
achieve the greatest absolute increase post training (figure 8.7), however 
this did not necessarily represent the greatest percentage improvement in all 
patients. 
In summary the ESWT was sensitive to an intervention of rehabilitation, 
which included both educational and exercise training components. The test 
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possessed good short and medium term repeatability. It was easy to 
administer for both the operator and patients. All the patients remained 
unaware of the 20 minute limit to the test, including those who were stopped 
by the operator during the post-rehabilitation assessment. Endurance times 
were only revealed to patients at the end of the study. There was evidence 
the test may identify additional, covert clinical problems which might act to 
override any therapeutic benefits of rehabilitation. The issue of re-calibrating 
the test intensity for patients who achieve the maximum 20 minute limit was 
not addressed, and this might form a natural extension to future evaluations 
of the test. In addition, the long term stability of the test is worthy of further 
consideration. 
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Chapter 9 
GENERAL DISCUSSION 
The studies presented in this thesis were designed to examine two relatively 
unexplored aspects of the exercise response in patients with COPD, namely 
respiratory muscle performance and whole body endurance capacity. 
Exercise, and the exertion required to perform routine daily activities, 
becomes increasingly limited as a result of the extent and severity of the 
pathophysiological changes associated with COPD. Breathlessness, 
especially on exercise, is the major symptom whilst regular chest infections 
and cardio-vascular complications increase in prevalence during the later 
stages of the disease. The predominant pathological changes associated 
with COPD are increased resistance to airflow and hyperinflation of the 
lungs, with symptoms of cough and sputum production. RV and FRC are 
typically elevated and may occupy as much as 70 - 85% of the TLC. Such 
hyperinflation causes the inspiratory muscles, especially the diaphragm, to 
be shortened before they contract, and thus operate at a distinct mechanical 
disadvantage (Rochester 1991). The total work, and energy cost of breathing 
in COPD is greatly elevated as a result of the increased resistive and 
threshold loads, and the requirement to maintain normal levels of PaC02 in 
the face of gas exchange and perfusion abnormalities (Rochester 1991). 
The response of the respiratory muscles to the increased ventilatory 
demands of physical exertion will constitute an important component of the 
whole body exercise response in COPD. The participants in the series of 
studies presented in this thesis had moderate to severe COPD, with reduced 
exercise tolerance, and reported breathlessness to a wide range of daily 
activities. Although the V02peak was not measured directly in all the patients, 
the direct and indirect measurements indicated most had a reduced V02peak 
of less than 1.5 l.min·l . In healthy individuals the oxygen cost of increasing 
ventilation is unlikely to constitute a limiting factor to exercise, however a 
number of workers propose it may be an important factor in COPD (Levison 
1968, Rochester 1979, Bye 1983). 
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In the first experimental study incremental threshold loading was evaluated 
as a simple indicator of performance for the respiratory muscles. The 
imposition of the incremental threshold load, from the electronic solenoid 
valve, was likened to the increases in PEEPi which result from increased 
dynamic hyperinflation during exercise in patients with COPD (Pride 1995). 
The cardio-respiratory and metabolic demands of the ITL were measured 
and related to the whole body exercise performance. The O2 cost of the 
exercise was 367 ml.min·1, and this equated to 30% of the V02peak measured 
during peak treadmill exercise. If ITL reflects the magnitude of energy 
expenditure required to increase ventilation during whole body exercise, this 
high energy cost of the respiratory musculature would form a substantial 
drain from the total oxygen available for the non-respiratory exercising 
muscles. In one of the first published studies which evaluated the oxygen 
cost of increasing ventilation during exercise in COPD, Levison and 
Cherniack (1968) measured a high cost of ventilation during steady state 
exercise in COPD. These workers found the respiratory musculature was 
responsible for an oxygen consumption of 35 - 40% of the total, even at low 
levels of exercise, therefore only 60 - 65% was available for the exercising 
non-respiratory muscles. In comparison, the same experiment with healthy 
individuals revealed an oxygen cost of exercise ventilation of 10 - 15% of the 
total available oxygen. 
There was no relationship between the absolute values of V02 measured 
during ITL and the V02 measured during the treadmill exercise. However 
there was a significant relationship between ITL V02peak' as a proportion of 
the absolute value of the treadmill V02peak' Figure 5.3 illustrated those 
patients with the lowest whole body V02peak used a large proportion of the 
total V02 available to perform the ITL exercise. The figure revealed patients 
with a whole body V02peak < 1.51.min·1 utilised> 20% of their available V02 
to perform the ITL test, and those patients with a V02peak of :;;1.0 l.min·' 
utilised ~30%. 
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If the O2 utilisation during the ITL test was a reasonable reflection of the O2 
cost of ventilation during whole body exercise it is likely the most severely 
affected patients, with substantially reduced exercise capacities, incur a 
large oxygen debt during exercise, as a result of the reduced oxygen 
availability. However, there was inconclusive evidence of blood lactate 
accumulation following the ITL test, and low concentrations following whole 
body exercise. Figure 4.8 revealed a strong relationship between peak Pm 
and the blood lactate concentrations suggesting ITL was a sufficient 
challenge to induce a blood lactate response. Further investigations of the 
effect of respiratory muscle lactate production, and its importance in the 
response to whole body exercise in COPD, was suggested in chapter 4, and 
especially in patients with severe exercise limitation. This proposition was 
supported by figure 5.4 which revealed those patients with the lowest whole 
body exercise blood lactate response had the highest proportional 
concentrations following ITL. Any future studies would benefit from serial 
blood lactate measurements throughout the ITL test, since there was 
evidence of a sample time effect, and the possibility of rapid clearance of the 
metabolite. Thus the initial study, which examined the performance and the 
metabolic effects, identified ITL as a useful method for inducing a blood 
lactate response, and the technique benefits from the use of standardised 
increments in respiratory muscle work rate. 
To investigate further the clinical relevance and application of ITL, the test 
was examined following a single dose of inhaled ipratropium bromide, and 
was also related to the whole body exercise response. The oxygen cost of 
the task did not change significantly following the bronchodilator and it 
continued to constitute a similar proportion of the total V O2, This finding 
would suggest any bronchodilator induced deflationary effects in the lung 
did not lead to measurable improvements in respiratory muscle efficiency. 
Measurement following a period of bronchodilator pre-treatment, as 
opposed to a single dose, may have had a greater effect, and this is a valid 
criticism of the study. However the majority of patients were already using 
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regular inhaled bronchodilators, and thus benefiting from maintenance 
inhalation therapy. 
The lack of improvement in respiratory muscle efficiency following the 
bronchodilator therapy suggested additional interventions to improve 
respiratory muscle performance, especially during exercise, may be of 
benefit to patients with a reduced exercise capacity. This is an outstanding 
issue, and the use of ITL following an intervention of whole body exercise 
training, or respiratory muscle training was not pursued. There was wide 
variability in the cardio-respiratory response during ITL, which would make 
the application of these measurements less reliable for serial assessment. 
However ITL, as a measure of respiratory muscle performance, was 
reproducible and simple for the patients and operator, and therefore a useful 
instrument for the evaluation for respiratory muscle performance. 
In the time since the ITL study was performed data concerning the reliability 
of a small and inexpensive threshold training device, which patients could 
use at home, has been published (Gosselink 1996a, Johnson 1996). 
However definitive evidence of the beneficial effects of respiratory muscle 
training in patients with COPD remains elusive. In a meta-analysis 
performed on 17 randomised, controlled trials of inspiratory muscle training 
there was little evidence of a clinically important benefit or improvements in 
functional capacity in patients with COPD (Smith 1992). The meta-analysis 
only considered respiratory muscle training in isolation. A number of studies 
have examined the effect of combined inspiratory and general exercise 
training (Weiner 1992, Wanke 1994), and demonstrated greater 
improvements in those patients who received the combined training. 
In an editorial, Gosselink (1994) suggested the strongest indication for 
inspiratory muscle training lies in its combination with general exercise 
training. However further conflicting evidence has recently emerged. In a 
randomised controlled trial, Berry (1996) did not find additional 
improvements in functional capacity when patients received combined 
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training compared to a general training only group. Alternatively, in an 
examination of the effects of inspiratory muscle training alone, Lisboa (1997) 
found significant improvements in the 6 minute walk test and improved 
efficiency during cycle exercise, with reductions in the ventilatory and 
oxygen cost of equivalent pre-training work rates. The study incorporated a 
control group using a 15% training load. The author concluded a 30% 
inspiratory muscle training load was able to produce significant transfer 
effects to whole body functional capacity. 
There is evidence of generalised muscle weakness, and deconditioning, as 
significant limiting factors of exercise in COPD, additional to the ventilatory 
limit. This proposal is supported by the findings from the second 
experimental study, where improvements in exercise ventilation, following 
the bronchodilator, were not accompanied by significant improvements in 
peak exercise work rates (ITL, treadmill or shuttle test). Thus improving the 
ventilatory capacity in isolation did not improve exercise capacity. Additional 
to this finding was the improvement in the relationships between respiratory 
muscle performance (peak Pm), exercise ventilation and gas exchange, 
following the bronchodilator. This suggested an improved coupling between 
the mechanical events of respiratory muscle performance, and the resultant 
exercise ventilation and gas exchange. The two aforementioned factors, in 
addition to the lack of improvement in respiratory muscle efficiency following 
the bronchodilator, and the high oxygen cost of the ITL test (suggestive of a 
high cost of exercise ventilation), led to a proposal for the introduction of 
exercise training in order to maximise the bronchodilator changes, and 
address the issue of deconditioning. 
In order to progress the investigation into the effects of deconditioning and 
exercise training in this patient group, there were strong arguments for the 
development of a new instrument for the assessment of endurance capacity. 
This took the form of a standardised constant-paced field test based on the 
concept of the incremental shuttle walk test. The new test, the ESWT was 
complementary to the ISWT, the intensity of the endurance test was related 
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to the maximal performance assessed from the ISWT, and utilised the same 
10 metre shuttle course. Initially three endurance intensities were examined 
which related to 75%, 85% and 95% of the predicted V02P• ak' These high 
intensities were chosen for two reasons: firstly a number of studies had 
demonstrated patients with COPD were able to tolerate near maximal work 
intensities and had gained significant improvements following high intensity 
training programmes; secondly, it was necessary to develop a test which 
avoided lengthy testing periods since the test needed to be practical for the 
clinical situation, and not to onerous for the patient. 
The exercise intensities chosen for the ESWT were related to percentages of 
the V02peak predicted from the ISWT. This was different from previous studies 
which have related submaximal exercise testing and training intensities to 
percentages of the maximal work rate achieved at initial testing (Ries 1987, 
Carter 1988, Punzal 1991). To date there is no consensus on the optimal 
exercise testing or training strategy for this patient group. In many reports the 
training programme is described in general terms and there is little indication 
of regular physiological monitoring. Examination of the cardio-respiratory 
response to endurance exercise on the treadmill, and described in chapter 
7, revealed a wide range of responses in V02, with few patients achieving a 
steady state, whilst many patients exceeded the target V02• The lowest 
intensity examined, the 75% test, provoked a mean level of V02 which 
related to 84% of the V02P• ak' The energy expenditure for walking speeds of 
2 mph has been estimated at < 1 l.min·' (Astrand 1986), and this was close to 
the maximum V02 available in this patient group. Thus for patients at the 
severe end of the COPD spectrum, low absolute levels of exercise were 
found to engage a high percentage of the maximum available V02• 
Many routine activities of daily living are likely to be associated with levels of 
energy expenditure similar to slow and moderate walking. In many cases 
patients avoid the most demanding tasks, proceed at a slower pace, or take 
frequent rests. However the studies presented in this thesis support the 
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contention that patients can tolerate exercise at a high level of V02• Since 
untrained, healthy individuals would rarely sustain exercise at a similar 
intensity, the question of how patients achieve exercise at such a high 
relative intensity deserves consideration. The pathological changes 
associated with COPD are long term, and in many cases the decline in 
maximal capacity and functional capability occurs over a number of years. It 
is likely patients adapt to the loss of functional capacity in a continuous 
manner, and learn to tolerate high levels of breathlessness. Additional to this 
process is the loss of fitness, which further compounds the problem of 
breathlessness and exercise intolerance. It is at this point where an 
intervention of exercise training is likely to benefit. 
In a recently published study, the exercise training intensities patients 
actually achieved during pulmonary rehabilitation were examined closely 
during a 12 week programme (Maltais 1997). Although patients were 
prescribed a target training intensity of 80% of their maximal work rate, few 
patients achieved this level and the mean intensity at the end of the 12 
weeks, was 60% of the initial maximal work rate. Despite achieving a lower 
training intensity (60%) than the prescribed level (80%), the patients 
demonstrated significant improvements in V02peak and maximum work rate, 
and reductions in ventilation and blood lactate concentrations at equivalent 
pre-training work rates. The authors concluded the changes constituted a 
physiological adaptation to training, and most patients with severe COPD 
were unable to achieve higher intensity training targets. However, the V02 
was not measured during the training sessions in the study from Maltais 
(1997), and the findings described in chapter 7 demonstrated exercise 
intensities of 75% will engage a high proportion of the maximum available 
V 02. It is likely the 60% work rate training intensity achieved in the study 
from Maltais (1997) engaged high proportions of the V02peak in most of the 
patients. 
In an earlier study Maltais (1996b) examined muscle biopsy material pre-
and post-exercise training from 11 patients with severe COPD. There was a 
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significant increase in the activity of two oxidative enzymes and reductions in 
the blood lactic acid concentration. The training intensity achieved with these 
patients was 69% of the target work rate, and in this study, the original 
training intensity was related to V02peak' Interestingly, the use of dyspnoea 
ratings for prescribing and regulating the intensity of exercise training in 
patients with COPD has been examined recently (Horowitz 1996). The study 
aimed to determine if patients were able to reproduce intensities of exercise, 
based on target levels of oxygen consumption, using dyspnoea ratings 
obtained from a previous exercise test. The study found patients were more 
successful at reproducing higher intensities of exercise (80% of V02peak) 
than lower intensities (50% of V02peaJ. 
The findings from the aforementioned studies, and from the studies 
presented in this thesis raise a number of issues: significant improvements in 
exercise capacity have been measured following training at a variety of 
intensities. The ideal training level, and how this is determined, has yet to be 
elucidated. There may be a minimum intensity below which physiological 
adaptation in terms of skeletal muscle changes, lactic acid production and 
cardiac conditioning does not occur. However, the relative importance of 
such changes to the improvements in the exercise response for this patient 
group, with moderate to severe COPD, are unclear. Belman (1993) notes a 
large number of rehabilitation studies have employed an 'unstructured' 
approach to training and, despite many not documenting reductions in the 
blood lactate levels, have shown severely obstructed patients can be 
exercised safely, and show impressive gains in submaximal exercise 
endurance. There is a wide range of potential mechanisms of improvement, 
involving physiological, sensory and psychological factors, whilst the 
importance of each component is unresolved, and probably varies between 
patients. 
The standardised field test for the assessment of endurance capacity was 
developed for two reasons: firstly many studies have demonstrated large 
improvements in endurance capacity following rehabilitation suggesting it is 
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more sensitive to change than the maximal capacity; secondly, the lack of 
standardisation of the 6 minute walk test renders the test difficult to regulate, 
and the imposition of a set time questions the validity of the test as a true test 
of endurance. The ESWT had standardised, externally regulated walking 
speeds and a clearly defined end-point. The intensity of the test was 
individualised and based on prior measurement of maximal capacity, 
evaluated during the similar incremental shuttle field test. Each patient 
experienced the same relative level of exertion i.e. 85% of the predicted 
V02peak. The standardisation of intensity will act to improve inter-subject and 
intra-subject comparisons. There was a time limit to the ESWT test. However 
this was not revealed to any of the patients in the studies, and patients were 
instructed to keep walking for as long as possible until they felt too tired or 
too breathless to continue. In this respect the test was open ended and 
avoided setting external targets. In addition, most patients seemed to 
concentrate on maintaining the correct walking speed and few queried the 
time, thus suggesting there was little emphasis on any internal targets 
patients may have set themselves. 
The substantial changes in the ESWT following the intervention of 
pulmonary rehabilitation suggests endurance capacity is particu larly 
sensitive to improvement, and amplifies any training induced improvements. 
It also supports the use of the test as a worthwhile assessment tool and 
outcome measure for this patient group. Whether the exercise training 
component was singularly responsible for the improvements in endurance 
capacity, or the rehabilitation intervention as a whole, cannot be confirmed. 
The effects of presenting the educational component alone compared to a 
combined programme of education and exercise training have been 
examined (Toshima 1990, Ries 1995). Both studies demonstrated significant 
improvements in endurance capacity (time of treadmill walking) in the 
comprehensive rehabilitation groups, whilst there were non-significant 
changes in the education only group. In a meta-analysis of 14 randomised, 
controlled trials of a rehabilitation intervention there were significant 
improvements in dyspnoea and mastery, and maximal exercise capacity 
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(Lacasse 1996). Improvements in functional capacity, defined as changes in 
the 6 minute walk distance, were non-significant. The 14 trials analysed 
included lower limb exercise in the rehabilitation programme, whilst 5 trials 
included an additional educational component. The analysis found a strong 
degree of homogeneity amongst the results, which suggested all the 
programmes had produced significant improvements in mastery and 
dyspnoea, despite the differences in content and duration. The authors 
concluded pulmonary rehabilitation should include at least 4 weeks exercise 
training as part of the management for patients with COPD. 
Since walking is central to many every day activities and normal functioning, 
improving the skill and duration of its performance, irrespective of the 
mechanisms which bring about the improvement would seem to be a valid 
outcome of the intervention. The magnitude of change in walking endurance, 
perceived by the patient as important, was not evaluated in the current 
studies. In the meta-analysis from Lacasse (1996) the size of the 
improvement in the 6 MWT was not significantly different from the minimally 
Clinically important difference, defined as the smallest difference perceived 
as important by the average patient. Although the ESWT was examined for 
statistical repeatability, and this was good in both the short (2 weeks) and 
medium term (5 weeks), differences were not compared to subjective ratings 
of walking ability. This aspect of the test may warrant further investigation to 
gain a wider description of the application and clinical usefulness of the test. 
However the simple statistical repeatability revealed 95% confidence 
intervals of 0.6 to 29 s for short term repeatability, and -17 to 25 s for medium 
term repeatability, following one practice walk. 
The changes in endurance capacity were positive, and large (minimum 
percentage improvement was +30%), for the majority of patients. Although it 
would be unwise to draw conclusions from the evidence of one patient, the 
lack of improvement in patient 10, and the subsequent events, suggested the 
test may be useful in the identification of deterioration, or for highlighting the 
presence of additional clinical problems, and which may require further 
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treatment. In a study of the effects of pulmonary rehabilitation in an outpatient 
community referred group of 68 patients with moderate to severe respiratory 
disease, 20% were found to have previously unsuspected cardiac disease at 
initial assessment (Holle 1988). Following cardiological evaluation 6 of the 
patients were placed on new medications and completed the rehabilitation, 
whilst 9 patients had significant arrhythmias and were closely observed 
throughout the programme. The patients in the current study were all 
referred from the Hospital respiratory clinics. However, the findings from the 
present study would indicate a small number of patients may have covert 
medical problems, and this additional aspect warrants further research. 
In summary, the studies reported in this thesis have examined two aspects of 
the exercise performance in patients with COPD. Incremental threshold 
loading was found to be a repeatable indicator of respiratory muscle 
performance, and was significantly related to peak exercise ventilation. This 
association contrasted with the lack of a relationship between the static 
measure of respiratory muscle function, Plmax, and exercise ventilation. 
These findings would support a hypothesis in which dynamic measures of 
respiratory muscle performance were more closely associated with indices 
of whole body exercise performance than static measures of respiratory 
muscle function in severe COPD. The test appeared to be as efficient as 
other methods of respiratory muscle exercise at eliCiting an increase in the 
blood lactate concentration, and additionally benefits from the use of 
standardised increments in work rate. The test performance did not improve 
following to an intervention of inhaled bronchodilator, though there were 
significant increases in the ventilatory response. The test was easy to 
perform and repeatable without the requirement of external breathing 
regulation. The variability in the measurement of the oxygen consumption 
during the test suggested the strategies adopted by patients to overcome the 
additional threshold load were varied, whilst the external work performed 
remained consistent. 
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The progress of the experimental work led to the examination of whole body 
endurance capacity in COPD and the development of a standardised field 
test of assessment. A range of exercise intensities were examined. The most 
practicable intensity for the field test related to 85% of the predicted V02peaJ(' 
At this intensity the ESWT was simple to perform, was not too onerous for the 
patient, and possessed a suitable margin for improvement. The heart rate 
response and Borg ratings following the field tests were not significantly 
different from those measured during equivalent treadmill testing. There was 
a wide variability in the pattern of the V02 response to the treadmill 
endurance tests, whilst the cardio-respiratory responses to the 95% 
endurance test were not significantly different to incremental testing. In some 
patients, the heart rate and V02 measured during the endurance tests were 
greater than the incremental values, suggesting high intensity endurance 
tests may be preferable to incremental tests for the measurement of peak 
values, in a number of patients. The 85% field test possessed good short 
and medium term repeatability, and was sensitive to an intervention of 
pulmonary rehabilitation. The field test has the advantage of avoiding costly 
treadmill or cycle ergometer assessments, and it is less likely to be 
associated with the anxiety of laboratory tests. The test was complementary 
to the ISWT, and did not involve additional resources, except the pre-
recorded cassette tapes. 
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Appendix 1 
EQUIPMENT EVALUATION 
A 1.1 INTRODUCTION 
The laboratory based studies involved the use of a computerised exercise 
testing system. The system (Oxycon Beta, Mijnhardt) had been evaluated by 
a group of workers at the University of Limberg, Holland (Keizer at ai, 
unpublished). The evaluation involved a comparison of measurements with 
the classical Douglas bag method, and an assessment of measurement 
reproducibility over a wide range of expiratory flows including very high rates 
( V E > 180 l.min·'). A copy of the report was made available to our laboratory. 
The study found no significant difference between the Oxycon Beta system 
and the Douglas bag method for V °2, V CO2 and V E with both systems 
connected in series for simultaneous analysis, or when tests were performed 
on separate days. The reproducibility was also found to be acceptable 
(coefficient of variation for maximal V02 < 5%). 
The accuracy, repeatability and quality control of any measurement involves 
the interaction of operator, protocol, equipment and environment. The aim of 
this experiment was to quantify the repeatability of HR, V02 and V E during 
an incremental maximal exercise test. Appendix 2 describes the on-going 
quality control of measurements throughout the study periods. 
A1.2 METHODS 
Six healthy subjects were recruited for the repeatability study (1 man, 5 
women, mean age 29). Signed informed consent was obtained. Each 
subject performed a maximal incremental exercise test on a cycle ergometer 
(Jaeger, ER900) on three separate occasions (mean time between tests 9 
days). The first test was considered a practice test and was excluded from 
analysis. All tests were repeated at the same time of day. Measurements of 
HR, V02 and V E were made at rest and continuously throughout the 
exercise period. The initial workload on the cycle ergometer was 25 watts, 
with increments of 25 watts every 2 minutes until the subject was unable to 
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sustain the correct pedalling rate (40-45 rpm), despite encouragement from 
the operator. 
A1.3 RESULTS 
The characteristics of the subject group are given in table A 1.1. The mean 
maximal workload achieved was 175 watts (range 125 to 250) for both tests. 
The mean oxygen consumption for each workload (25 to 250 watts) during 
both tests is shown in figure A 1.1. There were no significant differences 
between the measurements of V 02ma>.' V Ema>. or HR. The mean values for 
both tests are given in table A1.2. The mean differences between tests and 
the 95% confidence intervals are also shown in table A 1.2. The mean (SE) 
% differences between repeat tests were 2.1 (0.8) % for V 02ma>.' 5.4 (2.9) % 
for V Ema>.' and 0.8 (0.5) % for HRmax" 
The limits of agreement (mean difference ±2SD), which provide an estimate 
of the widest deviation likely to be observed, were "11.7 to 13.5 Lmin" for 
V Emax' and "2.7 to 2.1 ml.min"'.kg"' ("148 to 121 ml.min"') for V02ma>: The range 
of differences about the mean for V02max' and the limits of agreement, are 
illustrated in figure A 1.2. 
A1.4 DISCUSSION 
In comparison to other published data the reapeatability of the exercise 
measurements was good. Jones (1979) carried out repeat steady state 
exercise tests on 9 subjects over 5 consecutive days and reported short term 
variabilities of 3.8%, 3.0% and 8.0% for V °2, HR and V E respectively. In the 
current study the differences between repeat measurements for V 02mOJ( and 
for HRma>. represented less than 3 % of the actual measurements. There was 
slightly more variability for the measurement of V Ema>. were the differences 
between repeat tests represented 5.4 % of the actual measurements. The 
on-going quality control of the system is described in Appendix 2. 
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Table A1.1 
Table A1.2 
Test 1 
Test 2 
Characteristics of subject group (mean{SO» 
Age 
Height (m) 
Weight (kg) 
29 (7.7) 
1.65 (0.05) 
65 (13.8) 
Mean (SO) V02max' V Emax and HR at maximal workload 
for tests 1 and 2, and mean differences (SE) and 95% 
confidence intervals between repeat tests. 
V02max V Emax HR 
(ml.min'l.kg'l) (l.min·l) (beats.min'l) 
38.4 (11.6) 84.8 (22.0) 178 (6.0) 
38.3 (11.1) 85.7 (18.9) 177 (6.6) 
mean difference (SE) 0.27 (0.49) 0.9 (2.6) '1.3 (0.8) 
(95% Cl) ('1.47 - 0.93) ('5.4 - 7.2) ('S.3 - 0.7) 
n=6 
Mean (SO) V02max in l.min'l: Test 1,2.447 (0.812); Test 2, 2.433 (0.798) 
mean difference (SE) V02max in ml.min'l = -14 (27) (95% Cl, '81 - 53) 
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Appendix 2 
QUALITY CONTROL OF THE EXERCISE TEST SYSTEM 
The quality control of the integrated exercise system (Le. tread m ill, heart rate 
and gas analysis) used throughout the study periods consisted of a 
biological control performing repeat exercise tests on a regular basis. One 
subject (SMR) performed 4 x 2 minute increments on the treadmill 
throughout the study periods. Tests were performed on a weekly or two 
weekly basis depending on laboratory activity. Initially 5 tests were 
performed over 5 consecutive days to establish an average baseline. All 
subsequent data was compared to the baseline. The deviations of V02 and 
heart rate values from the baseline were plotted on a graph to enable any 
trends in the equipment analysis to be identified. Figure A2.1 is an example 
of the quality control data obtained during one study period when the gas 
analysis system and treadmill were in regular use. 
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APPENDIX 3 
TREADMILL CALIBRATION 
The speed of the treadmill was checked at the start of a study period and 
periodically throughout. A marker was placed on the treadmill belt and 30 or 
40 belt revolutions were timed over a range of walking speeds. For each set 
speed, the timing of the belt was measured twice and the average 
calculated. The speed of the belt was calculated and compared to the set 
speed. A sample of calibration checks is illustrated in table A3.1 . 
Table A3.1 Treadmill speed calibration 
Date Set Speed Measured Speed % error 
(km.hr1) (km.hr1) 
15/8/95 1.50 1.528 1.9 
2.50 2.531 1.2 
3.50 3.538 1.1 
4.50 4.541 0.9 
5.50 5.542 0.8 
7/12/95 1.50 1.530 2.0 
2.50 2.538 1.5 
3.50 3.538 1.1 
4.50 4.542 0.9 
5.50 5.544 0.8 
26/2/96 1.50 1.530 2.0 
2.50 2.533 1.3 
3.50 3.537 1.1 
4.50 4.542 0.9 
5.50 5.539 0.7 
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Appendix 4 
BLOOD LACTATE ASSAY 
Blood lactate assays were performed using the fluorometric method 
described by Maughan (1982). The reaction depends on the release of 
NADH: 
Lactate 
LDH 
-7 pyruvate 
In the conversion of lactate to pyruvate, catalysed by lactate dehydrogenase 
(LDH), the co-factor NAD+ is reduced to NADH. NADH has a natural 
fluorescence, the intensity of which is an indication of the concentration of 
lactate. The actual values were established by relating each sample to a 
regression equation computed from a series of lactate standards of known 
concentration. 
The process of analysis was as follows: 
Solutions: 
i) 2.5% perchloric acid 
ii) Hydrazine buffer (1.1 mmol.1"1, pH 9.4) 
ii) Fresh reaction mixture: 2 mg NAD+ and 10 1-11 LDH per ml of hydrazine 
buffer. 
iv) Standard lactate solutions for calibration curve (concentrations of 1, 2, 3, 
5 and 8 mmol.1"1 were used throughout). 
Procedure 
1) 20 1-11 blood samples were de-proteinised by adding 200 1-11 of perchloric 
acid. The samples were mixed thoroughly and stored at minus 700e for 
analysis in batches at a later date. 
2) Samples were removed from the freezer and allowed to thaw at room 
temperature. 
3) Samples were broken up with whirlimix and centrifuged for 4 minutes to 
separate the supernatant. 
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4) From each sample (including the standard solutions), in duplicate, 20 I.LI of 
supernatant was pipetted into a series of labelled, clean test tubes. 200fll of 
reaction mixture was then added. 
5) The solutions were mixed and allowed to incubate at room temperature 
for 30 minutes. 
6) The reaction was stopped with 1 ml of lactate diluent (0.07 M Hel), and 
mixed thoroughly. 
7) 1 ml of each sample was transferred to a series of fluorometer tubes. 
8) The samples were read against blanks and the standard solutions using 
fluorometer (Perkin Elmer 1000M). 
9) The lactate concentration was established from the regression equation 
derived from the analysis of the standard solutions. 
Determination of the coefficient of variation for the technique 
Twelve aliquots from one blood sample were analysed and the coefficient of 
variation calculated: 
Fluorometer Reading 
116.5 
118.9 
119.2 
116.6 
118.1 
118.5 
119.8 
121.3 
118.8 
124.8 
114.1 
127.8 
lactate concentration (mmol.t') 
7.01 
7.16 
7.18 
7.01 
7.11 
7.14 
7.22 
7.32 
7.16 
7.55 
6.85 
7.75 
mean (SO) 7.21 (0.24) 
coefficient of variation 3.3% 
254 
Appendix 5 
BORG SCALES 
Scale to rate breathlessness Scale to rate perceived exertion 
0 Nothing at all 6 
0.5 Very, Very Slight 7 Very, Very Light 
(Just Noticeable) 
8 
1 Very Slight 
9 Very Light 
2 Slight 
10 
3 Moderate 
11 Fairly Light 
4 Somewhat Severe 
12 
5 Severe 
13 Somewhat Hard 
6 
14 
7 Very Severe 
15 Hard 
8 
16 
9 Very, Very Severe 
(Almost Maximal) 17 Very Hard 
10 Maximal 18 
19 Very, Very Hard 
20 
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Appendix 6 
PREDICTION EQUATIONS 
Variable Reference 
FVC (1) Quanjer (1993) 
Men 5.76H - 0.026A - 4.34 
Women 4.43H - 0.026A - 2.89 
FEV, (1) Quanjer (1993) 
Men 4.30H - 0.029A - 2.49 
Women 3.95H - 0.025A - 2.60 
Plmax (cm H20) 
Men 143 - 0.55A 
Women 104 - 0.51A 
V02max (ml.min·' .kg·') 
Men 57.8 - 0.445A 
Women 41.2 - 0.343A 
V Emax (l.min·') 
19.7FEV, +21.8 
HRmax (beats.min·') 
220 - A 
(A Age in years; H Height in metres) 
Black (1969) 
Bruce (1973) 
Spire (1975) 
Wasserman (1994) 
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Appendix 7 
THE ENDURANCE SHUTTLE WALK TEST 
Instructions to the operator/patient: 
Before you start the shuttle endurance walking test it is important to check 
that your cassette player and the tape are running at the correct speed. To 
help you with this we have recorded two accurately timed bleeps 60 seconds 
apart. Check the timing now. 
Timed Minute 
The object of the shuttle endurance test is to walk for as long as possible 
around the course keeping to the speed indicated by the bleeps on the 
cassette. You will hear these bleeps at regular intervals. You should walk at 
a steady pace aiming to turn around the cone at one end of the course when 
you hear the first bleep and at the other end when you hear the next bleep. 
For the first two minutes your walking speed will be very slow, but you will 
need to speed up when you hear the triple bleep. You should maintain this 
faster pace for the remainder of the test. Your aim should be to follow the set 
rhythm for as long as you can. You should stop walking only when you 
become too breathless to maintain the required speed, or you can no longer 
keep up the set pace. 
The walking speed for the first two minutes is fairly slow so don't go too fast. 
The test will start in 10 seconds so get ready at the start now. The test starts 
with a triple bleep after a 4 second count-down. 
257 

